0001755672-24-000024 | 10-Q | XBRL Viewer

Print Document

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	INCOME TAXES The effective tax rate for the three and nine months ended September 30, 2024 was 18.0 percent and 23.1 percent, respectively, and 29.1 percent and 17.2 percent for the three and nine months ended September 30, 2023, respectively. During the three and nine months ended September 30, 2024, the company recognized $10 million and $25 million, respectively, of net tax benefits for income taxes on continuing operations associated with changes in deferred taxes and accruals for certain prior year tax positions in various jurisdictions as well as from stock-based compensation. During the three and nine months ended September 30, 2023, the company recognized $11 million and $79 million, respectively, of net tax benefits for income taxes on continuing operations associated with changes in deferred taxes, accruals for certain prior year tax positions in various jurisdictions, stock-based compensation, as well as the impact of changes to deferred taxes associated with a tax currency change for a legal entity. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of the program, which resides in the U.S., is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions, which can drive material impacts on the company's effective tax rate. For further discussion of pre-tax and after-tax impacts of the company's foreign currency hedging program and net monetary asset programs, refer to Note 6 - Supplementary Information, to the interim Consolidated Financial Statements.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//740/tableOfContent

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-14

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-21

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482526/740-270-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-17

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482603/740-30-50-2

+ Details

Stockholders' Equity Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2024

Jun. 30, 2024

Mar. 31, 2024

Sep. 30, 2023

Jun. 30, 2023

Mar. 31, 2023

Sep. 30, 2024

Sep. 30, 2023

Accumulated Other Comprehensive Income (Loss) [Line Items]

Beginning Balance

$ (2,677)

Beginning Balance

$ 25,421

$ 25,008

25,279

$ 26,461

$ 25,839

$ 25,541

25,279

$ 25,541

Amounts Reclassified from Accumulated Other Comprehensive Loss

(46)

Other comprehensive (loss) income

438

(314)

(333)

(324)

(209)

(195)

Ending Balance

24,979

25,421

25,008

25,467

26,461

25,839

24,979

25,467

Ending Balance

(2,886)

(3,001)

(2,886)

(3,001)

Pension Plan

Accumulated Other Comprehensive Income (Loss) [Line Items]

Beginning Balance

(353)

(163)

(353)

(163)

Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax

Amounts Reclassified from Accumulated Other Comprehensive Loss

(1)

Other comprehensive (loss) income

Ending Balance

(352)

(157)

(352)

(157)

Other Benefit Plans

Accumulated Other Comprehensive Income (Loss) [Line Items]

Beginning Balance

189

160

189

160

Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax

Amounts Reclassified from Accumulated Other Comprehensive Loss

(7)

(6)

Other comprehensive (loss) income

(7)

(6)

Ending Balance

182

154

182

154

Cumulative Translation Adjustment

Accumulated Other Comprehensive Income (Loss) [Line Items]

Beginning Balance

(2,458)

(2,883)

(2,458)

(2,883)

Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax

^[1]

(206)

(41)

Amounts Reclassified from Accumulated Other Comprehensive Loss

Other comprehensive (loss) income

(206)

(41)

Ending Balance

(2,664)

(2,924)

(2,664)

(2,924)

Derivative Instruments

Accumulated Other Comprehensive Income (Loss) [Line Items]

Beginning Balance

(55)

Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax

(8)

(114)

Amounts Reclassified from Accumulated Other Comprehensive Loss

(40)

Other comprehensive (loss) income

(154)

Ending Balance

(38)

(74)

(38)

(74)

Unrealized Gain (loss) on Investments

Accumulated Other Comprehensive Income (Loss) [Line Items]

Beginning Balance

Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax

(14)

Amounts Reclassified from Accumulated Other Comprehensive Loss

Other comprehensive (loss) income

(14)

Ending Balance

(14)

Total

Accumulated Other Comprehensive Income (Loss) [Line Items]

Beginning Balance

(2,677)

(2,806)

(2,677)

(2,806)

Beginning Balance

(3,324)

(3,010)

(2,677)

(2,739)

(2,806)

(2,677)

(2,806)

Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax

(226)

(149)

Amounts Reclassified from Accumulated Other Comprehensive Loss

(46)

Other comprehensive (loss) income

438

(314)

(333)

(324)

(209)

(195)

Ending Balance

(2,886)

$ (3,324)

$ (3,010)

(3,001)

$ (2,677)

$ (2,739)

(2,886)

(3,001)

Ending Balance

$ (2,886)

$ (3,001)

$ (2,886)

$ (3,001)

[1]

The cumulative translation adjustment loss for the nine months ended September 30, 2024 was primarily driven by the strengthening of the USD against the Brazilian Real (“BRL”) and Mexican Peso ("MXN"). The cumulative translation adjustment loss for the nine months ended September 30, 2023 was primarily driven by the strengthening of the USD against the South African Rand ("ZAR") and Euro ("EUR"), partially offset by the weakening of the USD against the Brazilian Real (BRL).

Financial Instruments

9 Months Ended

Sep. 30, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Financial Instruments Disclosure [Text Block]

FINANCIAL INSTRUMENTS

At September 30, 2024, December 31, 2023 and September 30, 2023, the company had $1,543 million, $1,746 million and $1,619 million, respectively, of held-to-maturity securities (primarily time deposits and money market funds) classified as cash equivalents in the interim Consolidated Balance Sheets, as these securities had maturities of three months or less at the time of purchase; $56 million, $98 million and $108 million of held-to-maturity securities (primarily time deposits and foreign government bonds) classified as marketable securities in the interim Consolidated Balance Sheets at September 30, 2024, December 31, 2023 and September 30, 2023, respectively, as these securities had maturities of more than three months to less than one year at the time of purchase; and $55 million of held-to-maturity securities (primarily foreign government bonds) classified as marketable securities and included in other assets in the interim Consolidated Balance Sheets at December 31, 2023, as these securities had maturities of more than one year at the time of purchase. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value. Additionally, at September 30, 2024, the company had $16 million and $90 million of available-for-sale securities (primarily foreign government bonds) classified as marketable securities and other assets, respectively, in the interim Consolidated Balance Sheets, as these securities had maturities of more than three months to less than one year and more than one year, respectively, at the time of purchase. The company’s held-to-maturity and available-for-sale securities relating to investments in foreign government bonds at September 30, 2024 are discussed further in the “Debt Securities” section.

Derivative Instruments

Objectives and Strategies for Holding Derivative Instruments

In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.

Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any non-derivatives as hedging instruments.

The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges, and multinational grain exporters. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.

The aggregate notional amounts for the company's derivative instruments (both designated and not designated) was a net buy (sell) position of $1,305 million, $(1,600) million and $2,199 million at September 30, 2024, December 31, 2023 and September 30, 2023, respectively.

Foreign Currency Risk

The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes and to mitigate the exposure of certain investments in foreign subsidiaries against changes in the Euro/USD exchange rate. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments, investments and cash flows.

The company uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, after related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to certain forecasted transactions as well as the translation of foreign currency-denominated earnings. The company also uses commodity contracts to offset risks associated with foreign currency devaluation in certain countries.

Commodity Price Risk

Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as corn and soybeans. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures.

Derivatives Designated as Cash Flow Hedges

Commodity Contracts

The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, forwards, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures.

While each risk management program has a different maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring.

The following table summarizes the after-tax effect of commodity contract cash flow hedges on accumulated other comprehensive income (loss):


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Beginning balance	$	(92)	$	(71)	$	(71)	$	55
Additions and revaluations of derivatives designated as cash flow hedges	25		(20)		(13)		(94)
Clearance of hedge results to earnings	7		2		24		(50)
Ending balance	$	(60)	$	(89)	$	(60)	$	(89)

At September 30, 2024, an after-tax net loss of $70 million is expected to be reclassified from accumulated other comprehensive income (loss) into earnings over the next twelve months.

Foreign Currency Contracts

The company enters into forward contracts to hedge the foreign currency risk associated with forecasted transactions within certain foreign subsidiaries.

While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring.

The following table summarizes the after-tax effect of foreign currency cash flow hedges on accumulated other comprehensive income (loss):


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Beginning balance	$	20	$	(16)	$	1	$	10
Additions and revaluations of derivatives designated as cash flow hedges	—		7		19		(20)
Clearance of hedge results to earnings	1		9		1		10
Ending balance	$	21	$	—	$	21	$	—

At September 30, 2024, an after-tax net gain of $21 million is expected to be reclassified from accumulated other comprehensive income (loss) into earnings over the next twelve months.

Derivatives Designated as Net Investment Hedges

Foreign Currency Contracts

In May 2024, the company designated €500 million of forward contracts to exchange Euro as net investment hedges. An additional tranche of €500 million of forward contracts to exchange Euro were executed in July 2024 and also designated as net investment hedges. The purpose of these forward contracts is to mitigate foreign exchange exposure related to a portion of the company’s Euro net investments in certain foreign subsidiaries against changes in Euro/USD exchange rates. These hedges will

expire and be settled in December 2024. The company had previously designated €1.2 billion and €450 million of forward contracts to exchange Euro as net investment hedges, which expired and were settled in May 2024 and March 2023, respectively.

The company elected to apply the spot method in testing for effectiveness of the hedging relationship.

Derivatives not Designated in Hedging Relationships

Foreign Currency Contracts

The company uses foreign exchange contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to the translation of certain foreign currency-denominated earnings so that gains and losses on the contracts offset changes in the USD value of the related foreign currency-denominated earnings over the relevant aggregate period.

Commodity Contracts

The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn and soybeans. The company uses commodity contracts to offset a portion of the company’s exposure to commodity price fluctuations so that gains and losses on the contracts offset changes in the commodity price over the relevant aggregate period. The company uses forward agreements, with durations less than one year, to buy and sell USD-priced commodities in order to reduce its exposure to currency devaluation for a portion of its local currency cash balances. Counterparties to the forward sales agreements are multinational grain exporters and subject to the company’s financial risk management procedures.

Fair Value of Derivative Instruments

Asset and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the interim Consolidated Balance Sheets. The presentation of the company's derivative assets and liabilities is as follows:


		September 30, 2024
(In millions)	Balance Sheet Location	Gross		Counterparty and Cash Collateral Netting1		Net Amounts Included in the interim Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Commodity contracts	Other current assets	$	2	$	—	$	2

Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	105		(61)		44
Commodity contracts	Other current assets	3		—		3
Total asset derivatives		$	110	$	(61)	$	49

Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	23	$	—	$	23
Commodity contracts	Accrued and other current liabilities	1		—		1
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	64		(61)		3
Commodity contracts	Accrued and other current liabilities	3		—		3
Total liability derivatives		$	91	$	(61)	$	30


		December 31, 2023
(In millions)	Balance Sheet Location	Gross		Counterparty and Cash Collateral Netting1		Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:

Commodity contracts	Other current assets	$	3	$	—	$	3
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	83		(33)		50
Commodity contracts	Other current assets	2		—		2
Total asset derivatives		$	88	$	(33)	$	55

Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	23	$	—	$	23
Commodity contracts	Accrued and other current liabilities	6		—		6
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	38		(33)		5
Commodity contracts	Accrued and other current liabilities	8		—		8
Total liability derivatives		$	75	$	(33)	$	42


		September 30, 2023
(In millions)	Balance Sheet Location	Gross		Counterparty and Cash Collateral Netting1		Net Amounts Included in the interim Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other current assets	$	7	$	—	$	7
Commodity Contracts	Other current assets	1		—		1
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	45		(39)		6

Total asset derivatives		$	53	$	(39)	$	14

Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	7	$	—	$	7
Commodity contracts	Accrued and other current liabilities	3		—		3
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	87		(39)		48
Commodity contracts	Accrued and other current liabilities	3		—		3
Total liability derivatives		$	100	$	(39)	$	61

1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

Effect of Derivative Instruments


	Amount of Gain (Loss) Recognized in OCI - Pre-Tax1
	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Derivatives designated as hedging instruments:
Net investment hedges:
Foreign currency contracts	$	(36)	$	—	$	(19)	$	—
Cash flow hedges:
Foreign currency contracts	1		11		29		(30)
Commodity contracts	34		(26)		(18)		(133)
Total derivatives designated as hedging instruments	$	(1)	$	(15)	$	(8)	$	(163)

1.OCI is defined as other comprehensive income (loss).


	Amount of Gain (Loss) Recognized in Income - Pre-Tax1
	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Derivatives designated as hedging instruments:
Cash flow hedges:
Foreign currency contracts2	$	(2)	$	(13)	$	(3)	$	(15)
Commodity contracts2	(10)		(3)		(35)		65
Total derivatives designated as hedging instruments	$	(12)	$	(16)	$	(38)	$	50
Derivatives not designated as hedging instruments:
Foreign currency contracts3	$	59	$	(3)	$	(32)	$	(65)
Foreign currency contracts2	(6)		4		12		(67)
Commodity contracts2,4	3		1		(41)		4
Commodity contracts3	1		5		(2)		5
Total derivatives not designated as hedging instruments	$	57	$	7	$	(63)	$	(123)
Total derivatives	$	45	$	(9)	$	(101)	$	(73)

1.For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.

2.Recorded in cost of goods sold in the interim Consolidated Statements of Operations.

3.Recognized in other income (expense). Note that net loss from foreign currency contracts was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 - Supplementary Information, to the interim Consolidated Financial Statements, for additional information.

4.The net gain (loss) relating to commodity contracts that are not designated as hedging instruments that were recorded in cost of goods sold, in the interim Consolidated Statements of Operations, are mostly offset by the related net gain (loss) on third-party grower contracts denominated as liabilities.

Debt Securities

The company’s debt securities include foreign government bonds classified as held-to-maturity securities at September 30, 2024, December 31, 2023 and September 30, 2023, and available-for-sale securities at September 30, 2024. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value, and are held by certain foreign subsidiaries in which the USD is the functional currency. The debt securities classified as held-to-maturity at September 30, 2024 with a contractual maturity within one year was $55 million.

The company’s investments in debt securities classified as available-for-sale are recorded at fair value with unrealized gains and losses recorded in accumulated other comprehensive income (loss), within the interim Consolidated Statements of Equity, or current period earnings if an allowance for credit losses has been established, within the interim Consolidated Statements of Operations. The debt securities classified as available-for-sale at September 30, 2024 with a contractual maturity within one year had an amortized cost of $17 million, gross unrealized gains (losses) of $(1) million and a fair value of $16 million. The debt securities classified as available-for-sale at September 30, 2024 with a contractual maturity of one to five years had an amortized cost of $103 million, gross unrealized gains (losses) of $(13) million and a fair value of $90 million.

The estimated fair value of the available-for-sale securities as of September 30, 2024 was determined using Level 2 inputs within the fair value hierarchy. Level 2 measurements were based on the closing price at the end of the period quoted market prices in active markets for identical assets and liabilities.

Revenue Disaggregation of Revenue - Geography (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Sep. 30, 2023

Disaggregation of Revenue [Line Items]

Net Sales

$ 2,326

$ 2,590

$ 12,930

$ 13,519

Seed [Member]

Disaggregation of Revenue [Line Items]

Net Sales

691

878

7,773

7,837

Seed [Member] | North America

Disaggregation of Revenue [Line Items]

Net Sales

^[1]

170

173

5,394

5,192

Seed [Member] | EMEA

Disaggregation of Revenue [Line Items]

Net Sales

^[2]

196

198

1,365

1,441

Seed [Member] | Latin America

Disaggregation of Revenue [Line Items]

Net Sales

218

380

696

847

Seed [Member] | Asia Pacific

Disaggregation of Revenue [Line Items]

Net Sales

107

127

318

357

Crop Protection [Member]

Disaggregation of Revenue [Line Items]

Net Sales

1,635

1,712

5,157

5,682

Crop Protection [Member] | North America

Disaggregation of Revenue [Line Items]

Net Sales

^[1]

440

399

1,703

1,901

Crop Protection [Member] | EMEA

Disaggregation of Revenue [Line Items]

Net Sales

^[2]

219

271

1,311

1,555

Crop Protection [Member] | Latin America

Disaggregation of Revenue [Line Items]

Net Sales

771

844

1,458

1,537

Crop Protection [Member] | Asia Pacific

Disaggregation of Revenue [Line Items]

Net Sales

$ 205

$ 198

$ 685

$ 689

[1]	Represents U.S. & Canada.
[2]	Europe, Middle East and Africa ("EMEA").

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481687/323-10-50-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-28

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-42

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-40

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-41

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1

+ Details

Segment Reporting Segment Reconciliation (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Sep. 30, 2023

Segment Reporting Information [Line Items]

Income (loss) from continuing operations after income taxes

$ (519)

$ (315)

$ 913

$ 1,172

Provision for (benefit from) income taxes on continuing operations

(114)

(129)

274

244

Income from continuing operations before income taxes

(633)

(444)

1,187

1,416

Depreciation and Amortization

925

899

Interest income

153

Interest Expense

173

171

Exchange (gains) losses - net

^[1]

(97)

(102)

(234)

(242)

Segment operating EBITDA

(74)

2,937

3,079

EIDP

Segment Reporting Information [Line Items]

Income (loss) from continuing operations after income taxes

(505)

(317)

942

1,155

Provision for (benefit from) income taxes on continuing operations

(110)

(129)

283

239

Income from continuing operations before income taxes

(615)

(446)

1,225

1,394

Depreciation and Amortization

925

899

Interest Expense

173

193

Segment operating EBITDA

(74)

2,937

3,079

Segment Reconciling Items [Member]

Segment Reporting Information [Line Items]

Depreciation and Amortization

306

925

899

Interest income

(33)

(59)

(93)

(153)

Exchange (gains) losses - net

102

234

242

Nonoperating (benefits) costs

132

115

Mark-to-market (gain) loss on certain foreign currency contracts not designated as hedges

(44)

(4)

Significant Items (benefits) charge

(33)

(71)

(297)

(271)

Corporate Expenses

Segment Reconciling Items [Member] | EIDP

Segment Reporting Information [Line Items]

Depreciation and Amortization

306

925

899

Interest income

(51)

(59)

(131)

(153)

Exchange (gains) losses - net

102

234

242

Nonoperating (benefits) costs

132

115

Mark-to-market (gain) loss on certain foreign currency contracts not designated as hedges

(44)

(4)

Significant Items (benefits) charge

297

271

Corporate Expenses

$ 26

$ 28

$ 86

$ 84

[1]

Includes net pre-tax exchange gains (losses) of $(26) million and $(54) million associated with impacts from the devaluation of the Argentine Peso for the three and nine months ended September 30, 2024, respectively, and $(83) million and $(150) million for the three and nine months ended September 30, 2023, respectively.

Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)

Sep. 30, 2024

Dec. 31, 2023

Sep. 30, 2023

Sep. 01, 2023

Dec. 31, 2022

Restricted Cash and Cash Equivalents Items [Line Items]

Cash and cash equivalents

$ 2,421,000,000

$ 2,644,000,000

$ 2,254,000,000

Restricted Cash

335,000,000

514,000,000

522,000,000

$ 1.185

Total Cash, Cash Equivalents and Restricted Cash Equivalents

$ 2,756,000,000

^[1]

$ 3,158,000,000

$ 2,776,000,000

^[1]

$ 3,618,000,000

[1]	See page 15 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in interim Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows.

Commitments and Contingent Liabilities Corteva Separation (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Accounts and Notes Receivable [Member]
Loss Contingencies [Line Items]
Indemnification Assets	$ 36,000,000	$ 44,000,000	$ 36,000,000
Other Assets [Member]
Loss Contingencies [Line Items]
Indemnification Assets	129,000,000	104,000,000	126,000,000
Accrued and Other Current Liabilities [Member]
Loss Contingencies [Line Items]
Indemnified Liabilities	19,000,000	30,000,000	38,000,000
Other noncurrent obligations
Loss Contingencies [Line Items]
Indemnified Liabilities	141,000,000	$ 106,000,000	$ 108,000,000
PFAS [Member] \| Minimum [Member]
Loss Contingencies [Line Items]
De minimis threshold	1,000,000
Corteva and DuPont stray liability threshold for PFAS	1
Corteva [Member]
Loss Contingencies [Line Items]
Stray liability threshold	$ 200,000,000
Stray liability sharing percentage	29.00%
Corteva [Member] \| PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50.00%
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	71.00%
Corteva and DuPont stray liability threshold for PFAS	$ 200,000,000
DuPont de Nemours [Member] \| PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50.00%
DuPont de Nemours [Member] \| DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability threshold	$ 200,000,000

Consolidated Statements of Cash Flows - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2024

Mar. 31, 2024

Sep. 30, 2023

Mar. 31, 2023

Sep. 30, 2024

Sep. 30, 2023

Dec. 31, 2023

Net income

$ (521)

$ 423

$ (318)

$ 599

$ 958

$ 998

Income (loss) from discontinued operations after income taxes

(45)

174

Depreciation and Amortization

925

899

Provision for (benefit from) deferred income tax

(422)

(268)

Net Periodic Pension and OPEB (credits) costs, net

121

105

Pension and OPEB Contributions

(123)

Net (gain) loss on sales of property, businesses, consolidated companies, and investments

(17)

(12)

Restructuring Charges

199

Other net loss

377

342

Accounts and notes receivable

(1,450)

(773)

Inventories

1,060

492

Accounts Payable

(518)

(1,218)

Deferred Revenue

(2,974)

(2,840)

Other Assets and Liabilities

(38)

445

Net Cash Provided by (Used in) Operating Activities, Continuing Operations

(1,871)

(2,574)

Cash Provided by (Used in) Operating Activities, Discontinued Operations

(157)

(30)

Net Cash Provided by (Used in) Operating Activities

(2,028)

(2,604)

Capital expenditures

(416)

(412)

Proceeds from sales of property, businesses, and consolidated companies - net of cash divested

Payments to Acquire Businesses, Net of Cash Acquired

(1,456)

Purchases of investments

(137)

(83)

Proceeds from Sale and Maturities of Investments

115

127

Proceeds from Hedge, Investing Activities

Other investing activities - net

(38)

(2)

Cash provided by (used for) investing activities

(466)

(1,773)

Net change in borrowings (less than 90 days)

1,715

2,419

Proceeds from debt

3,047

3,427

Payments on Debt

(1,529)

(1,314)

Repurchase of Common Stock

(757)

(585)

Proceeds from Exercise of Stock Options

Dividends paid to stockholders

(340)

(327)

Other financing activities

(29)

(45)

Cash provided by (used for) financing activities

2,137

3,603

Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash

(45)

(68)

Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash

(402)

(842)

Cash, Cash Equivalents and Restricted Cash at Beginning of Period

3,158

3,618

3,158

3,618

$ 3,618

Cash, Cash Equivalents and Restricted Cash at End of Period

2,756

^[1]

2,776

^[1]

2,756

^[1]

2,776

^[1]

3,158

Investments in and loans to nonconsolidated affiliates

(7)

(31)

EIDP

Net income

(507)

428

(320)

589

987

981

Income (loss) from discontinued operations after income taxes

(45)

174

Depreciation and Amortization

925

899

Provision for (benefit from) deferred income tax

(422)

(268)

Net Periodic Pension and OPEB (credits) costs, net

121

105

Pension and OPEB Contributions

(123)

Net (gain) loss on sales of property, businesses, consolidated companies, and investments

(17)

(12)

Restructuring Charges

199

Other net loss

377

342

Accounts and notes receivable

(1,450)

(773)

Inventories

1,060

492

Accounts Payable

(518)

(1,218)

Deferred Revenue

(2,974)

(2,840)

Other Assets and Liabilities

1,097

(439)

Net Cash Provided by (Used in) Operating Activities, Continuing Operations

(2,977)

(2,585)

Cash Provided by (Used in) Operating Activities, Discontinued Operations

(157)

(30)

Net Cash Provided by (Used in) Operating Activities

(3,134)

(2,615)

Capital expenditures

(416)

(412)

Proceeds from sales of property, businesses, and consolidated companies - net of cash divested

Payments to Acquire Businesses, Net of Cash Acquired

(1,456)

Purchases of investments

(137)

(83)

Proceeds from Sale and Maturities of Investments

115

127

Proceeds from Hedge, Investing Activities

Other investing activities - net

(38)

(2)

Cash provided by (used for) investing activities

(466)

(1,773)

Net change in borrowings (less than 90 days)

1,715

2,419

Repayments of Related Party Debt

(924)

Proceeds from debt

3,047

3,427

Payments on Debt

(1,529)

(1,314)

Proceeds from Exercise of Stock Options

Other financing activities

(20)

(51)

Cash provided by (used for) financing activities

3,243

3,614

Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash

(45)

(68)

Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash

(402)

(842)

Cash, Cash Equivalents and Restricted Cash at Beginning of Period

$ 3,158

$ 3,618

3,158

3,618

Cash, Cash Equivalents and Restricted Cash at End of Period

$ 2,756

$ 2,776

2,756

2,776

$ 3,158

Investments in and loans to nonconsolidated affiliates

(7)

(31)

Proceeds from Related Party Debt

$ 0

$ 29

[1]	See page 15 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in interim Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows.

Commitments and Contingent Liabilities

9 Months Ended

Sep. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

COMMITMENTS AND CONTINGENT LIABILITIES

Guarantees

Indemnifications

In connection with acquisitions and divestitures, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transactions. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited. See below for additional information relating to the indemnification obligations under the Chemours Separation Agreement and the Corteva Separation Agreement.

Obligations for Supplier Finance Programs

The company enters into supplier finance programs with various finance providers in which the company agrees to pay these finance providers the stated amount of confirmed invoices from participating suppliers by the original maturity date. The company or the financial provider may terminate the agreement upon providing at least thirty days’ written notice. The payment terms that the company has with its finance providers under supplier finance programs are less than one year. At September 30, 2024, December 31, 2023 and September 30, 2023, the outstanding obligations under supplier finance programs was $124 million, $115 million and $115 million, respectively, and included within accounts payable in the interim Consolidated Balance Sheets.

The rollforward of the company’s outstanding obligations confirmed as valid under its supplier finance programs for the period ended September 30, 2024 is as follows:


(In millions)
Confirmed obligations outstanding at December 31, 2023	$	115
Invoices confirmed during the year	460
Confirmed invoices paid during the year	(451)
Confirmed obligations outstanding at September 30, 2024	$	124

Obligations for Customers and Other Third Parties

The company has directly guaranteed various debt obligations under agreements with third parties related to customers and other third parties. At September 30, 2024, December 31, 2023 and September 30, 2023, the company had directly guaranteed $75 million, $84 million and $73 million, respectively, of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the company could be required to make under the guarantees in the event of default by the guaranteed party. Of the maximum future payments at September 30, 2024, approximately $15 million had terms greater than one year. The maximum future payments include $4 million, $2 million and $4 million at September 30, 2024, December 31, 2023 and September 30, 2023, respectively, of guarantees related to the various factoring agreements into which the company enters with third-party financial institutions to sell its trade receivables. See Note 9 - Accounts and Notes Receivable - Net, to the interim Consolidated Financial Statements, for additional information.

The maximum future payments also include agreements with lenders to establish programs that provide financing for select customers. The terms of the guarantees are equivalent to the terms of the customer loans that are primarily made to finance customer invoices. The total amounts owed from customers to the lenders relating to these agreements was $598 million, $187 million and $492 million at September 30, 2024, December 31, 2023 and September 30, 2023, respectively.

The company assesses the payment/performance risk by assigning default rates based on the duration of the guarantees. These default rates are assigned based on the external credit rating of the counterparty or through internal credit analysis and historical default history for counterparties that do not have published credit ratings. For counterparties without an external rating or available credit history, a cumulative average default rate is used.

Indemnifications under Separation Agreements

The company has entered into various agreements where the company is indemnified for certain liabilities. The term of this indemnification is generally indefinite, with exceptions, and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable.

Chemours Separation Agreement (Performance Chemicals)

Pursuant to the Chemours Separation Agreement resulting from the 2015 spin-off of the Performance Chemicals segment from Historical DuPont, Chemours indemnifies the company against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the distribution.

In 2017, the Chemours Separation Agreement was amended to provide for a limited sharing of potential future liabilities related to alleged historical releases of perfluorooctanoic acids and its ammonium salts (“PFOA”) for a five-year period that began on July 6, 2017. In addition, in 2017, Chemours and EIDP settled multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”), resolving claims of about 3,550 plaintiffs alleging injury from exposure to PFOA in drinking water as a result of the historical manufacture or use of PFOA at the Washington Works plant outside Parkersburg, West Virginia. This plant was previously owned and/or operated by the Performance Chemicals segment of EIDP and is now owned and/or operated by Chemours.

On May 13, 2019, Chemours filed suit in the Delaware Court of Chancery against DuPont, EIDP, and Corteva, seeking, among other things, to limit its responsibility for the litigation and environmental liabilities allocated to and assumed by Chemours under the Chemours Separation Agreement (the “Delaware Litigation”). On March 30, 2020, the Court of Chancery granted a motion to dismiss. On December 15, 2020, the Delaware Supreme Court affirmed the judgment of the Court of Chancery. Meanwhile, a confidential arbitration process regarding the same and other claims proceeded (the “Arbitration”).

On January 22, 2021, Chemours, DuPont, Corteva and EIDP entered into a binding memorandum of understanding containing a settlement to resolve legal disputes originating from the Delaware Litigation and Arbitration, and to establish a cost sharing arrangement and escrow account to be used to support and manage potential future legacy per- and polyfluoroalkyl substances (“PFAS”) liabilities arising out of pre-July 1, 2015 conduct (the “MOU”). The MOU replaced the 2017 amendment to the Chemours Separation Agreement. According to the terms of the cost sharing arrangement within the MOU, Corteva and DuPont together, on one hand, and Chemours, on the other hand, agreed to a 50-50 split of certain qualified expenses related to PFAS liabilities incurred over a term not to exceed twenty years or $4 billion of qualified spend and escrow account contributions (see below for discussion of the escrow account) in the aggregate. DuPont’s and Corteva’s 50% share under the MOU will be limited to $2 billion, including qualified expenses and escrow account contributions. These expenses and escrow account contributions will be subject to the existing Letter Agreement, under which DuPont and Corteva will each bear 50% of the first $300 million (up to $150 million each), and thereafter DuPont bears 71% and Corteva bears the remaining 29%. Under the terms of the MOU, Corteva’s estimated aggregate share of the potential $2 billion is approximately $600 million.

In order to support and manage any potential future PFAS liabilities, the parties also agreed to establish an escrow account (“MOU Escrow Account”). The MOU provides that (1) no later than each of September 30, 2021 and September 30, 2022, Chemours shall deposit $100 million into an escrow account and DuPont and Corteva shall together deposit $100 million in the aggregate into an escrow account and (2) no later than September 30 of each subsequent year through and including 2028, Chemours shall deposit $50 million into an escrow account and DuPont and Corteva shall together deposit $50 million in the aggregate into an escrow account. Subject to the terms and conditions set forth in the MOU, each party may be permitted to defer funding in any year (excluding 2021). Over this period, Chemours will deposit a total of $500 million in the account and DuPont and Corteva will deposit an additional $500 million pursuant to the terms of the Letter Agreement. Additionally, if on December 31, 2028, the balance of the escrow account (including interest) is less than $700 million, Chemours will make 50% of the deposits and DuPont and Corteva together will make 50% of the deposits necessary to restore the balance of the escrow account to $700 million, pursuant to the terms of the Letter Agreement. Such payments will be made in a series of consecutive annual equal installments commencing on September 30, 2029, pursuant to the escrow account replenishment terms as set forth in the MOU. The MOU provides that no withdrawals from the MOU Escrow Account can be made before year six, except to fund mutually agreed upon third-party settlements in excess of $125 million. Starting with year six, withdrawals can only be made to fund qualified spend if the parties’ aggregate qualified spend in that particular year is greater than $200 million. Beginning with year 11, the amounts in the MOU Escrow Account can be used to fund any qualified spend. The company made its annual installment deposits due to the MOU Escrow Account through September 30, 2024.

In April 2024, Corteva, EIDP, DuPont, and Chemours received a final judgment resolving all drinking water claims related to PFAS of a defined class of U.S. public water systems that serve the vast majority of the United States population (the “Nationwide Water District Settlement”). In connection with the Nationwide Water District Settlement, the MOU was supplemented to waive funding due to the MOU Escrow Account by Chemours, DuPont and Corteva for 2023 provided that each party fully funds its portion of the Nationwide Water District Settlement and said settlement is consummated. The funding obligation to the MOU Escrow Account with respect to 2024 and due September 30, 2024 was to be waived if (i) between October 1, 2023 and September 30, 2024, the parties had entered into settlement agreements resolving liabilities under the MOU that in the aggregate exceed $100 million; (ii) each company had fully funded its respective share, in accordance with the MOU, of such settlements; and (iii) such settlements were consummated. No such waiver was triggered for the 2024 escrow funding obligation due September 30, 2024 and, therefore, the company made its required contribution.

After the term of this arrangement, Chemours’ indemnification obligations under the original 2015 Chemours Separation Agreement, would continue unchanged, subject in each case to certain exceptions set out in the MOU. Under the MOU, Chemours waived specified claims regarding the construct of its 2015 spin-off transaction, and the parties dismissed the pending arbitration regarding those claims. Additionally, the parties have agreed to resolve the Ohio MDL PFOA personal injury litigation (as discussed below). The parties are expected to cooperate in good faith to enter into additional agreements reflecting the terms set forth in the MOU.

Corteva Separation Agreement

On April 1, 2019, in connection with the Dow Distribution, Corteva, DuPont and Dow entered into the Corteva Separation Agreement, the Tax Matters Agreement ("TMA"), the Employee Matters Agreement, and certain other agreements (collectively, the “Corteva Separation Agreements”). The Corteva Separation Agreements allocate among Corteva, DuPont and Dow assets, employees, certain liabilities and obligations (including its investments, property and employee benefits and tax-related assets and liabilities) and provides for indemnification obligation among the parties. Under the Corteva Separation Agreement, DuPont indemnifies Corteva against certain litigation, environmental, tax, workers' compensation and other liabilities that arose prior to the Corteva Distribution, Dow indemnifies Corteva against certain litigation, environmental, tax, workers' compensation and other liabilities that relate to the Historical Dow business, and Corteva indemnifies DuPont and Dow for certain liabilities.

Indemnification matters under the Corteva Separation Agreements contain dispute resolution clauses. Corteva and DuPont are pursuing a resolution of a matter under the terms of the TMA. The company believes its interpretation of the TMA is correct, but it is reasonably possible that the required third party assessment may differ from our interpretation, which could have a significant impact to the current carrying value of our indemnification liability. Under the terms of the TMA, the dispute resolution process is expected to be concluded in the first half of 2025.

Under the Corteva Separation Agreements, certain legacy EIDP liabilities from discontinued and/or divested operations and businesses of EIDP (including Performance Chemicals) (a “stray liability”) were allocated to Corteva or DuPont. For those stray liabilities allocated to Corteva and DuPont (which may include a specified amount of liability associated with that liability), Corteva and DuPont are responsible for liabilities in an amount up to that specified amount plus an additional $200 million each. Once each company has met the $200 million threshold, Corteva and DuPont will share future liabilities

proportionally on the basis of 29% and 71%, respectively; provided, however, that for PFAS, DuPont managed such liabilities with Corteva and DuPont sharing the costs on a 50% - 50% basis starting from $1 and up to $300 million (with such amount, up to $150 million, to be credited to each company’s $200 million threshold) and once the $300 million threshold was met, the companies share proportionally on the basis of 29% and 71% respectively, subject to a $1 million de minimis requirement. The aggregate amount of cash remitted by Corteva has exceeded the stray liability thresholds, including PFAS, noted above.

At September 30, 2024, December 31, 2023 and September 30, 2023, the indemnification assets were $36 million, $44 million and $36 million, respectively, within accounts and notes receivable - net and $129 million, $104 million and $126 million, respectively, within other assets in the interim Consolidated Balance Sheets. At September 30, 2024, December 31, 2023 and September 30, 2023, the indemnification liabilities were $19 million, $30 million and $38 million, respectively, within accrued and other current liabilities and $141 million, $106 million and $108 million, respectively, within other noncurrent obligations in the interim Consolidated Balance Sheets.

Discontinued Operations Activity

The company recorded benefits (charges) of $(2) million and $45 million for the three and nine months ended September 30, 2024, respectively, and $(3) million and $(174) million, respectively, for the three and nine months ended September 30, 2023 to income (loss) from discontinued operations after income taxes, in the interim Consolidated Statements of Operations. The after-tax charge for the three months ended September 30, 2024 was primarily driven by litigation-related activity. The after-tax benefits recognized during the nine months ended September 30, 2024 was driven by charges recognized relating to the MOU with Chemours and DuPont relating to PFAS environmental remediation activities primarily at Chemours' Fayetteville Works facility and litigation-related activity, more than offset by a favorable adjustment of certain prior year tax positions for previously divested businesses and the derecognition of an indemnification liability associated with the Water District Settlement Fund contribution. The after-tax charges recognized during the three and nine months ended September 30, 2023 primarily related to the settlement of certain legacy PFAS related legal matters that are subject to the MOU, including the Nationwide Water District Settlement.

Litigation

The company is subject to various legal proceedings, including, but not limited to, product liability, intellectual property, antitrust, commercial, property damage, personal injury, environmental and regulatory matters arising out of the normal course of its current businesses or legacy EIDP businesses unrelated to Corteva’s current businesses but allocated to Corteva as part of the separation of Corteva from DuPont. It is not possible to predict the outcome of these various proceedings, as considerable uncertainty exists. The company records accruals for legal matters when the information available indicates that it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Accruals may reflect the impact and status of negotiations, settlements, rulings, advice from counsel and other information and events that may pertain to a particular matter. For the litigation matters discussed below, management believes that it is reasonably possible that the company could incur liabilities in excess of amounts accrued, for which the ultimate liability could be material to the results of operations and the cash flows in the period recognized. However, the company is unable to estimate the possible loss beyond amounts accrued due to various reasons, including, among others, that the underlying matters are either in early stages and/or have significant factual issues to be resolved. In addition, even when the company believes it has substantial defenses, the company may consider settlement of matters if it believes it is in the best interest of the company.

Lorsban® Lawsuits

As of September 30, 2024, there were pending personal injury lawsuits filed and additional asserted claims against the former Dow Agrosciences LLC, alleging injuries related to chlorpyrifos exposure, the active ingredient in Lorsban®, an insecticide used by commercial farms for field fruit, nut and vegetable crops. Corteva ended its production of Lorsban® in 2020. Chlorpyrifos products are restricted-use pesticides, which are not available for purchase or use by the general public, and may only be sold to, and used by, certified applicators or someone under the certified applicator's direct supervision. These lawsuits do not relate to Dursban®, a residential type chlorpyrifos product that was authorized for indoor purposes, which was discontinued over two decades ago prior to the Merger and Corteva’s formation and Separation. Claimants allege personal injury, including autism, developmental delays and/or decreased neurologic function, resulting from farm worker exposure and bystander drift and in utero exposure to chlorpyrifos. Certain claimants have also put forth remediation claims due to alleged property contamination from chlorpyrifos. As of September 30, 2024, an accrual has been established for the estimated resolution of certain claims.

Federal Trade Commission Investigation

On May 26, 2020, Corteva received a subpoena from the Federal Trade Commission (“FTC”) directing it to submit documents pertaining to its Crop Protection products generally, as well as business plans, rebate programs, offers, pricing and marketing materials specifically related to its acetochlor, oxamyl, rimsulfuron and other related products in order to determine whether

Corteva engaged in unfair methods of competition through anticompetitive conduct. Corteva has fully cooperated with all requests related to this subpoena. On September 29, 2022, the FTC, along with ten state attorneys general in California, Colorado, Illinois, Indiana, Iowa, Minnesota, Nebraska, Oregon, Wisconsin, and Texas, filed a lawsuit against Corteva and another competitor alleging the parties engaged in unfair methods of competition, unlawful conditioning of payments, unreasonably restrained trade, and have an unlawful monopoly (the “FTC lawsuit”). In December 2022, attorneys general in Tennessee and Washington joined the FTC lawsuit and the Arkansas state attorney general filed a separate lawsuit against Corteva and another competitor based on the allegations set forth in the FTC lawsuit. Several proposed private class action lawsuits were also filed in federal court alleging anticompetitive conduct based on the allegations set forth in the FTC lawsuit.

Virtually all of these private lawsuits were centralized into a multi-district litigation in the U.S. District Court for the Middle District of North Carolina. Corteva expects to continue a meritorious defense of its business practices.

Bayer Dispute

In August 2022, Bayer filed a breach of contract/declaratory judgment lawsuit in Delaware state court against Corteva relating to an agrobacterium cross-license agreement and E3® soybeans. Bayer alleges that Corteva practiced two Bayer patents in developing E3® soybeans, and therefore, is entitled to royalties pursuant to the terms of the cross-license agreement. In April 2023, Corteva's motion to dismiss the complaint on the basis that, under the terms of the cross-license agreement and the law, E3® soybeans cannot infringe expired patents was denied. At that time the court also denied Bayer’s motion to dismiss our invalidity counterclaim. Recently Corteva asserted a counterclaim against Bayer for inequitable conduct during the patent prosecution process, which Bayer has moved to dismiss. A ruling on the patent claims construction is expected by the end of 2024 and the trial date is currently scheduled for June 2025.

Litigation related to legacy EIDP businesses unrelated to Corteva’s current businesses

For purposes of this report, the term PFOA means collectively perfluorooctanoic acid and its salts, including the ammonium salt and does not distinguish between the two forms, and PFAS, including PFOA, PFOS (perfluorooctanesulfonic acid), GenX and other perfluorinated chemicals and compounds ("PFCs").

EIDP is a party to various legal proceedings relating to the use of PFOA by its former Performance Chemicals segment for which potential liabilities would be subject to the cost sharing arrangement under the MOU as long as it remains effective.

Leach Settlement and Ohio MDL Settlement

EIDP has residual liabilities under its 2004 settlement of a West Virginia state court class action, Leach v. EIDP, which alleged that PFOA from EIDP’s former Washington Works facility had contaminated area drinking water supplies and affected the health of area residents. The settlement class has about 80,000 members. In addition to relief that was provided to class members years ago, the settlement requires EIDP to continue providing PFOA water treatment to six area water districts and private well users and to fund, through an escrow account, up to $235 million for a medical monitoring program for eligible class members. As of September 30, 2024, approximately $2 million had been disbursed from the account since its establishment in 2012 and the remaining balance is approximately $1 million.

The Leach settlement permits class members to pursue personal injury claims for six health conditions (and no others) that an expert panel appointed under the settlement reported in 2012 had a “probable link” (as defined in the settlement) with PFOA: pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol. After the panel reported its findings, approximately 3,550 personal injury lawsuits were filed in federal and state courts in Ohio and West Virginia and consolidated in multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”). The Ohio MDL was settled in early 2017 for approximately $670 million in cash, with Chemours and EIDP (without indemnification from Chemours) each paying half.

Post-MDL Settlement PFOA Personal Injury Claims

The 2017 Ohio MDL settlement did not resolve claims of plaintiffs who did not have claims in the Ohio MDL or whose claims are based on diseases first diagnosed after February 11, 2017.

In January 2021, Chemours, DuPont and Corteva agreed to settle approximately 95 filed and unfiled matters remaining in the Ohio MDL for $83 million, with Chemours contributing $29 million to the settlement, and DuPont and Corteva contributing $27 million each. The company paid $27 million during the year ended December 31, 2021. The defendants have reached a tentative settlement of all of the currently filed and unfiled personal injury cases in the Ohio MDL contingent upon the court dissolving the MDL. As of September 30, 2024, an accrual has been established for the estimated resolution of these claims.

Other PFOA Matters

EIDP is a party to other PFOA lawsuits involving claims for property damage, medical monitoring and personal injury. Defense costs and any future liabilities that may arise out of these lawsuits are subject to the MOU and the cost sharing arrangement disclosed above. Under the MOU, fraudulent conveyance claims associated with these matters are not qualified expenses, unless Corteva, Inc. and EIDP would prevail on the merits of these claims.

EIDP did not make any film-forming foams, PFOS, or PFOS products. While EIDP made surfactants and intermediaries that some manufacturers used in making foams, which may have contained PFOA as an unintended byproduct or an impurity, EIDP’s products were not formulated with PFOA, nor was PFOA an ingredient of these products. EIDP has never made or sold PFOA as a commercial product.

In April 2024, the U.S. Environmental Protection Agency ("EPA") announced that it established a maximum contaminant level in drinking water for certain PFOA, including four parts per trillion for PFOA and PFOS, individually, and ten parts per trillion for Dimer Acid (“GenX”). In April 2024, the EPA also designated PFOA and PFAS as hazardous substances under the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”).

Aqueous Film-Forming Foams. Approximately 4,500 cases remain filed against 3M and other defendants, including EIDP and Chemours, and some including Corteva and DuPont, alleging personal injury (primarily prostate, kidney, and testicular cancer) from the use of aqueous film-forming foams (“AFFF”) and consolidated in a multi-district litigation proceeding in federal district court in South Carolina (“SC MDL”). Most of these recent cases also assert claims that the EIDP and Chemours separation constituted a fraudulent conveyance. The SC MDL ordered the dismissal of plaintiff claims by September 10, 2024, without prejudice, if such plaintiff could not produce peer reviewed science and expert reports supporting PFAS as both the general and specific causation of their personal injury. The trial for the first potential bellwether personal injury cases are expected to begin in October 2025. Additionally, in December 2023, a class action was filed in Canada against 3M and other defendants, including EIDP and Chemours, alleging PFOS and PFOA environmental contamination and personal injury from use of AFFF.

Nationwide Water District Settlement. In April 2024, Corteva, EIDP, DuPont, and Chemours (collectively, the “settling companies”) comprehensively resolved all drinking water claims related to PFAS of a defined class of U.S. public water systems that serve the vast majority of the United States population, including, but not limited to the AFFF claims in the SC MDL, under the Nationwide Water District Settlement. PFAS, as defined in the settlement, includes PFOA and HFPO-DA, among a broad range of fluorinated organic substances. The Nationwide Water District Settlement was entered into solely by way of compromise and settlement and is not in any way an admission of liability or fault by Corteva or EIDP.

The class represented by the Nationwide Water District Settlement is composed of all Public Water Systems, as defined in 42 U.S.C. § 300f, with a current detection of PFAS or that are currently required to monitor for PFAS under the Environmental Protection Agency’s Fifth Unregulated Contaminant Monitoring Rule (“UCMR 5”) or other applicable federal or state law (the “Class”). Approximately 88 percent of the U.S. is served by systems required to test under UCMR 5. The Class does not include water systems owned and operated by a State or the United States government; small systems that have not detected the presence of PFAS and are not currently required to monitor for it under federal or state requirements; and, unless they otherwise request to be included, water systems in the lower Cape Fear River Basin of North Carolina. The total number of requests for exclusion (“opt-outs”) was approximately 900 water districts, while most public water districts (approximately 93 percent of the Class) remain in the class settlement.

New Jersey. In late March 2019, the New Jersey State Attorney General filed four lawsuits against EIDP, Chemours, and others alleging that operations at and discharges from former EIDP sites in New Jersey (Chambers Works, Pompton Lakes, Parlin and Repauno) damaged the State’s natural resources. Two of these lawsuits (those involving the Chambers Works and Parlin sites) allege contamination from PFAS. DuPont and Corteva were subsequently added as defendants to these lawsuits. These lawsuits include claims under the New Jersey Industrial Site Recovery Act (“ISRA”) and for fraudulent conveyance. These cases are proceeding to trial with the Chambers Works site case expected to begin in June 2025.

EIDP and Chemours are also defendants in two lawsuits by a private water utility provider in New Jersey and New York alleging damages from PFAS releases into the environment, that impacted water sources that the utilities use to provide water, as well as product liability, negligence, nuisance, and trespass claims. The court dismissed the New York plaintiff's trespass claims and limited plaintiffs’ nuisance claims to abatement damages.

Ohio. EIDP is a defendant in two lawsuits, including an action by the State of Ohio based on alleged damage to natural resources. The natural resources damage claim was settled in December 2023 for $110 million and received final approval

under Ohio's judicial consent order process. Pending any permitted appeals, Corteva’s share of the settlement under the MOU will be approximately $16 million. The second, a putative nationwide class action ("the Hardwick Class Action") brought on behalf of anyone who has detectable levels of PFAS in their blood serum seeks declaratory and injunctive relief, including the establishment of a “PFAS Science Panel”. In December 2023, the Sixth Circuit Court of Appeals dismissed the Hardwick Class Action due to lack of standing by Mr. Hardwick. With further opportunities for appeals expired, the plaintiffs filed a new case, narrowing their original claims, in June 2024.

New York. EIDP is a defendant in a putative class action (the "Baker Class Action"), brought by persons who live in and around Hoosick Falls, New York asserting claims for medical monitoring and property damage based on alleged PFOA releases from manufacturing facilities owned and operated by co-defendants in Hoosick Falls. The lawsuits allege that EIDP and others supplied materials used at these facilities resulting in PFOA air and water contamination. A court approved settlement was reached between the plaintiffs and the other co-defendants regarding the Baker Class Action case. In September 2022, the class certification of the Baker Class Action was granted, with the court certifying three separate classes consisting of a private well property damage class, a medical monitoring class and a nuisance class. EIDP will challenge the certification and continue to defend itself on the merits of the case, while seeking an out of court resolution.

EIDP is a defendant in a lawsuit brought by the Town of East Hampton, New York alleging PFOA and PFOS contamination of the town’s water wells. This district submitted a timely op-out request from the Nationwide Water District Settlement.

Other Natural Resource Damage Cases. In addition to the natural resource damage cases in New Jersey and New York, natural resource damage filed lawsuits against EIDP, Chemours, and others, claiming, among other things, PFC (including PFOA) contamination of groundwater and drinking water, have been filed in 31 other states, the District of Columbia and three U.S. territories. Certain cases also name DuPont and Corteva as defendants and include claims of fraudulent conveyance. The complaints seek reimbursement for past and future costs to investigate and remediate the alleged contamination and compensation for the loss of value and use of the state’s natural resources. Due to overlapping AFFF allegations, virtually all of these cases have been transferred, or are pending transfer to the SC MDL. These cases are largely in the discovery phase. While the recent mediation of the natural resource case in North Carolina and New Jersey concluded without resolution, discussions continue between the parties to seek a resolution.

On July 13, 2021, Chemours, DuPont, EIDP and Corteva entered into a settlement agreement with the State of Delaware reflecting the companies' and the State's agreement to settle and fully resolve claims alleged against the companies regarding their historical Delaware operations, manufacturing, use and disposal of all chemical compounds, including PFAS. Under the settlement, if the companies, individually or jointly, within 8 years of the settlement, enter into a proportionally similar agreement to settle or resolve claims of another state for PFAS-related natural resource damages, for an amount greater than $50 million, the companies shall make a supplemental payment directly to the Natural Resources and Sustainability Trust (the “NRS Trust”) in an amount equal to such other states’ recovery in excess of $50 million ("Supplemental Payment"). Supplemental Payment(s), if any, will not exceed $25 million in the aggregate. All amounts paid by the companies under the settlement are subject to the MOU and the Corteva Separation Agreement. Due to the settlement of natural resource damages claims with the State of Ohio, the one-time Supplemental Payment will be triggered when further opportunities for appeals expires under the Ohio judicial consent order process, with Corteva’s share under the MOU being approximately $4 million. Under the settlement, if the state sues other parties and those parties seek contribution from the companies, the companies will have protection from contribution up to the amounts previously paid under the settlement agreement. The companies will also receive a credit up to the amount of the payment if the state seeks natural resource damage claims against the companies outside the scope of the settlement’s release of claims.

Canada. The Province of British Columbia, filed a class action against various defendants, including 3M, DuPont Canada, EIDP, and Chemours alleging harms caused by PFAS/AFFF. The class consists of all municipalities, regional districts, and other governance authorities and other persons in Canada that were responsible for a “Drinking Water System” from 1970 to the present. The plaintiff seeks to recover costs for the treatment and restoration of natural resources, as well as property, economic, and punitive damages. A putative class action was also filed in July 2024 on behalf of citizens of Quebec, Canada seeking class certification to recover for alleged PFAS and AFFF contamination of private wells and public water treatment facilities.

Netherlands. In April 2021, four municipalities in the Netherlands filed complaints alleging contamination of land and groundwater resulting from the emission of PFOA and GenX by Corteva, DuPont and Chemours. The municipalities seek to recover costs incurred due to the alleged emissions, including damages for investigation costs, construction project delays, depreciation of land, soil remediation, liabilities to contractors, and attorneys’ fees. In September 2023, the court entered a second interlocutory judgment, ruling, inter alia, that defendants were liable to the municipalities for PFOA emissions during a certain time period, and the removal costs of deposited emissions on the municipalities land infringes their property rights by an

objective standard. While the parties continue to seek a resolution to these matters, a separate hearing related to damages is expected to be scheduled in the future. Additionally, the Office of Public Prosecutor in the Netherlands opened a criminal investigation against certain Dutch subsidiaries of Chemours and Historical DuPont, as well as each subsidiary's directors, alleging unlawful PFOA and GenX emissions from Chemours' Dordrecht Works facility.

Carpet Mill Cases. The city of Centre, Alabama water district alleged defendants, including EIDP, Chemours, other chemical suppliers and large carpet mills, discharged PFAS in their industrial wastewater, and that this wastewater after treatment, resulted in PFAS contamination of drinking water supplies. The trial for the Centre, Alabama water district carpet mill case is scheduled for March 2025. Numerous carpet manufacturers, their alleged suppliers and former suppliers, including EIDP and Chemours, and certain municipal or utility defendants are also subject to several lawsuits in Georgia and Alabama, alleging negligence, nuisance and trespass related to the release of PFOA, and requesting injunctive relief related to PFOA contamination.

Fayetteville Works Facility, North Carolina

Prior to the separation of Chemours, EIDP introduced GenX as a polymerization processing aid and a replacement for PFOA at the Fayetteville Works facility in Bladen County, North Carolina. The facility is now owned and operated by Chemours, which continues to manufacture and use GenX.

At September 30, 2024, several actions, including for personal injury, are pending in federal court against Chemours and EIDP relating to PFC discharges from the Fayetteville Works facility. One of these is a consolidated putative class action that asserts claims for medical monitoring and property damage on behalf of putative classes of property owners and residents in areas near or who draw drinking water from the Cape Fear River. Another action is a consolidated action brought by various North Carolina water authorities, including the Cape Fear Public Utility Authority (“CFPUA”) and Brunswick County, that seek actual and punitive damages as well as injunctive relief. In a state court action, approximately 2,400 private property owners near the Fayetteville Works facility filed a complaint against Chemours and EIDP. The plaintiffs seek compensatory and punitive damages for their claims of private nuisance, trespass, negligence and property damage allegedly caused by release of certain PFCs. In March 2023, CFPUA filed a Delaware Chancery Court action claiming the spin-off of Chemours and the Dow and Historical DuPont merger were unlawful and should be voided, so CFPUA is not precluded from recovering amounts it is entitled in its pending litigation. EIDP filed a motion to dismiss the Delaware Chancery Court action based upon failure to state a claim under Delaware law in June 2023, along with a counterclaim in October 2023. CFPUA’s motion to stay the case was granted in January 2024. In addition, several personal injury cases have been filed alleging thyroid disease, and prostate, breast and kidney cancers as a result of PFAS exposure.

Generally, site-related expenses related to GenX claims are subject to the cost sharing arrangements as defined in the MOU.

Environmental

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. These obligations are included in accrued and other current liabilities and other noncurrent obligations in the interim Consolidated Balance Sheets. It is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration.

For a discussion of the allocation of environmental liabilities under the Chemours Separation Agreement and the Corteva Separation Agreement, see page 22-23.

The accrued environmental obligations and indemnification assets include the following:


	As of September 30, 2024
(In millions)	Indemnification Asset		Accrual balance3		Potential exposure above amount accrued3
Environmental Remediation Stray Liabilities
Chemours related obligations - subject to indemnity1,2	$	150	$	153	$	277
Other discontinued or divested businesses obligations1	34		71		203

Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont2	49		52		61

Environmental remediation liabilities not subject to indemnity	—		105		90

Indemnification liabilities related to the MOU4	26		96		13
Total	$	259	$	477	$	644

1.Represents liabilities that are subject to the $200 million threshold and sharing arrangements as discussed on page 23, under the header "Corteva Separation Agreement."

2.The company has recorded an indemnification asset related to these accruals, including $19 million related to the Superfund sites.

3.Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balance includes $47 million for remediation of Superfund sites. Amounts do not include all possible impacts from the remediation elements of the EPA's October 2021 PFAS Strategic Roadmap (as applicable), except as disclosed on page 28 relating to Chemours' remediation activities at the Fayetteville Works Facility pursuant to the Consent Order with the North Carolina Department of Environmental Quality ("NC DEQ").

4.Represents liabilities that are subject to the $150 million threshold and sharing agreements as discussed on page 22, under the header "Chemours Separation Agreement (Performance Chemicals)."

Chambers Works, New Jersey

On January 28, 2022, the State of New Jersey filed a request for a preliminary injunction against EIDP and Chemours seeking the establishment of a Remediation Funding Source (“RFS”) in an amount exceeding $900 million for environmental remediation at EIDP’s former Chambers Works facility in New Jersey. The RFS primarily relates to non-PFAS remediation, which is not subject to the MOU. Chemours has accepted indemnity and defense for these matters, while reserving rights and declining EIDP’s demand relating to the ISRA and fraudulent transfer matters as alleged under the existing New Jersey natural resource lawsuits discussed on page 26.

Nebraska Department of Environment and Energy, AltEn Facility

The EPA and the Nebraska Department of Environment and Energy (“NDEE”) are pursuing investigations, response and removal actions, litigation and enforcement action related to an ethanol plant located near Mead, Nebraska that is owned and operated by AltEn LLC (“AltEn”). The agencies have alleged violations under the Resource Conservation and Recovery Act (“RCRA”) and other federal and state laws stemming from AltEn’s lack of compliance with the terms and conditions of its operating permits and other regulatory requirements. Corteva is one of six seed companies, who were customers of AltEn (collectively, the "Facility Response Group"), participating in the NDEE’s Voluntary Cleanup Program to address certain interim remediation needs at the site. In February 2022, the Facility Response Group filed a lawsuit against AltEn and certain of its affiliates to preserve certain contractual and common law indemnification claims. As of September 30, 2024, an accrual was established for Corteva’s estimated voluntary contribution to the solid waste and wastewater remedial action plans for the AltEn location.

California Department of Toxic Substances Control, Pittsburg Plant

The California Department of Toxic Substances Control (“DTSC”) has filed a state court lawsuit over challenging whether the Pittsburg plant’s high purity water system (“HPWS”), as operated by Dow and now Corteva, required a permit pursuant to the Federal Resource Conservation and Recovery Act (“RCRA”). Discussions between the parties remain ongoing and further litigation, including discovery, is stayed.

Restructuring and Asset Related Charges Asset Impairments (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Other Asset Related [Member]
Restructuring Cost and Reserve [Line Items]
Non-cash accelerated prepaid royalty amortization Charges (Benefits)	$ (2)	$ (55)	$ (66)

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Revenue (Tables)

9 Months Ended

Sep. 30, 2024

Disaggregation of Revenue [Line Items]

Contract Balances


Contract Balances	September 30, 2024		December 31, 2023		September 30, 2023
(In millions)	September 30, 2024		December 31, 2023		September 30, 2023
Accounts and notes receivable - trade1	$	5,501	$	4,329	$	5,320
Contract assets - current2	$	29	$	27	$	27
Contract assets - noncurrent3	$	73	$	67	$	67
Deferred revenue - current	$	429	$	3,406	$	552
Deferred revenue - noncurrent4	$	115	$	108	$	109

1.Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets.

2.Included in other current assets in the interim Consolidated Balance Sheets.

3.Included in other assets in the interim Consolidated Balance Sheets.

4.Included in other noncurrent obligations in the interim Consolidated Balance Sheets.

Major Product Line [Member]

Disaggregation of Revenue [Line Items]

Disaggregation of Revenue


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Corn	$	315	$	487	$	5,085	$	5,139
Soybean	164		189		1,773		1,713
Other oilseeds	135		142		566		637
Other	77		60		349		348
Seed	691		878		7,773		7,837
Herbicides	736		815		2,568		3,043
Insecticides	437		416		1,225		1,156
Fungicides	216		226		761		837
Other	246		255		603		646
Crop Protection	1,635		1,712		5,157		5,682
Total	$	2,326	$	2,590	$	12,930	$	13,519

Geography [Domain]

Disaggregation of Revenue [Line Items]

Disaggregation of Revenue


Seed	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
North America1	$	170	$	173	$	5,394	$	5,192
EMEA2	196		198		1,365		1,441
Latin America	218		380		696		847
Asia Pacific	107		127		318		357
Total	$	691	$	878	$	7,773	$	7,837


Crop Protection	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
North America1	$	440	$	399	$	1,703	$	1,901
EMEA2	219		271		1,311		1,555
Latin America	771		844		1,458		1,537
Asia Pacific	205		198		685		689
Total	$	1,635	$	1,712	$	5,157	$	5,682

1.Represents U.S. & Canada.

2.Europe, Middle East and Africa ("EMEA").

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Segment Reporting Segment Asset Reconciliation (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Segment Reporting Information [Line Items]
Total Assets	$ 41,908	$ 42,996	$ 43,110
Segments
Segment Reporting Information [Line Items]
Total Assets	37,087	37,736	38,275
Corporate
Segment Reporting Information [Line Items]
Total Assets	$ 4,821	$ 5,260	$ 4,835

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 810
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (bb)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481203/810-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 810
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481231/810-10-45-25

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481687/323-10-50-3

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-28

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481372/852-10-55-10

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480167/946-830-55-12

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(8))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(18))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481404/852-10-50-7

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1

+ Details

Accounts and Notes Receivable Allowance Rollforward (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Receivables [Abstract]
Accounts Receivable, Allowance for Credit Loss, Beginning Balance	$ 205	$ 194
Net Provision for Credit Losses	31	10
Write-offs charged against allowance/ other	(48)	(3)
Accounts Receivable, Allowance for Credit Loss, Ending Balance	$ 188	$ 201

Earnings Per Share Earnings Per Share Calculations - Basic (Details) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Earnings Per Share [Abstract]
Basic earnings (loss) per share of common stock from continuing operations	$ (0.76)	$ (0.45)	$ 1.30	$ 1.64
Basic earnings (loss) per share of common stock from discontinued operations	0	0	0.06	(0.24)
Basic earnings (loss) per share of common stock	$ (0.76)	$ (0.45)	$ 1.36	$ 1.40

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-15

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-7

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-10

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-52

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-7

+ Details

- Definition

The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-7

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-03(13))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-1

Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(20))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

+ Details

Inventories

9 Months Ended

Sep. 30, 2024

Inventory Disclosure [Abstract]

Inventory Disclosure [Text Block]

INVENTORIES


(In millions)	September 30, 2024		December 31, 2023		September 30, 2023
Finished products	$	2,399	$	3,273	$	2,786
Semi-finished products	2,785		2,775		2,690
Raw materials and supplies	490		851		844
Total inventories	$	5,674	$	6,899	$	6,320

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Debt (Tables)

9 Months Ended

Sep. 30, 2024

Debt Instrument [Line Items]

Schedule of Long-term Debt Instruments [Table Text Block]


Long-term debt
(In millions)	September 30, 2024				December 31, 2023				September 30, 2023
	Amount		Weighted Average Rate		Amount		Weighted Average Rate		Amount		Weighted Average Rate
Promissory notes and debentures:
Maturing in 2025	$	500	1.70	%	$	500	1.70	%	$	500	1.70	%
Maturing in 2026	600		4.50	%	600		4.50	%	600		4.50	%
Maturing in 2030	500		2.30	%	500		2.30	%	500		2.30	%
Maturing in 2033	600		4.80	%	600		4.80	%	600		4.80	%
Other loans:
Foreign currency loans, various rates and maturities	184		12.70	%	196		14.80	%	188		14.80	%
Medium-term notes, varying maturities through 2041	104		4.94	%	106		5.34	%	106		5.33	%
Finance lease obligations	—				1				1
Less: Unamortized debt discount and issuance costs	13				16				17
Less: Long-term debt due within one year	500				196				188
Total long-term debt	$	1,975			$	2,291			$	2,290

Schedule of Short-term Debt [Table Text Block]


Short-term borrowings and finance lease obligations
(In millions)	September 30, 2024		December 31, 2023		September 30, 2023
Commercial paper	$	2,969	$	—	$	3,417
364-Day Revolving Credit Facility	—		—		—
Other loans - various currencies	271		1		3
Long-term debt payable within one year	500		196		188
Finance lease obligations payable within one year	1		1		1
Total short-term borrowings and finance lease obligations	$	3,741	$	198	$	3,609

Schedule of Long-term Debt Instruments [Table Text Block]


Long-term debt
(In millions)	September 30, 2024				December 31, 2023				September 30, 2023
	Amount		Weighted Average Rate		Amount		Weighted Average Rate		Amount		Weighted Average Rate
Promissory notes and debentures:
Maturing in 2025	$	500	1.70	%	$	500	1.70	%	$	500	1.70	%
Maturing in 2026	600		4.50	%	600		4.50	%	600		4.50	%
Maturing in 2030	500		2.30	%	500		2.30	%	500		2.30	%
Maturing in 2033	600		4.80	%	600		4.80	%	600		4.80	%
Other loans:
Foreign currency loans, various rates and maturities	184		12.70	%	196		14.80	%	188		14.80	%
Medium-term notes, varying maturities through 2041	104		4.94	%	106		5.34	%	106		5.33	%
Finance lease obligations	—				1				1
Less: Unamortized debt discount and issuance costs	13				16				17
Less: Long-term debt due within one year	500				196				188
Total long-term debt	$	1,975			$	2,291			$	2,290

Schedule of Line of Credit Facilities

Committed and Available Credit Facilities at September 30, 2024

(In millions)

Effective Date

Committed Credit

Credit Available

Maturity Date

Interest

Revolving Credit Facility

June 2024

2,850

June 2029

Floating Rate

Revolving Credit Facility

June 2024

1,900

June 2027

Floating Rate

364-Day Revolving Credit Facility

February 2024

1,000

February 2025

Floating Rate

Total Committed and Available Credit Facilities

5,750

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482900/835-30-50-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(f))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69F
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

+ Details

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482925/835-30-45-2

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-3

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482949/835-30-55-8

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480848/942-470-50-3

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-8

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-6

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-7

+ Details

Earnings Per Share Earnings Per Share Calculations - Diluted (Details) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Earnings Per Share [Abstract]
Diluted earnings (loss) per share of common stock from continuing operations	$ (0.76)	$ (0.45)	$ 1.29	$ 1.63
Diluted earnings (loss) per share of common stock from discontinued operations	0	0	0.06	(0.24)
Diluted earnings (loss) per share of common stock	$ (0.76)	$ (0.45)	$ 1.35	$ 1.39

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-15

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-7

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-52

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-7

+ Details

- Definition

The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-7

Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-03(13))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-1

+ Details

Supplementary Information

9 Months Ended

Sep. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Additional Financial Information Disclosure [Text Block]

SUPPLEMENTARY INFORMATION


Other Income (Expense) - Net	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Interest income	$	33	$	59	$	93	$	153
Equity in earnings (losses) of affiliates - net	—		(2)		7		4
Net gain (loss) on sales of businesses and other assets	—		10		17		11
Net exchange gains (losses)1	(97)		(102)		(234)		(242)
Non-operating pension and other post employment benefit credits (costs)2	(37)		(30)		(109)		(91)
Miscellaneous income (expenses) - net3	(6)		(84)		(93)		(189)
Other income (expense) - net	$	(107)	$	(149)	$	(319)	$	(354)

1.Includes net pre-tax exchange gains (losses) of $(26) million and $(54) million associated with impacts from the devaluation of the Argentine Peso for the three and nine months ended September 30, 2024, respectively, and $(83) million and $(150) million for the three and nine months ended September 30, 2023, respectively.

2.Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)).

3.The three and nine months ended September 30, 2024 includes tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont ("Tax Indemnification Adjustments"), while the nine months ended September 30, 2024 additionally includes the receipt of an indemnification payment negotiated with the prior Stoller owners and estimated settlement reserves. The three and nine months ended September 30, 2023 includes Tax Indemnification Adjustments and an adjustment to the Employee Retention Credit pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”) due to a change in estimate as well as estimated settlement reserves. The nine months ended September 30, 2023 also includes gains on the sale of assets, and a loss on the sale of the company's interest in an equity investment.

The following table summarizes the impacts of the company's foreign currency hedging program on the company's results of operations. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the U.S., whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income (expense) - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the interim Consolidated Statements of Operations.


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Subsidiary Monetary Position Gain (Loss)
Pre-tax exchange gain (loss)	$	(156)	$	(104)	$	(199)	$	(182)
Local tax (expenses) benefits	5		19		23		27
Net after-tax impact from subsidiary exchange gain (loss)	$	(151)	$	(85)	$	(176)	$	(155)

Hedging Program Gain (Loss)
Pre-tax exchange gain (loss)	$	59	$	2	$	(35)	$	(60)
Tax (expenses) benefits	(12)		(4)		7		12
Net after-tax impact from hedging program exchange gain (loss)	$	47	$	(2)	$	(28)	$	(48)

Total Exchange Gain (Loss)
Pre-tax exchange gain (loss)	$	(97)	$	(102)	$	(234)	$	(242)
Tax (expenses) benefits	(7)		15		30		39
Net after-tax exchange gain (loss)	$	(104)	$	(87)	$	(204)	$	(203)

Non-Controlling Interest Adjustment	—		—		1		—

Net after-tax exchange gain (loss) attributable to Corteva	$	(104)	$	(87)	$	(203)	$	(203)

Cash, cash equivalents and restricted cash equivalents

The following table provides a reconciliation of cash and cash equivalents and restricted cash equivalents presented in the interim Consolidated Balance Sheets to the total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows. Corteva classifies restricted cash equivalents as current or noncurrent based on the nature of the restrictions, which are included in other current assets and other assets, respectively, in the interim Consolidated Balance Sheets.


(In millions)	September 30, 2024		December 31, 2023		September 30, 2023
Cash and cash equivalents	$	2,421	$	2,644	$	2,254
Restricted cash equivalents	335		514		522
Total cash, cash equivalents and restricted cash equivalents	$	2,756	$	3,158	$	2,776

Restricted cash equivalents is primarily comprised of a trust funded by EIDP for cash obligations under certain non-qualified benefit and deferred compensation plans due to the Merger, which was a change in control event, and contributions to escrow accounts established for the settlement of certain legal matters and the settlement of legacy PFAS matters and the associated qualified spend. During the second quarter of 2024, the previously-restricted cash in the Water District Settlement Fund, which was established by the settling companies in September 2023 under the Nationwide Water District Settlement, was released. Collective contributions amounted to $1.185 billion, with Chemours contributing 50 percent and DuPont and Corteva collectively contributing the remaining 50 percent pursuant to the terms of the Letter Agreement. All of the company's

restricted cash equivalents are classified as current as of September 30, 2024, December 31, 2023 and September 30, 2023, except for the 2024 contribution to the MOU Escrow Account, which is classified as noncurrent as of September 30, 2024.

Accounts payable

At September 30, 2024, December 31, 2023 and September 30, 2023, accounts payable was $3,753 million, $4,280 million and $3,678 million, respectively, which includes accounts payable - trade of $2,051 million, $2,952 million, and $2,046 million, respectively. Included in accounts payable – trade was seed grower compensation of approximately $214 million, $560 million, and $217 million at September 30, 2024, December 31, 2023 and September 30, 2023, respectively, which is measured at fair value using Level 2 inputs for each period presented.

Revenue Disaggregation of Revenue - Principal Product Groups (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Disaggregation of Revenue [Line Items]
Net Sales	$ 2,326	$ 2,590	$ 12,930	$ 13,519
Seed [Member]
Disaggregation of Revenue [Line Items]
Net Sales	691	878	7,773	7,837
Seed [Member] \| Corn [Member]
Disaggregation of Revenue [Line Items]
Net Sales	315	487	5,085	5,139
Seed [Member] \| Soybean [Member]
Disaggregation of Revenue [Line Items]
Net Sales	164	189	1,773	1,713
Seed [Member] \| Other oilseeds [Member]
Disaggregation of Revenue [Line Items]
Net Sales	135	142	566	637
Seed [Member] \| Other [Member]
Disaggregation of Revenue [Line Items]
Net Sales	77	60	349	348
Crop Protection [Member]
Disaggregation of Revenue [Line Items]
Net Sales	1,635	1,712	5,157	5,682
Crop Protection [Member] \| Herbicides [Member]
Disaggregation of Revenue [Line Items]
Net Sales	736	815	2,568	3,043
Crop Protection [Member] \| Insecticides [Member]
Disaggregation of Revenue [Line Items]
Net Sales	437	416	1,225	1,156
Crop Protection [Member] \| Fungicides [Member]
Disaggregation of Revenue [Line Items]
Net Sales	216	226	761	837
Crop Protection [Member] \| Other [Member]
Disaggregation of Revenue [Line Items]
Net Sales	$ 246	$ 255	$ 603	$ 646

EIDP Income Taxes (Notes)	9 Months Ended
EIDP Income Taxes (Notes)	Sep. 30, 2024
Income Tax Disclosure [Text Block]	INCOME TAXES The effective tax rate for the three and nine months ended September 30, 2024 was 18.0 percent and 23.1 percent, respectively, and 29.1 percent and 17.2 percent for the three and nine months ended September 30, 2023, respectively. During the three and nine months ended September 30, 2024, the company recognized $10 million and $25 million, respectively, of net tax benefits for income taxes on continuing operations associated with changes in deferred taxes and accruals for certain prior year tax positions in various jurisdictions as well as from stock-based compensation. During the three and nine months ended September 30, 2023, the company recognized $11 million and $79 million, respectively, of net tax benefits for income taxes on continuing operations associated with changes in deferred taxes, accruals for certain prior year tax positions in various jurisdictions, stock-based compensation, as well as the impact of changes to deferred taxes associated with a tax currency change for a legal entity. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of the program, which resides in the U.S., is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions, which can drive material impacts on the company's effective tax rate. For further discussion of pre-tax and after-tax impacts of the company's foreign currency hedging program and net monetary asset programs, refer to Note 6 - Supplementary Information, to the interim Consolidated Financial Statements.
EIDP
Income Tax Disclosure [Text Block]	INCOME TAXES Refer to page 16 of the Corteva, Inc. Interim Consolidated Financial Statements for discussion of tax items that do not differ between Corteva, Inc. and EIDP. The effective tax rate was 17.9 percent and 23.1 percent for the three and nine months ended September 30, 2024 and 28.9 percent and 17.1 percent for the three and nine months ended September 30, 2023, respectively. EIDP's effective tax rates for the three and nine months ended September 30, 2024 and 2023 were driven by the net tax benefits discussed on page 16 of the Corteva, Inc. Interim Consolidated Financial Statements.

- Definition

+ References

+ Details

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTSIn April 2024, the company entered into a committed receivable repurchase facility of up to XX (the "2024 Repurchase Facility"), which expires in December 20XX. Under the 2024 Repurchase Facility, Corteva may sell a portfolio of available and eligible outstanding customer notes receivables to participating institutions and simultaneously agree to repurchase at a future date. The 2024 Repurchase Facility is considered a secured borrowing with the customer notes receivables inclusive of those that are sold and repurchased, equal to XX of the outstanding amounts borrowed utilized as collateral. Borrowings under the 2024 Repurchase Facility have an interest rate equal to the Adjusted Term Secured Overnight Financing Rate ("SOFR"), which is Term SOFR plus XX, plus the margin.

Summary of Significant Accounting Policies (Notes)	9 Months Ended
Summary of Significant Accounting Policies (Notes)	Sep. 30, 2024
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included. Results for interim periods should not be considered indicative of results for a full year. These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2023, collectively referred to as the “2023 Annual Report.” The interim Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained. The interim Consolidated Financial Statements and other financial information included in this Form 10-Q, unless otherwise specified, have been presented to separately show the effects of discontinued operations. During the fourth quarter of 2023, the company made the decision, which was retrospectively applied, to adjust the presentation of the interim Consolidated Statement of Cash Flows to separately present the cash provided by (used for) operating activities – discontinued operations, which was previously presented within cash provided by (used for) operating activities. See Note 13 – Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements, for additional information on discontinued operations activities. Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 4 percent to the company's annual net sales and less than 4 percent to each of the company's annual Seed and Crop Protection segment operating EBITDA. The company remeasures net monetary assets utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 6 – Supplementary Information, to the interim Consolidated Financial Statements, and Note 7 – Supplementary Information, to the Consolidated Financial Statements, in the company's 2023 Annual Report). The Argentina government has offered USD-denominated bonds to importers, the proceeds from which could be used to pay off outstanding intercompany payables. During the first quarter of 2024, the company purchased $125 million of these foreign government bonds as part of its strategy to manage its net monetary asset exposure in Argentina. Refer to the “Debt Securities” section in Note 16 - Financial Instruments, to the interim Consolidated Financial Statements, for additional information. As of September 30, 2024, a further 10 percent deterioration in the official Peso to USD exchange rate would not have a significant impact on the USD value of our net monetary assets or pre-tax earnings. The company will continue to assess the implications to our operations and financial reporting.

Commitments and Contingent Liabilities PFOA / Leach Settlement (Details)		3 Months Ended		9 Months Ended	12 Months Ended
	Jan. 31, 2021 USD ($)	Mar. 31, 2021 lawsuits	Jun. 30, 2017 USD ($) lawsuits	Sep. 30, 2024 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2004 USD ($)	Jan. 01, 2012
MDL Settlement [Domain]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party	$ 83,000,000
DuPont de Nemours and Corteva Contribution to MDL Settlement
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party	$ 27,000,000
Payments for Legal Settlements					$ 27,000,000
PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Binding Settlement Agreement Class Size						80,000
Loss Contingency, Number Of Water Districts Receiving Water Treatment							6
Litigation Settlement, Liability For Medical Monitoring Program, Threshold						$ 235,000,000
Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date				$ 2,000,000
Escrow Balance				$ 1,000,000
PFOA Matters: Drinking Water Actions [Member] \| WEST VIRGINIA AND OHIO [Domain] \| Settled Litigation
Loss Contingencies [Line Items]
Loss Contingency, Claims Settled, Number \| lawsuits		95
PFOA Matters: Multi-District Litigation [Member]
Loss Contingencies [Line Items]
Disease Categories for MDL							6
Lawsuits alleging personal injury filed \| lawsuits			3,550
Litigation Settlement, Amount Awarded to Other Party			$ 670,000,000

Pension Plans and Other Post Employment Benefit Plans (Tables)

9 Months Ended

Sep. 30, 2024

Retirement Benefits [Abstract]

Schedule of Net Benefit Costs [Table Text Block]


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Defined Benefit Pension Plans:
Service cost	$	3	$	3	$	12	$	13
Interest cost	162		171		488		518
Expected return on plan assets	(133)		(151)		(399)		(454)

Amortization of prior service (benefit) cost	—		—		(2)		(2)
Settlement loss	1		1		1		1
Net periodic benefit (credit) cost	$	33	$	24	$	100	$	76
Other Post Employment Benefits:
Service cost	$	—	$	1	$	—	$	1
Interest cost	11		12		31		36
Amortization of unrecognized (gain) loss	(3)		(2)		(9)		(7)
Amortization of prior service (benefit) cost	(1)		(1)		(1)		(1)

Net periodic benefit (credit) cost	$	7	$	10	$	21	$	29

Supplementary Information Supplementary Information (Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Accounts payable	$ 3,753	$ 4,280	$ 3,678
Accounts Payable, Trade, Current	2,051	2,952	2,046
Seed Grower Compensation
Accounts Payable, Trade, Current	$ 214	$ 560	$ 217

Restructuring and Asset Related Charges (Tables)

3 Months Ended

9 Months Ended

Sep. 30, 2024

Sep. 30, 2023

2022 Restructuring Actions

Restructuring Cost and Reserve [Line Items]

Schedule of Restructuring Reserve by Type of Cost [Table Text Block]


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Severance and related benefit costs1	$	—	$	—	$	—	$	4
Asset related charges	—		—		(2)		11
Contract termination charges3	3		1		3		4
Total restructuring and asset related charges - net2,3	$	3	$	1	$	1	$	19

1.Reflects corporate-related charges.

2.The nine months ended September 30, 2024, reflects a benefit of $(2) million, associated with sales of inventory previously reserved for impacting the Seed segment. The three and nine months ended September 30, 2023 reflects charges of $1 million and $10 million, respectively, impacting the Seed segment, and $— and $5 million, respectively, impacting the Crop Protection segment.

3.This amount excludes other pre-tax charges recorded during the nine months ended September 30, 2024 and the three and nine months ended September 30, 2023 impacting the Seed segment included in cost of goods sold and other income (expense) – net, in the company’s interim Consolidated Statement of Operations, relating to inventory write-offs and a loss on the sale of the company's interest in an equity investment. See Note 18 - Segment Information, to the interim Consolidated Financial Statements, for additional information.

Crop Protection Strategy Operations Program [Member]

Restructuring Cost and Reserve [Line Items]

Schedule of Restructuring Reserve by Type of Cost [Table Text Block]


(In millions)	Three Months Ended September 30, 2024		Nine Months Ended September 30, 2024
Severance and related benefit costs1	$	19	$	60
Asset related charges2, 3	10		83

Total restructuring and asset related charges - net	$	29	$	143

1.Reflects corporate-related charges.

2.Reflects charges associated with the Crop Protection segment.

3.The three and nine months ended September 30, 2024 include charges of $4 million for decommissioning costs associated with the exit of the company’s production activities at its site in Pittsburg, California.

A reconciliation of the December 31, 2023 to the September 30, 2024 liability balances related to the Crop Protection Operations Strategy Restructuring Program is summarized below:


(In millions)	Severance and Related Benefit Costs		Asset Related Charges1		Total
Balance at December 31, 2023	$	—	$	—	$	—
Charges to income from continuing operations	60		83		143
Payments	(3)		(4)		(7)
Asset write-offs	—		(79)		(79)
Balance at September 30, 2024	$	57	$	—	$	57

1. Includes charges of $4 million for decommissioning costs associated with the exit of the company’s production activities at its site in Pittsburg, California.

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Commitments and Contingent Liabilities (Tables)

9 Months Ended

Sep. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

Schedule of Environmental Loss Contingencies by Site [Table Text Block]


	As of September 30, 2024
(In millions)	Indemnification Asset		Accrual balance3		Potential exposure above amount accrued3
Environmental Remediation Stray Liabilities
Chemours related obligations - subject to indemnity1,2	$	150	$	153	$	277
Other discontinued or divested businesses obligations1	34		71		203

Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont2	49		52		61

Environmental remediation liabilities not subject to indemnity	—		105		90

Indemnification liabilities related to the MOU4	26		96		13
Total	$	259	$	477	$	644

1.Represents liabilities that are subject to the $200 million threshold and sharing arrangements as discussed on page 23, under the header "Corteva Separation Agreement."

2.The company has recorded an indemnification asset related to these accruals, including $19 million related to the Superfund sites.

4.Represents liabilities that are subject to the $150 million threshold and sharing agreements as discussed on page 22, under the header "Chemours Separation Agreement (Performance Chemicals)."

EID - Basis of Presentation (Notes)	9 Months Ended
EID - Basis of Presentation (Notes)	Sep. 30, 2024
EIDP
Entity Information [Line Items]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	BASIS OF PRESENTATION Corteva, Inc. owns 100% of the outstanding common stock of EIDP. EIDP is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Exchange Act. The primary differences between Corteva, Inc. and EIDP are outlined below: •Preferred Stock - EIDP has preferred stock outstanding to third parties which is accounted for as a non-controlling interest at the Corteva, Inc. level. Each share of EIDP Preferred Stock - $4.50 Series and EIDP Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EIDP and was unaffected by the Corteva Distribution. •Related Party Loan - EIDP engaged in a series of debt redemptions during the second quarter of 2019 that were partially funded through an intercompany loan from Corteva, Inc. This was eliminated in consolidation at the Corteva, Inc. level but remained on EIDP's consolidated financial statements at the standalone level (including the associated interest) through its repayment date in the fourth quarter of 2023. •Capital Structure - At September 30, 2024, Corteva, Inc.'s capital structure consists of 689,170,000 issued shares of common stock, par value $0.01 per share. The accompanying footnotes relate to EIDP only, and not to Corteva, Inc., and are presented to show differences between EIDP and Corteva, Inc. For the footnotes listed below, refer to the following Corteva, Inc. footnotes: •Note 1 - Summary of Significant Accounting Policies - refer to page 10 of the Corteva, Inc. interim Consolidated Financial Statements •Note 2 - Recent Accounting Guidance - refer to page 10 of the Corteva, Inc. interim Consolidated Financial Statements •Note 3 - Business Combinations - refer to page 11 of the Corteva, Inc. interim Consolidated Financial Statements •Note 4 - Revenue - refer to page 11 of the Corteva, Inc. interim Consolidated Financial Statements •Note 5 - Restructuring and Asset Related Charges - Net - refer to page 12 of the Corteva, Inc. interim Consolidated Financial Statements •Note 6 - Supplementary Information - refer to page 14 of the Corteva, Inc. interim Consolidated Financial Statements. In addition, EIDP has a related party loan receivable from Corteva, Inc.; refer to EIDP Note 2 - Related Party Transactions, below. •Note 7 - Income Taxes - Differences exist between Corteva, Inc. and EIDP; refer to EIDP Note 3 - Income Taxes, of the EIDP interim Consolidated Financial Statements, below •Note 8 - Earnings Per Share of Common Stock - Not applicable for EIDP •Note 9 - Accounts and Notes Receivable - Net - refer to page 18 of the Corteva, Inc. interim Consolidated Financial Statements •Note 10 - Inventories - refer to page 19 of the Corteva, Inc. interim Consolidated Financial Statements •Note 11 - Other Intangible Assets - refer to page 19 of the Corteva, Inc. interim Consolidated Financial Statements •Note 12 - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities - refer to page 19 of the Corteva, Inc. interim Consolidated Financial Statements. In addition, EIDP had a related party loan payable to Corteva, Inc. which was repaid during the fourth quarter of 2023; refer to EIDP Note 2 - Related Party Transactions, below. •Note 13 - Commitments and Contingent Liabilities - refer to page 21 of the Corteva, Inc. interim Consolidated Financial Statements •Note 14 - Stockholders' Equity - refer to page 30 of the Corteva, Inc. interim Consolidated Financial Statements •Note 15 - Pension Plans and Other Post Employment Benefits - refer to page 32 of the Corteva, Inc. interim Consolidated Financial Statements •Note 16 - Financial Instruments - refer to page 33 of the Corteva, Inc. interim Consolidated Financial Statements •Note 17 - Fair Value Measurements - refer to page 38 of the Corteva, Inc. interim Consolidated Financial Statements •Note 18 - Segment Information - Differences exist between Corteva, Inc. and EIDP; refer to EIDP Note 4 - Segment Information, below

Revenue (Notes)

9 Months Ended

Sep. 30, 2024

Revenue from Contract with Customer [Abstract]

Revenue from Contract with Customer

REVENUE

Remaining Performance Obligations

Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. The company applies the practical expedient to disclose the transaction price allocated to the remaining performance obligations for only those contracts with an original duration of more than one year. The transaction price allocated to remaining performance obligations with an original duration of more than one year related to material rights granted to customers for contract renewal options were $140 million, $134 million and $135 million at September 30, 2024, December 31, 2023 and September 30, 2023, respectively. The company expects revenue to be recognized for the remaining performance obligations evenly over the period of one year to six years.

Contract Balances

Contract liabilities primarily reflect deferred revenue from prepayments under contracts with customers where the company receives advance payments for products to be delivered in future periods. Corteva classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to conditional rights to consideration for completed performance not yet invoiced. Accounts receivable are recorded when the right to consideration becomes unconditional.


Contract Balances	September 30, 2024		December 31, 2023		September 30, 2023
(In millions)	September 30, 2024		December 31, 2023		September 30, 2023
Accounts and notes receivable - trade1	$	5,501	$	4,329	$	5,320
Contract assets - current2	$	29	$	27	$	27
Contract assets - noncurrent3	$	73	$	67	$	67
Deferred revenue - current	$	429	$	3,406	$	552
Deferred revenue - noncurrent4	$	115	$	108	$	109

1.Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets.

2.Included in other current assets in the interim Consolidated Balance Sheets.

3.Included in other assets in the interim Consolidated Balance Sheets.

4.Included in other noncurrent obligations in the interim Consolidated Balance Sheets.

Revenue recognized during the nine months ended September 30, 2024 and 2023 from amounts included in deferred revenue at the beginning of the period was $3,314 million and $3,287 million, respectively.

Disaggregation of Revenue

Corteva's operations are classified into two reportable segments: Seed and Crop Protection. The company disaggregates its revenue by major product line and geographic region, as the company believes it best depicts the nature, amount and timing of its revenue and cash flows. Net sales by major product line are included below:


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Corn	$	315	$	487	$	5,085	$	5,139
Soybean	164		189		1,773		1,713
Other oilseeds	135		142		566		637
Other	77		60		349		348
Seed	691		878		7,773		7,837
Herbicides	736		815		2,568		3,043
Insecticides	437		416		1,225		1,156
Fungicides	216		226		761		837
Other	246		255		603		646
Crop Protection	1,635		1,712		5,157		5,682
Total	$	2,326	$	2,590	$	12,930	$	13,519

Sales are attributed to geographic regions based on customer location. Net sales by geographic region and segment are included below:


Seed	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
North America1	$	170	$	173	$	5,394	$	5,192
EMEA2	196		198		1,365		1,441
Latin America	218		380		696		847
Asia Pacific	107		127		318		357
Total	$	691	$	878	$	7,773	$	7,837


Crop Protection	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
North America1	$	440	$	399	$	1,703	$	1,901
EMEA2	219		271		1,311		1,555
Latin America	771		844		1,458		1,537
Asia Pacific	205		198		685		689
Total	$	1,635	$	1,712	$	5,157	$	5,682

1.Represents U.S. & Canada.

2.Europe, Middle East and Africa ("EMEA").

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-9

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-10

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-15

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-13

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org//606/tableOfContent

+ Details

EIDP Segment FN (Notes)

9 Months Ended

Sep. 30, 2024

Segment Reporting Information [Line Items]

Segment Reporting Disclosure [Text Block]

SEGMENT INFORMATION

Corteva’s reportable segments reflects the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (Seed and Crop Protection). For purposes of allocating resources to the segments and assessing segment performance, segment operating EBITDA is the primary measure used by Corteva’s CODM. The company defines segment operating EBITDA as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating benefits (costs), foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Non-operating benefits (costs) consists of non-operating pension and other post-employment benefit (OPEB) credits (costs), tax indemnification adjustments and environmental remediation and legal costs associated with legacy EIDP businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the respective segment results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility.


As of and for the Three Months Ended September 30, (In millions)	Seed		Crop Protection		Total
2024
Net sales	$	691	$	1,635	$	2,326
Segment operating EBITDA	(320)		246		(74)
Segment assets1	22,192		14,895		37,087

2023
Net sales	$	878	$	1,712	$	2,590
Segment operating EBITDA	(138)		184		46
Segment assets1	22,829		15,446		38,275

1. Segment assets at December 31, 2023 were $22,732 million and $15,004 million for Seed and Crop Protection, respectively.


As of and for the Nine Months Ended September 30, (In millions)	Seed		Crop Protection		Total
2024
Net sales	$	7,773	$	5,157	$	12,930
Segment operating EBITDA	2,126		811		2,937


2023
Net sales	$	7,837	$	5,682	$	13,519
Segment operating EBITDA	1,972		1,107		3,079

Reconciliation to interim Consolidated Financial Statements


Income (loss) from continuing operations after income taxes to segment operating EBITDA	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Income (loss) from continuing operations after income taxes	$	(519)	$	(315)	$	913	$	1,172
Provision for (benefit from) income taxes on continuing operations	(114)		(129)		274		244
Income (loss) from continuing operations before income taxes	$	(633)	$	(444)	$	1,187	$	1,416
Depreciation and amortization	306		306		925		899
Interest income	(33)		(59)		(93)		(153)
Interest expense	66		58		173		171
Exchange (gains) losses	97		102		234		242
Non-operating (benefits) costs	50		28		132		115

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges	14		(44)		(4)		34
Significant items (benefit) charge	33		71		297		271

Corporate expenses	26		28		86		84
Segment operating EBITDA	$	(74)	$	46	$	2,937	$	3,079


Segment assets to total assets (In millions)	September 30, 2024		December 31, 2023		September 30, 2023
Total segment assets	$	37,087	$	37,736	$	38,275
Corporate assets	4,821		5,260		4,835
Total assets	$	41,908	$	42,996	$	43,110

Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA

The three and nine months ended September 30, 2024 and 2023, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA:


(In millions)	Seed		Crop Protection		Corporate		Total
For the Three Months Ended September 30, 2024
Restructuring and asset related charges - net1	$	(3)	$	(10)	$	(19)	$	(32)



Acquisition-related costs4	—		(1)		—		(1)

Total	$	(3)	$	(11)	$	(19)	$	(33)


(In millions)	Seed		Crop Protection		Corporate		Total
For the Three Months Ended September 30, 2023
Restructuring and asset related charges - net1	$	1	$	—	$	(3)	$	(2)
Estimated settlement expense2	—		(66)		—		(66)
Gain (loss) on sale of business, assets and equity investments3	4		—		—		4

Acquisition-related costs4	—		(7)		—		(7)

Total	$	5	$	(73)	$	(3)	$	(71)


(In millions)	Seed		Crop Protection		Corporate		Total
For the Nine Months Ended September 30, 2024
Restructuring and asset related charges - net1	$	(56)	$	(83)	$	(60)	$	(199)
Estimated settlement expense2	—		(101)		—		(101)
Inventory write-offs3	2		—		—		2
Gain (loss) on sale of assets3	4		3		—		7
Acquisition-related costs4	—		(6)		—		(6)

Total	$	(50)	$	(187)	$	(60)	$	(297)


(In millions)	Seed		Crop Protection		Corporate		Total
For the Nine Months Ended September 30, 2023
Restructuring and asset related charges - net1	$	(74)	$	(11)	$	(10)	$	(95)
Estimated settlement expense2	—		(156)		—		(156)
Inventory write-offs3	(7)		—		—		(7)
Gain (loss) on sale of business, assets and equity investments3	4		3		—		7
Seed sale associated with Russia Exit3,5	18		—		—		18
Acquisition-related costs4	—		(41)		—		(41)
Employee Retention Credit	—		3		—		3
Total	$	(59)	$	(202)	$	(10)	$	(271)

1.Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements, for additional information.

2.Consists of estimated Lorsban® related charges.

3.Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions. The nine months ended September 30, 2024 includes a $2 million benefit associated with sales of inventory previously reserved for in association with the 2022 Restructuring Actions.

4.Relates to acquisition-related costs, including transaction and third-party integration costs associated with the completed acquisitions of Stoller and Symborg as well as the recognition of the inventory fair value step-up. See Note 3 - Business Combinations, to the interim Consolidated Financial Statements, for additional information.

5.Includes a benefit (charge) of $18 million for the nine months ended September 30, 2023, relating to the sale of seeds already under production in Russia when the decision to exit the country was made and that the company was contractually required to purchase. It consists of $71 million of net sales and $53 million of cost of goods sold for the nine months ended September 30, 2023.

EIDP

Segment Reporting Information [Line Items]

Segment Reporting Disclosure [Text Block]

SEGMENT INFORMATION

There are no differences in reporting structure or segments between Corteva, Inc. and EIDP. In addition, there are no differences between Corteva, Inc. and EIDP segment net sales, segment operating EBITDA, segment assets, or significant items by segment; refer to page 38 of the Corteva, Inc. interim Consolidated Financial Statements for background information on the segments as well as further details regarding segment metrics. The tables below reconcile income (loss) from continuing operations after income taxes to segment operating EBITDA, as differences exist between Corteva, Inc. and EIDP.

Reconciliation to interim Consolidated Financial Statements


Income (loss) from continuing operations after income taxes to segment operating EBITDA	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Income (loss) from continuing operations after income taxes	$	(505)	$	(317)	$	942	$	1,155
Provision for (benefit from) income taxes on continuing operations	(110)		(129)		283		239
Income (loss) from continuing operations before income taxes	$	(615)	$	(446)	$	1,225	$	1,394
Depreciation and amortization	306		306		925		899
Interest income	(51)		(59)		(131)		(153)
Interest expense	66		60		173		193
Exchange (gains) losses	97		102		234		242
Non-operating (benefits) costs	50		28		132		115

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges	14		(44)		(4)		34
Significant items (benefit) charge	33		71		297		271

Corporate expenses	26		28		86		84
Segment operating EBITDA	$	(74)	$	46	$	2,937	$	3,079

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-15

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-31

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-42

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-40

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//280/tableOfContent

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-26

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-34

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-41

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-21

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-21

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

+ Details

EIDP Segment FN (Tables)

9 Months Ended

Sep. 30, 2024

Segment Reporting Information [Line Items]

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

Reconciliation to interim Consolidated Financial Statements


Income (loss) from continuing operations after income taxes to segment operating EBITDA	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Income (loss) from continuing operations after income taxes	$	(519)	$	(315)	$	913	$	1,172
Provision for (benefit from) income taxes on continuing operations	(114)		(129)		274		244
Income (loss) from continuing operations before income taxes	$	(633)	$	(444)	$	1,187	$	1,416
Depreciation and amortization	306		306		925		899
Interest income	(33)		(59)		(93)		(153)
Interest expense	66		58		173		171
Exchange (gains) losses	97		102		234		242
Non-operating (benefits) costs	50		28		132		115

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges	14		(44)		(4)		34
Significant items (benefit) charge	33		71		297		271

Corporate expenses	26		28		86		84
Segment operating EBITDA	$	(74)	$	46	$	2,937	$	3,079

Reconciliation of Assets from Segment to Consolidated [Table Text Block]


Segment assets to total assets (In millions)	September 30, 2024		December 31, 2023		September 30, 2023
Total segment assets	$	37,087	$	37,736	$	38,275
Corporate assets	4,821		5,260		4,835
Total assets	$	41,908	$	42,996	$	43,110

EIDP

Segment Reporting Information [Line Items]

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]


Income (loss) from continuing operations after income taxes to segment operating EBITDA	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Income (loss) from continuing operations after income taxes	$	(505)	$	(317)	$	942	$	1,155
Provision for (benefit from) income taxes on continuing operations	(110)		(129)		283		239
Income (loss) from continuing operations before income taxes	$	(615)	$	(446)	$	1,225	$	1,394
Depreciation and amortization	306		306		925		899
Interest income	(51)		(59)		(131)		(153)
Interest expense	66		60		173		193
Exchange (gains) losses	97		102		234		242
Non-operating (benefits) costs	50		28		132		115

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges	14		(44)		(4)		34
Significant items (benefit) charge	33		71		297		271

Corporate expenses	26		28		86		84
Segment operating EBITDA	$	(74)	$	46	$	2,937	$	3,079

Supplementary Information Foreign Currency Exchange Gain (Loss) (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Sep. 30, 2023

Foreign Currency Exchange Gain (Loss) [Line Items]

Pre-tax exchange (losses) gains - net

^[1]

$ (97)

$ (102)

$ (234)

$ (242)

Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit

(7)

Foreign Currency Transaction (Loss) Gain After Tax

(104)

(87)

(204)

(203)

Corteva [Member]

Foreign Currency Exchange Gain (Loss) [Line Items]

Foreign Currency Transaction (Loss) Gain After Tax

(104)

(87)

(203)

EIDP

Foreign Currency Exchange Gain (Loss) [Line Items]

Foreign Currency Transaction (Loss) Gain After Tax

Subsidiary Monetary Position

Foreign Currency Exchange Gain (Loss) [Line Items]

Pre-tax exchange (losses) gains - net

(156)

(104)

(199)

(182)

Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit

Foreign Currency Transaction (Loss) Gain After Tax

(151)

(85)

(176)

(155)

Hedging Program [Member]

Foreign Currency Exchange Gain (Loss) [Line Items]

Pre-tax exchange (losses) gains - net

(35)

(60)

Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit

(12)

(4)

Foreign Currency Transaction (Loss) Gain After Tax

$ 47

$ (2)

$ (28)

$ (48)

[1]

Stockholders' Equity

9 Months Ended

Sep. 30, 2024

Equity [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

STOCKHOLDERS' EQUITY

Share Buyback Plan

On September 13, 2022, Corteva, Inc. announced that its Board of Directors authorized a $2 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2022 Share Buyback Plan"). The timing, price and volume of purchases will be based on market conditions, relevant securities laws and other factors. In connection with the 2022 Share Buyback Plan, the company repurchased and retired 4,722,000 shares and 4,913,000 shares in the open market for a total cost (excluding excise taxes) of $250 million for both the three months ended September 30, 2024 and 2023, respectively, and 13,838,000 shares and 6,330,000 shares in the open market for a total cost (excluding excise taxes) of $750 million and $330 million during the nine months ended September 30, 2024 and 2023 respectively.

On August 5, 2021, Corteva, Inc. announced that its Board of Directors authorized a $1.5 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2021 Share Buyback Plan"). The company completed the 2021 Share Buyback Plan during the first quarter of 2023 and repurchased and retired 4,098,000, 17,425,000 and 5,572,000 shares in the open market for a total cost of $250 million, $1 billion and $250 million during the years ended December 31, 2023, 2022 and 2021, respectively.

Shares repurchased pursuant to Corteva's share buyback plans are immediately retired upon repurchase. Repurchased common stock is reflected as a reduction of stockholders' equity. The company's accounting policy related to its share repurchases is to reduce its common stock based on the par value of the shares and to reduce its retained earnings for the excess of the repurchase price over the par value. When Corteva has an accumulated deficit balance, the excess over the par value is applied to additional paid-in capital ("APIC"). When Corteva has retained earnings, the excess is charged entirely to retained earnings.

Noncontrolling Interest

Corteva, Inc. owns 100 percent of the outstanding common shares of EIDP. However, EIDP has preferred stock outstanding to third parties which is accounted for as a non-controlling interest in Corteva's interim Consolidated Balance Sheets. Each share of EIDP Preferred Stock - $4.50 Series and EIDP Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EIDP and was unaffected by the Corteva Distribution.

Below is a summary of the EIDP Preferred Stock at September 30, 2024, December 31, 2023 and September 30, 2023, which is classified as noncontrolling interests in Corteva's interim Consolidated Balance Sheets.


(Shares in thousands)			Number of Shares
Authorized			23,000
$4.50 Series, callable at $120			1,673
$3.50 Series, callable at $102			700

Other Comprehensive Income (Loss)

The changes and after-tax balances of components comprising accumulated other comprehensive income (loss) are summarized below:


(In millions)	Cumulative Translation Adjustment1		Derivative Instruments		Pension Benefit Plans		Other Benefit Plans		Unrealized Gain (Loss) on Investments		Total






2023
Balance at January 1, 2023	$	(2,883)	$	80	$	(163)	$	160	$	—	$	(2,806)
Other comprehensive income (loss) before reclassifications	(41)		(114)		6		—		—		(149)
Amounts reclassified from accumulated other comprehensive income (loss)	—		(40)		—		(6)		—		(46)
Net other comprehensive income (loss)	(41)		(154)		6		(6)		—		(195)
Balance at September 30, 2023	$	(2,924)	$	(74)	$	(157)	$	154	$	—	$	(3,001)

2024
Balance at January 1, 2024	$	(2,458)	$	(55)	$	(353)	$	189	$	—	$	(2,677)
Other comprehensive income (loss) before reclassifications	(206)		(8)		2		—		(14)		(226)
Amounts reclassified from accumulated other comprehensive income (loss)	—		25		(1)		(7)		—		17
Net other comprehensive income (loss)	(206)		17		1		(7)		(14)		(209)

Balance at September 30, 2024	$	(2,664)	$	(38)	$	(352)	$	182	$	(14)	$	(2,886)

1.The cumulative translation adjustment loss for the nine months ended September 30, 2024 was primarily driven by the strengthening of the USD against the Brazilian Real (“BRL”) and Mexican Peso ("MXN"). The cumulative translation adjustment loss for the nine months ended September 30, 2023 was primarily driven by the strengthening of the USD against the South African Rand ("ZAR") and Euro ("EUR"), partially offset by the weakening of the USD against the Brazilian Real (BRL).

The tax (expense) benefit on the net activity related to each component of other comprehensive income (loss) was as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Derivative instruments	$	(4)	$	(3)	$	(13)	$	59
Pension benefit plans - net	—		—		—		—
Other benefit plans - net	1		1		3		2
Unrealized gains (losses) on investments	—		—		—		—
(Provision for) benefit from income taxes related to other comprehensive income (loss) items	$	(3)	$	(2)	$	(10)	$	61

A summary of the reclassifications out of accumulated other comprehensive income (loss) is provided as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Derivative instruments1:	$	12	$	16	$	38	$	(50)
Tax (benefit) expense2	(4)		(5)		(13)		10
After-tax	$	8	$	11	$	25	$	(40)
Amortization of pension benefit plans:
Prior service (benefit) cost3,4	$	(1)	$	—	$	(2)	$	(2)


Settlement (gain) loss3,4	1		1		1		1
Total before tax	$	—	$	1	$	(1)	$	(1)
Tax (benefit) expense2	(1)		—		—		1
After-tax	$	(1)	$	1	$	(1)	$	—
Amortization of other benefit plans:
Prior service (benefit) cost3,4	$	—	$	(1)	$	(1)	$	(1)
Actuarial (gains) loss3,4	(3)		(2)		(9)		(7)

Total before tax	$	(3)	$	(3)	$	(10)	$	(8)
Tax (benefit) expense2	1		1		3		2
After-tax	$	(2)	$	(2)	$	(7)	$	(6)






Total reclassifications for the period, after-tax	$	5	$	10	$	17	$	(46)

1.Reflected in cost of goods sold in the interim Consolidated Statements of Operations.

2.Reflected in provision for (benefit from) income taxes from continuing operations in the interim Consolidated Statements of Operations.

3.These accumulated other comprehensive income (loss) components are included in the computation of net periodic benefit (credit) cost of the company's pension and other benefit plans. See Note 15 - Pension Plans and Other Post Employment Benefits, to the interim Consolidated Financial Statements, for additional information.

4.Reflected in other income (expense) - net in the interim Consolidated Statements of Operations.

- Definition

The entire disclosure for equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481004/946-505-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480237/815-40-50-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//505/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 16
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-16

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

+ Details

Consolidated Statements of Comprehensive (Loss) Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Net income	$ (521)	$ (318)	$ 958	$ 998
Cumulative Translation Adjustments	424	(323)	(206)	(41)
Derivative Instruments	7	(2)	17	(154)
Unrealized Gain (Loss) on Investments	9	0	(14)	0
Total other comprehensive income (loss)	438	(324)	(209)	(195)
Comprehensive income (loss)	(83)	(642)	749	803
Comprehensive Income Attributable to Noncontrolling Interest - Net of Tax	3	3	10	10
Comprehensive Income (Loss) Attributable to Corteva	(86)	(645)	739	793
Net Cash Provided by (Used in) Operating Activities, Continuing Operations			(1,871)	(2,574)
Pension Plan
Adjustments to other benefit plans	0	3	1	6
Other Benefit Plans
Adjustments to other benefit plans	(2)	(2)	(7)	(6)
EIDP
Net income	(507)	(320)	987	981
Cumulative Translation Adjustments	424	(323)	(206)	(41)
Derivative Instruments	7	(2)	17	(154)
Unrealized Gain (Loss) on Investments	9	0	(14)	0
Total other comprehensive income (loss)	438	(324)	(209)	(195)
Comprehensive income (loss)	(69)	(644)	778	786
Comprehensive Income Attributable to Noncontrolling Interest - Net of Tax	1	0	3	2
Comprehensive Income (Loss) Attributable to Corteva	(70)	(644)	775	784
Net Cash Provided by (Used in) Operating Activities, Continuing Operations			(2,977)	(2,585)
EIDP \| Pension Plan
Adjustments to other benefit plans	0	3	1	6
EIDP \| Other Benefit Plans
Adjustments to other benefit plans	$ (2)	$ (2)	$ (7)	$ (6)

Revenue Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 140	$ 134	$ 135
Minimum [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Maximum [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	6 years

Consolidated Balance Sheets - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Sep. 30, 2023

Dec. 31, 2023

Cash and cash equivalents

$ 2,421

$ 2,254

$ 2,421

$ 2,254

$ 2,644

Marketable Securities

108

Accounts and notes receivable - net

6,651

6,581

6,651

6,581

5,488

Inventories

5,674

6,320

5,674

6,320

6,899

Other current assets

831

1,070

831

1,070

1,131

Total current assets

15,649

16,333

15,649

16,333

16,260

Investments in nonconsolidated affiliates

128

106

128

106

115

Property, Plant and Equipment

9,235

8,892

9,235

8,892

8,956

Less: Accumulated Depreciation

5,025

4,572

5,025

4,572

4,669

Net Property, Plant and Equipment

4,210

4,320

4,210

4,320

4,287

Goodwill

10,629

10,441

10,629

10,441

10,605

Other intangible assets

9,084

9,795

9,084

9,795

9,626

Deferred Income Taxes

564

554

564

554

584

Other assets

1,644

1,561

1,644

1,561

1,519

Total Assets

41,908

43,110

41,908

43,110

42,996

Short-term borrowings and finance lease obligations

3,741

3,609

3,741

3,609

198

Accounts payable

3,753

3,678

3,753

3,678

4,280

Income Taxes Payable

313

236

313

236

174

Deferred Revenue

429

552

429

552

3,406

Accrued and other current liabilities

2,188

2,273

2,188

2,273

2,351

Total current liabilities

10,424

10,348

10,424

10,348

10,409

Long-term Debt

1,975

2,290

1,975

2,290

2,291

Deferred income tax liabilities

496

1,070

496

1,070

899

Pension and other post employment benefits - noncurrent

2,473

2,228

2,473

2,228

2,467

Other noncurrent obligations

1,561

1,707

1,561

1,707

1,651

Total noncurrent liabilities

6,505

7,295

6,505

7,295

7,308

Common stock

Additional Paid in Capital

27,518

27,895

27,518

27,895

27,748

Retained earnings (accumulated deficit)

325

(41)

Accumulated Other Comprehensive Income (Loss), Net of Tax

(2,886)

(3,001)

(2,886)

(3,001)

(2,677)

Total stockholders' equity attributable to the company

24,737

25,226

24,737

25,226

25,037

Noncontrolling Interests

242

241

242

241

242

Total Equity

24,979

25,467

24,979

25,467

25,279

Liabilities and Equity

41,908

43,110

41,908

43,110

42,996

Net exchange gains (losses)

^[1]

(97)

(102)

(234)

(242)

Hedging Program [Member]

Net exchange gains (losses)

(35)

(60)

Argentine Peso Devaluation [Member] | Hedging Program [Member]

Net exchange gains (losses)

(26)

(83)

(54)

(150)

EIDP

Cash and cash equivalents

2,421

2,254

2,421

2,254

2,644

Marketable Securities

108

Accounts and notes receivable - net

6,651

6,581

6,651

6,581

5,488

Inventories

5,674

6,320

5,674

6,320

6,899

Other current assets

831

1,070

831

1,070

1,131

Total current assets

15,649

16,333

15,649

16,333

16,260

Investments in nonconsolidated affiliates

128

106

128

106

115

Property, Plant and Equipment

9,235

8,892

9,235

8,892

8,956

Less: Accumulated Depreciation

5,025

4,572

5,025

4,572

4,669

Net Property, Plant and Equipment

4,210

4,320

4,210

4,320

4,287

Goodwill

10,629

10,441

10,629

10,441

10,605

Other intangible assets

9,084

9,795

9,084

9,795

9,626

Deferred Income Taxes

564

554

564

554

584

Other assets

3,149

1,778

3,149

1,778

1,896

Total Assets

43,413

43,327

43,413

43,327

43,373

Short-term borrowings and finance lease obligations

3,741

3,609

3,741

3,609

198

Accounts payable

3,753

3,678

3,753

3,678

4,280

Income Taxes Payable

313

236

313

236

174

Deferred Revenue

429

552

429

552

3,406

Accrued and other current liabilities

2,177

2,284

2,177

2,284

2,347

Total current liabilities

10,413

10,474

10,413

10,474

10,405

Long-term Debt

1,975

2,290

1,975

2,290

2,291

Deferred income tax liabilities

496

1,070

496

1,070

899

Pension and other post employment benefits - noncurrent

2,473

2,228

2,473

2,228

2,467

Other noncurrent obligations

1,561

1,707

1,561

1,707

1,651

Total noncurrent liabilities

6,505

7,295

6,505

7,295

7,308

Common stock

Additional Paid in Capital

24,417

24,323

24,417

24,323

24,349

Retained earnings (accumulated deficit)

4,722

3,995

4,722

3,995

3,747

Accumulated Other Comprehensive Income (Loss), Net of Tax

(2,886)

(3,001)

(2,886)

(3,001)

(2,677)

Total stockholders' equity attributable to the company

26,492

25,556

26,492

25,556

25,658

Noncontrolling Interests

Total Equity

26,495

25,558

26,495

25,558

25,660

Liabilities and Equity

43,413

43,327

43,413

43,327

43,373

EIDP | $4.50 Series Preferred Stock [Member]

Preferred Stock

169

EIDP | $3.50 Series Preferred Stock [Member]

Preferred Stock

Corteva [Member] | EIDP

Other assets

1,505

217

1,505

217

377

Short-term borrowings

$ 0

$ 115

$ 0

$ 115

$ 0

[1]

Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2024

Segment Reporting Information [Line Items]

Schedule of Segment Reporting Information, by Segment [Table Text Block]


As of and for the Three Months Ended September 30, (In millions)	Seed		Crop Protection		Total
2024
Net sales	$	691	$	1,635	$	2,326
Segment operating EBITDA	(320)		246		(74)
Segment assets1	22,192		14,895		37,087

2023
Net sales	$	878	$	1,712	$	2,590
Segment operating EBITDA	(138)		184		46
Segment assets1	22,829		15,446		38,275

1. Segment assets at December 31, 2023 were $22,732 million and $15,004 million for Seed and Crop Protection, respectively.


As of and for the Nine Months Ended September 30, (In millions)	Seed		Crop Protection		Total
2024
Net sales	$	7,773	$	5,157	$	12,930
Segment operating EBITDA	2,126		811		2,937


2023
Net sales	$	7,837	$	5,682	$	13,519
Segment operating EBITDA	1,972		1,107		3,079

Reconciliation of Assets from Segment to Consolidated [Table Text Block]


Segment assets to total assets (In millions)	September 30, 2024		December 31, 2023		September 30, 2023
Total segment assets	$	37,087	$	37,736	$	38,275
Corporate assets	4,821		5,260		4,835
Total assets	$	41,908	$	42,996	$	43,110

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

Reconciliation to interim Consolidated Financial Statements


Income (loss) from continuing operations after income taxes to segment operating EBITDA	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Income (loss) from continuing operations after income taxes	$	(519)	$	(315)	$	913	$	1,172
Provision for (benefit from) income taxes on continuing operations	(114)		(129)		274		244
Income (loss) from continuing operations before income taxes	$	(633)	$	(444)	$	1,187	$	1,416
Depreciation and amortization	306		306		925		899
Interest income	(33)		(59)		(93)		(153)
Interest expense	66		58		173		171
Exchange (gains) losses	97		102		234		242
Non-operating (benefits) costs	50		28		132		115

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges	14		(44)		(4)		34
Significant items (benefit) charge	33		71		297		271

Corporate expenses	26		28		86		84
Segment operating EBITDA	$	(74)	$	46	$	2,937	$	3,079

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included. Results for interim periods should not be considered indicative of results for a full year. These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2023, collectively referred to as the “2023 Annual Report.” The interim Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained. The interim Consolidated Financial Statements and other financial information included in this Form 10-Q, unless otherwise specified, have been presented to separately show the effects of discontinued operations. During the fourth quarter of 2023, the company made the decision, which was retrospectively applied, to adjust the presentation of the interim Consolidated Statement of Cash Flows to separately present the cash provided by (used for) operating activities – discontinued operations, which was previously presented within cash provided by (used for) operating activities. See Note 13 – Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements, for additional information on discontinued operations activities. Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 4 percent to the company's annual net sales and less than 4 percent to each of the company's annual Seed and Crop Protection segment operating EBITDA. The company remeasures net monetary assets utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 6 – Supplementary Information, to the interim Consolidated Financial Statements, and Note 7 – Supplementary Information, to the Consolidated Financial Statements, in the company's 2023 Annual Report). The Argentina government has offered USD-denominated bonds to importers, the proceeds from which could be used to pay off outstanding intercompany payables. During the first quarter of 2024, the company purchased $125 million of these foreign government bonds as part of its strategy to manage its net monetary asset exposure in Argentina. Refer to the “Debt Securities” section in Note 16 - Financial Instruments, to the interim Consolidated Financial Statements, for additional information. As of September 30, 2024, a further 10 percent deterioration in the official Peso to USD exchange rate would not have a significant impact on the USD value of our net monetary assets or pre-tax earnings. The company will continue to assess the implications to our operations and financial reporting.

Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Earnings Per Share [Abstract]
Income (loss) from continuing operations after income taxes	$ (519)	$ (315)	$ 913	$ 1,172
Net income (loss) Attributable to Noncontrolling Interest, Continuing Operations	3	3	10	10
Net income (loss) from Continuing Operations Available to Common Shareholders	(522)	(318)	903	1,162
Income (loss) from discontinued operations after income taxes	(2)	(3)	45	(174)
Basic earnings (loss) per share of common stock	$ (524)	$ (321)	$ 948	$ 988

- Definition

Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 810
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 19
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481231/810-10-45-19

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481687/323-10-50-3

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-28

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(11))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 21: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-31

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

+ Details

- Definition

Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(12))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482551/740-270-45-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483499/205-20-50-7

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 3A
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483475/205-20-45-3A

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5C
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 3B
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483475/205-20-45-3B

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483475/205-20-45-4

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483499/205-20-50-1

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483475/205-20-45-3

+ Details

- Definition

Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 5
-Subparagraph (SAB Topic 6.B)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-10

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-31

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-11

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

+ Details

EID - Basis of Presentation Narrative (Details) - $ / shares	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 26, 2019
Common Stock, Shares, Outstanding	689,170,000	701,260,000	704,880,000
Common Stock, Par Value	$ 0.01	$ 0.01	$ 0.01
EIDP
Common Stock, Shares, Outstanding	200	200	200
Common Stock, Par Value	$ 0.30	$ 0.30	$ 0.30
EIDP \| $4.50 Series Preferred Stock [Member]
Preferred Stock, Dividend Rate, Per-Dollar-Amount	4.50
EIDP \| $3.50 Series Preferred Stock [Member]
Preferred Stock, Dividend Rate, Per-Dollar-Amount	3.50
Corteva [Member]
Common Stock, Par Value	$ 0.01			$ 0.01
Corteva [Member] \| EIDP
Ownership interest in an entity	100.00%

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]


Net Income (Loss) for Earnings (Loss) Per Share Calculations - Basic and Diluted	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Income (loss) from continuing operations after income taxes	$	(519)	$	(315)	$	913	$	1,172
Net income (loss) attributable to continuing operations noncontrolling interests	3		3		10		10

Income (loss) from continuing operations available to Corteva common stockholders	(522)		(318)		903		1,162
Income (loss) from discontinued operations available to Corteva common stockholders	(2)		(3)		45		(174)
Net income (loss) available to common stockholders	$	(524)	$	(321)	$	948	$	988

Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]


Earnings (Loss) Per Share Calculations - Basic	Three Months Ended September 30,				Nine Months Ended September 30,
(Dollars per share)	2024		2023		2024		2023
Earnings (loss) per share of common stock from continuing operations	$	(0.76)	$	(0.45)	$	1.30	$	1.64
Earnings (loss) per share of common stock from discontinued operations	—		—		0.06		(0.24)
Earnings (loss) per share of common stock	$	(0.76)	$	(0.45)	$	1.36	$	1.40

Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]


Earnings (Loss) Per Share Calculations - Diluted	Three Months Ended September 30,				Nine Months Ended September 30,
(Dollars per share)	2024		2023		2024		2023
Earnings (loss) per share of common stock from continuing operations	$	(0.76)	$	(0.45)	$	1.29	$	1.63
Earnings (loss) per share of common stock from discontinued operations	—		—		0.06		(0.24)
Earnings (loss) per share of common stock	$	(0.76)	$	(0.45)	$	1.35	$	1.39

Schedule of Weighted Average Number of Shares


Share Count Information	Three Months Ended September 30,		Nine Months Ended September 30,
(Shares in millions)	2024	2023	2024	2023
Weighted-average common shares - basic	691.1	708.4	695.8	710.7
Plus: dilutive effect of equity compensation plans1	—	—	2.5	2.9

Weighted-average common shares - diluted	691.1	708.4	698.3	713.6
Potential shares of common stock excluded from EPS calculations2	2.5	2.2	3.4	2.4

1.Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.

2.These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including them would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.

Financial Instruments Cash Flow Hedges Included in AOCI (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	$ 1,305	$ 2,199	$ 1,305	$ 2,199	$ 1,600
Designated as Hedging Instrument [Member] \| Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Remaining Maturity	2 years		2 years
Beginning Balance	$ (92)	(71)	$ (71)	55
Additions and revaluations of derivatives designated as cash flow hedges	25	(20)	(13)	(94)
Clearance of hedge results to earnings	7	2	24	(50)
Ending Balance	$ (60)	(89)	(60)	(89)
After-tax net gain (loss) to be reclassified from AOCL into earnings over the next twelve months			$ 70
Designated as Hedging Instrument [Member] \| Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Remaining Maturity	2 years		2 years
Beginning Balance	$ 20	(16)	$ 1	10
Additions and revaluations of derivatives designated as cash flow hedges	0	7	19	(20)
Clearance of hedge results to earnings	1	9	1	10
Ending Balance	$ 21	$ 0	21	$ 0
After-tax net gain (loss) to be reclassified from AOCL into earnings over the next twelve months			$ 21

EIDP Segment FN Segment reconciliation (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Sep. 30, 2023

Segment Reporting Information [Line Items]

Income (loss) from continuing operations after income taxes

$ (519)

$ (315)

$ 913

$ 1,172

Provision for (benefit from) income taxes on continuing operations

(114)

(129)

274

244

Income from continuing operations before income taxes

(633)

(444)

1,187

1,416

Depreciation and Amortization

925

899

Interest income

153

Interest Expense

173

171

Exchange (gains) losses - net

^[1]

(97)

(102)

(234)

(242)

Segment operating EBITDA

(74)

2,937

3,079

EIDP

Segment Reporting Information [Line Items]

Income (loss) from continuing operations after income taxes

(505)

(317)

942

1,155

Provision for (benefit from) income taxes on continuing operations

(110)

(129)

283

239

Income from continuing operations before income taxes

(615)

(446)

1,225

1,394

Depreciation and Amortization

925

899

Interest Expense

173

193

Segment operating EBITDA

(74)

2,937

3,079

Segment Reconciling Items [Member]

Segment Reporting Information [Line Items]

Depreciation and Amortization

306

925

899

Interest income

(33)

(59)

(93)

(153)

Exchange (gains) losses - net

102

234

242

Nonoperating (benefits) costs

132

115

Mark-to-market (gain) loss on certain foreign currency contracts not designated as hedges

(44)

(4)

Significant Items (benefits) charge

(33)

(71)

(297)

(271)

Corporate Expenses

Segment Reconciling Items [Member] | EIDP

Segment Reporting Information [Line Items]

Depreciation and Amortization

306

925

899

Interest income

(51)

(59)

(131)

(153)

Exchange (gains) losses - net

102

234

242

Nonoperating (benefits) costs

132

115

Mark-to-market (gain) loss on certain foreign currency contracts not designated as hedges

(44)

(4)

Significant Items (benefits) charge

297

271

Corporate Expenses

Crop Protection [Member] | Segment Reconciling Items [Member]

Segment Reporting Information [Line Items]

Significant Items (benefits) charge

$ (11)

$ (73)

$ (187)

$ (202)

[1]

Goodwill (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Goodwill [Line Items]
Goodwill, Beginning Balance	$ 10,605	$ 10,441
Goodwill, Ending Balance	$ 10,629	$ 10,605

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References + Details

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482548/350-20-55-24

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-2

+ Details

EIDP - Related Party Transactions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Related Party Transaction [Line Items]
Accrued and other current liabilities	$ 2,188	$ 2,273	$ 2,188	$ 2,273	$ 2,351
Other assets	1,644	1,561	1,644	1,561	1,519
EIDP
Related Party Transaction [Line Items]
Accrued and other current liabilities	2,177	2,284	2,177	2,284	2,347
Other assets	3,149	$ 1,778	3,149	$ 1,778	1,896
EIDP \| Corteva [Member]
Related Party Transaction [Line Items]
Debt, Weighted Average Interest Rate		7.00%		7.00%
Interest Expense		$ 2		$ 22
Short-term borrowings	0	115	0	115	0
Other assets	1,505	217	1,505	217	377
Interest Income, Other	18		38
Accrued and Other Current Liabilities [Member] \| EIDP \| Corteva [Member]
Related Party Transaction [Line Items]
Accrued and other current liabilities	19	38	19	38	30
Other noncurrent obligations \| EIDP \| Corteva [Member]
Related Party Transaction [Line Items]
Accounts Payable and Accrued Liabilities, Noncurrent	$ 141	$ 108	$ 141	$ 108	$ 106

Subsequent Events (Details) - USD ($) $ in Millions	9 Months Ended
Subsequent Events (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Subsequent Event [Line Items]
Restructuring Charges	$ 199	$ 95

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Long-term Debt (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Feb. 20, 2024	Dec. 31, 2023	Sep. 30, 2023	May 01, 2023	Feb. 01, 2023
Debt Instrument [Line Items]
Long-term Debt Payable within one year	$ 500		$ 196	$ 188
Long-term Debt and Lease Obligation	1,975		2,291	2,290
Finance Lease, Liability, Noncurrent	0		1	1
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	13		16	17
Line of Credit Facility, Maximum Borrowing Capacity	5,750
Line of Credit Facility, Remaining Borrowing Capacity	5,750
EIDP
Debt Instrument [Line Items]
Long-term Debt and Lease Obligation	1,975		2,291	2,290
Foreign Currency Loans
Debt Instrument [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	38
Revolving Credit Facilities due 2027
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	1,900
Line of Credit Facility, Remaining Borrowing Capacity	$ 1,900
Debt Instrument, Term	3 years
Revolving Credit Facilities due 2027 \| EIDP
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 3,000
Debt Instrument, Term	5 years
Revolving Credit Facilities due 2025 [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 2,000
Debt Instrument, Term	3 years
364-day Revolving Credit Facilities due 2023
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity					$ 1,000	$ 1,000
Revolving Credit Facilities due 2029
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 2,850
Line of Credit Facility, Remaining Borrowing Capacity	$ 2,850
Debt Instrument, Term	5 years
364-day Revolving Credit Facilities due 2025
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,000	$ 1,000
Line of Credit Facility, Remaining Borrowing Capacity	$ 1,000
Debt Instrument, Term	364 days
Medium-term Notes [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 104		$ 106	$ 106
Long-term Debt, Weighted Average Interest Rate, at Point in Time	4.94%		5.34%	5.33%
Loans Payable [Member] \| Foreign Currency Loans
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 184		$ 196	$ 188
Foreign Currency Loans
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time	12.70%		14.80%	14.80%
Senior Notes \| Notes Maturing 2025 [Domain]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 500		$ 500	$ 500
Long-term Debt, Weighted Average Interest Rate, at Point in Time	1.70%		1.70%	1.70%
Senior Notes \| Notes Maturing 2026 [Domain]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 600		$ 600	$ 600
Long-term Debt, Weighted Average Interest Rate, at Point in Time	4.50%		4.50%	4.50%
Senior Notes \| Notes Maturing 2030 [Domain]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 500		$ 500	$ 500
Long-term Debt, Weighted Average Interest Rate, at Point in Time	2.30%		2.30%	2.30%
Senior Notes \| Notes Maturing 2033 [Domain]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 600		$ 600	$ 600
Long-term Debt, Weighted Average Interest Rate, at Point in Time	4.80%		4.80%	4.80%
Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value	$ 2,437		$ 2,434	$ 2,320

Business Combinations and Asset Acquisitions (Details)- Purchase Price Allocation $ in Millions	12 Months Ended
	Feb. 29, 2024 USD ($)
Stoller
Asset Acquisition [Line Items]
Payments to Acquire Businesses, Gross	$ 1,220
Symborg
Asset Acquisition [Line Items]
Payments to Acquire Businesses, Gross	$ 370

DEI Document - shares	9 Months Ended
DEI Document - shares	Sep. 30, 2024	Oct. 31, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Amendment Flag	false
Document Transition Report	false
Entity File Number	001-38710
Entity Registrant Name	Corteva, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-4979096
Entity Address, Address Line One	9330 Zionsville Road,
Entity Address, City or Town	Indianapolis,
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	46268
City Area Code	(833)
Local Phone Number	267-8382
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		687,293,000
Entity Central Index Key	0001755672
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Small Business	false
Entity Current Reporting Status	Yes
Other Address
Document Information [Line Items]
Entity Address, Address Line One	974 Centre Road,
Entity Address, City or Town	Wilmington,
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19805
Common Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	CTVA
Security Exchange Name	NYSE
EIDP
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Amendment Flag	false
Document Transition Report	false
Entity File Number	1-815
Entity Registrant Name	EIDP, Inc.
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	9330 Zionsville Road,
Entity Address, City or Town	Indianapolis,
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	46268
City Area Code	(833)
Local Phone Number	267-8382
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		200
Entity Central Index Key	0000030554
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Small Business	false
Entity Current Reporting Status	Yes
EIDP \| Other Address
Document Information [Line Items]
Entity Address, Address Line One	974 Centre Road,
Entity Address, City or Town	Wilmington,
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19805
EIDP \| $3.50 Series Preferred Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	$3.50 Series Preferred Stock
Trading Symbol	CTAPrA
Security Exchange Name	NYSE
EIDP \| $4.50 Series Preferred Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	$4.50 Series Preferred Stock
Trading Symbol	CTAPrB
Security Exchange Name	NYSE

Income Taxes Income Tax Narrative (Details)	3 Months Ended		9 Months Ended
Income Taxes Income Tax Narrative (Details)	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Effective Income Tax Rate	18.00%	29.10%	23.10%	17.20%
EIDP
Effective Income Tax Rate	17.90%	28.90%	23.10%	17.10%

Financial Instruments Fair Value of Derivatives (Details) - USD ($)
$ in Millions

Sep. 30, 2024

Dec. 31, 2023

Sep. 30, 2023

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Asset, Statement of Financial Position [Extensible Enumeration]

Other current assets

Derivative Asset, Gross

$ 110

$ 88

$ 53

Derivative Asset, Counterparty and Cash Collateral Netting

^[1]

(61)

(33)

(39)

Derivative Asset, Net

$ 49

$ 55

$ 14

Derivative Liability, Statement of Financial Position [Extensible Enumeration]

Accrued and other current liabilities

Derivative Liability, Gross

$ 91

$ 75

$ 100

Derivative Liability, Counterparty and Cash Collateral Netting

^[1]

(61)

(33)

(39)

Derivative Liability, Net

Foreign Currency Contract [Member] | Designated as Hedging Instrument [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Asset, Gross

Derivative Asset, Counterparty and Cash Collateral Netting

^[1]

Derivative Asset, Net

Derivative Liability, Gross

Derivative Liability, Counterparty and Cash Collateral Netting

^[1]

Derivative Liability, Net

Foreign Currency Contract [Member] | Not Designated as Hedging Instrument [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Asset, Gross

105

Derivative Asset, Counterparty and Cash Collateral Netting

^[1]

(61)

(33)

(39)

Derivative Asset, Net

Derivative Liability, Gross

Derivative Liability, Counterparty and Cash Collateral Netting

^[1]

(61)

(33)

(39)

Derivative Liability, Net

Commodity Contract [Member] | Designated as Hedging Instrument [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Asset, Gross

Derivative Asset, Counterparty and Cash Collateral Netting

^[1]

Derivative Asset, Net

Derivative Liability, Gross

Derivative Liability, Counterparty and Cash Collateral Netting

^[1]

Derivative Liability, Net

Commodity Contract [Member] | Not Designated as Hedging Instrument [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Asset, Gross

Derivative Asset, Counterparty and Cash Collateral Netting

^[1]

Derivative Asset, Net

Derivative Liability, Gross

Derivative Liability, Counterparty and Cash Collateral Netting

^[1]

Derivative Liability, Net

$ 3

$ 8

$ 3

[1]

Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities

9 Months Ended

Sep. 30, 2024

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

The following tables summarize Corteva's short-term borrowings and finance lease obligations and long-term debt:


Short-term borrowings and finance lease obligations
(In millions)	September 30, 2024		December 31, 2023		September 30, 2023
Commercial paper	$	2,969	$	—	$	3,417
364-Day Revolving Credit Facility	—		—		—
Other loans - various currencies	271		1		3
Long-term debt payable within one year	500		196		188
Finance lease obligations payable within one year	1		1		1
Total short-term borrowings and finance lease obligations	$	3,741	$	198	$	3,609


Long-term debt
(In millions)	September 30, 2024				December 31, 2023				September 30, 2023
	Amount		Weighted Average Rate		Amount		Weighted Average Rate		Amount		Weighted Average Rate
Promissory notes and debentures:
Maturing in 2025	$	500	1.70	%	$	500	1.70	%	$	500	1.70	%
Maturing in 2026	600		4.50	%	600		4.50	%	600		4.50	%
Maturing in 2030	500		2.30	%	500		2.30	%	500		2.30	%
Maturing in 2033	600		4.80	%	600		4.80	%	600		4.80	%
Other loans:
Foreign currency loans, various rates and maturities	184		12.70	%	196		14.80	%	188		14.80	%
Medium-term notes, varying maturities through 2041	104		4.94	%	106		5.34	%	106		5.33	%
Finance lease obligations	—				1				1
Less: Unamortized debt discount and issuance costs	13				16				17
Less: Long-term debt due within one year	500				196				188
Total long-term debt	$	1,975			$	2,291			$	2,290

The estimated fair value of the company's short-term and long-term borrowings, including interest rate financial instruments, was determined using Level 2 inputs within the fair value hierarchy. Based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's short-term borrowings and finance lease obligations approximated carrying value.

The fair value of the company’s long-term borrowings, including debt due within one year, was $2,437 million, $2,434 million and $2,320 million as of September 30, 2024, December 31, 2023 and September 30, 2023, respectively.

Debt Offering

In May 2023, the company issued $600 million of 4.50 percent Senior Notes due in 2026 and $600 million of 4.80 percent Senior Notes due in 2033 (the “May 2023 Debt Offering”). The proceeds of this offering were used for general corporate purposes, including funding of working capital, capital expenditures and share repurchases.

Foreign Currency Loans

The company enters into short-term and long-term foreign currency loans from time-to-time by accessing uncommitted revolving credit lines to fund working capital needs of foreign subsidiaries in the normal course of business (“Foreign Currency Loans”). Interest rates are variable and determined at the time of borrowing. Total unused bank credit lines on the Foreign Currency Loans at September 30, 2024 was approximately $38 million. The company’s Foreign Currency Loans have varying maturities through 2026.

Available Committed Credit Facilities

The following table summarizes the company's credit facilities:

Committed and Available Credit Facilities at September 30, 2024

(In millions)

Effective Date

Committed Credit

Credit Available

Maturity Date

Interest

Revolving Credit Facility

June 2024

2,850

June 2029

Floating Rate

Revolving Credit Facility

June 2024

1,900

June 2027

Floating Rate

364-Day Revolving Credit Facility

February 2024

1,000

February 2025

Floating Rate

Total Committed and Available Credit Facilities

5,750

Revolving Credit Facilities

In May 2022, the company entered into a $3 billion, five-year revolving credit facility and a $2 billion, three-year revolving credit facility (the “Revolving Credit Facilities”) expiring in May 2027 and May 2025, respectively. Borrowings under the Revolving Credit Facilities will have an interest rate equal to Adjusted Term SOFR, which is Term SOFR plus 0.10 percent,

plus the applicable margin. In June 2024, the Revolving Credit Facilities were refinanced for purposes of extending the maturity dates for the five-year and three-year revolving credit facilities to June 2029 and June 2027, respectively, and lowering the facility amount of the five-year revolving credit facility to $2.85 billion and the three-year revolving credit facility to $1.9 billion. The Revolving Credit Facilities may serve as a substitute to the company's commercial paper program, and can be used, from time to time, for general corporate purposes including, but not limited to, the funding of seasonal working capital needs. The Revolving Credit Facilities contain customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings. Additionally, the Revolving Credit Facilities contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for Corteva and its consolidated subsidiaries not exceed 0.60. At September 30, 2024, the company was in compliance with these covenants.

364-Day Revolving Credit Facility

In February 2024, the company amended and restated its July 2023 (as amended in July 2023 and January 2024) 364-day revolving credit agreement (the “364-Day Revolving Credit Facility”) increasing the facility amount to $1 billion and extending the expiration date to February 2025. Borrowings under the 364-Day Revolving Credit Facility will have an interest rate equal to Adjusted Term SOFR, which is Term SOFR plus 0.10 percent, plus the applicable margin. The 364-Day Revolving Credit Facility includes a provision under which the company may convert any advances outstanding prior to the maturity date into term loans having a maturity date up to one year later. In February 2023, the company drew down $1 billion under the 364-Day Revolving Credit Facility, which was used for general corporate purposes, including funding seasonal working capital needs, capital spending, dividend payments, share repurchases and to partially fund the Stoller and Symborg acquisitions. In May 2023, the company repaid the $1 billion loan using the proceeds from the May 2023 Debt Offering. The 364-Day Revolving Credit Facility contains customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings. Additionally, the 364-Day Revolving Credit Facility contains a financial covenant requiring that the ratio of total indebtedness to total capitalization for Corteva and its consolidated subsidiaries not exceed 0.60. At September 30, 2024, the company was in compliance with these covenants.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//470/tableOfContent

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

+ Details

Other Intangible Assets Other Intangible Assets (Details) - USD ($)
$ in Millions

Sep. 30, 2024

Dec. 31, 2023

Sep. 30, 2023

Acquired Finite-Lived Intangible Assets [Line Items]

Finite-Lived Intangible Assets, Gross

$ 12,986

$ 13,073

$ 13,044

Finite-Lived Intangible Assets, Accumulated Amortization

(3,907)

(3,452)

(3,265)

Finite-Lived Intangible Assets, Net

9,079

9,621

9,779

Indefinite-lived Intangible Assets (Excluding Goodwill)

Intangible Assets, Gross (Excluding Goodwill)

12,991

13,078

13,060

Total other intangible assets

9,084

9,626

9,795

In Process Research and Development [Member]

Acquired Finite-Lived Intangible Assets [Line Items]

Indefinite-lived Intangible Assets (Excluding Goodwill)

Germplasm [Member]

Acquired Finite-Lived Intangible Assets [Line Items]

Finite-Lived Intangible Assets, Gross

6,291

Finite-Lived Intangible Assets, Accumulated Amortization

(1,272)

(1,081)

(1,017)

Finite-Lived Intangible Assets, Net

5,019

5,210

5,274

Acquired Finite-Lived Intangible Assets [Line Items]

Finite-Lived Intangible Assets, Gross

2,413

2,427

2,403

Finite-Lived Intangible Assets, Accumulated Amortization

(844)

(734)

(688)

Finite-Lived Intangible Assets, Net

1,569

1,693

1,715

Developed Technology Rights [Member]

Acquired Finite-Lived Intangible Assets [Line Items]

Finite-Lived Intangible Assets, Gross

1,838

1,849

1,845

Finite-Lived Intangible Assets, Accumulated Amortization

(1,126)

(1,004)

(958)

Finite-Lived Intangible Assets, Net

712

845

887

Trademarks and Trade Names [Member]

Acquired Finite-Lived Intangible Assets [Line Items]

Finite-Lived Intangible Assets, Gross

2,056

2,111

2,110

Finite-Lived Intangible Assets, Accumulated Amortization

(359)

(339)

(314)

Finite-Lived Intangible Assets, Net

1,697

1,772

1,796

Other Intangible Assets [Member]

Acquired Finite-Lived Intangible Assets [Line Items]

Finite-Lived Intangible Assets, Gross

^[1]

388

395

Finite-Lived Intangible Assets, Accumulated Amortization

^[1]

(306)

(294)

(288)

Finite-Lived Intangible Assets, Net

^[1]

$ 82

$ 101

$ 107

[1]	Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

Earnings Per Share (Notes)

9 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

EARNINGS PER SHARE OF COMMON STOCK

The following tables provide earnings per share calculations for the periods indicated below:


Net Income (Loss) for Earnings (Loss) Per Share Calculations - Basic and Diluted	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Income (loss) from continuing operations after income taxes	$	(519)	$	(315)	$	913	$	1,172
Net income (loss) attributable to continuing operations noncontrolling interests	3		3		10		10

Income (loss) from continuing operations available to Corteva common stockholders	(522)		(318)		903		1,162
Income (loss) from discontinued operations available to Corteva common stockholders	(2)		(3)		45		(174)
Net income (loss) available to common stockholders	$	(524)	$	(321)	$	948	$	988


Earnings (Loss) Per Share Calculations - Basic	Three Months Ended September 30,				Nine Months Ended September 30,
(Dollars per share)	2024		2023		2024		2023
Earnings (loss) per share of common stock from continuing operations	$	(0.76)	$	(0.45)	$	1.30	$	1.64
Earnings (loss) per share of common stock from discontinued operations	—		—		0.06		(0.24)
Earnings (loss) per share of common stock	$	(0.76)	$	(0.45)	$	1.36	$	1.40


Earnings (Loss) Per Share Calculations - Diluted	Three Months Ended September 30,				Nine Months Ended September 30,
(Dollars per share)	2024		2023		2024		2023
Earnings (loss) per share of common stock from continuing operations	$	(0.76)	$	(0.45)	$	1.29	$	1.63
Earnings (loss) per share of common stock from discontinued operations	—		—		0.06		(0.24)
Earnings (loss) per share of common stock	$	(0.76)	$	(0.45)	$	1.35	$	1.39


Share Count Information	Three Months Ended September 30,		Nine Months Ended September 30,
(Shares in millions)	2024	2023	2024	2023
Weighted-average common shares - basic	691.1	708.4	695.8	710.7
Plus: dilutive effect of equity compensation plans1	—	—	2.5	2.9

Weighted-average common shares - diluted	691.1	708.4	698.3	713.6
Potential shares of common stock excluded from EPS calculations2	2.5	2.2	3.4	2.4

Pension Plans and Other Post Employment Benefit Plans

9 Months Ended

Sep. 30, 2024

Retirement Benefits [Abstract]

Pension and other Post Employment Benefits

PENSION PLANS AND OTHER POST EMPLOYMENT BENEFITS

The following sets forth the components of the company's net periodic benefit (credit) cost for defined benefit pension plans and other post employment benefits ("OPEB"):


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Defined Benefit Pension Plans:
Service cost	$	3	$	3	$	12	$	13
Interest cost	162		171		488		518
Expected return on plan assets	(133)		(151)		(399)		(454)

Amortization of prior service (benefit) cost	—		—		(2)		(2)
Settlement loss	1		1		1		1
Net periodic benefit (credit) cost	$	33	$	24	$	100	$	76
Other Post Employment Benefits:
Service cost	$	—	$	1	$	—	$	1
Interest cost	11		12		31		36
Amortization of unrecognized (gain) loss	(3)		(2)		(9)		(7)
Amortization of prior service (benefit) cost	(1)		(1)		(1)		(1)

Net periodic benefit (credit) cost	$	7	$	10	$	21	$	29

Commitments and Contingent Liabilities Chemours (Details) $ in Millions	3 Months Ended	9 Months Ended
	Jun. 30, 2017 USD ($) lawsuits	Sep. 30, 2024 USD ($)	Dec. 31, 2028 USD ($)
PFOA Matters: Multi-District Litigation [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party	$ 670.0
Lawsuits alleging personal injury filed \| lawsuits	3,550
Corteva [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage		29.00%
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Corteva and DuPont stray liability threshold for PFAS		$ 200.0
Stray liability sharing percentage		71.00%
PFAS [Member]
Loss Contingencies [Line Items]
Minimum Settlement Amount Required To Allow Withdrawals From Escrow Account		$ 125.0
Threshold to waive MOU escrow account funding obligation		$ 100.0
PFAS [Member] \| Forecast [Member]
Loss Contingencies [Line Items]
Escrow Account Balance			$ 700.0
PFAS [Member] \| Maximum [Member]
Loss Contingencies [Line Items]
Cost Sharing Arrangement Term		20 years
Qualified Spend and Escrow Account Contribution Threshold		$ 4,000.0
PFAS [Member] \| Chemours [Member]
Loss Contingencies [Line Items]
Escrow Account Deposit Percentage		50.00%
PFAS [Member] \| Chemours [Member] \| No later than September 30 of each subsequent year through and including 2028
Loss Contingencies [Line Items]
Escrow Balance		$ 50.0
PFAS [Member] \| Chemours [Member] \| No later than each of September 30, 2021 and September 30, 2022
Loss Contingencies [Line Items]
Escrow Balance		100.0
PFAS [Member] \| Chemours [Member] \| Maximum [Member]
Loss Contingencies [Line Items]
Escrow Balance		$ 500.0
PFAS [Member] \| Corteva [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS		50.00%
PFAS [Member] \| Corteva [Member] \| Maximum [Member]
Loss Contingencies [Line Items]
Qualified Spend and Escrow Account Contribution Threshold		$ 600.0
PFAS [Member] \| DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS		50.00%
PFAS [Member] \| Corteva and DuPont
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS		50.00%
Escrow Account Deposit Percentage		50.00%
Amount credited to each company's threshold		$ 150.0
PFAS [Member] \| Corteva and DuPont \| No later than September 30 of each subsequent year through and including 2028
Loss Contingencies [Line Items]
Escrow Balance		50.0
PFAS [Member] \| Corteva and DuPont \| No later than each of September 30, 2021 and September 30, 2022
Loss Contingencies [Line Items]
Escrow Balance		100.0
PFAS [Member] \| Corteva and DuPont \| Maximum [Member]
Loss Contingencies [Line Items]
Qualified Spend and Escrow Account Contribution Threshold		2,000.0
Corteva and DuPont stray liability threshold for PFAS		300.0
Escrow Balance		$ 500.0

Restructuring and Asset Related Charges 2022 Restructuring Actions (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Sep. 30, 2023

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Incurred Cost

$ 32

$ 2

$ 199

$ 95

2022 Restructuring Actions

Restructuring Cost and Reserve [Line Items]

Anticipated Cash Payments

Restructuring and Related Cost, Incurred Cost

^[1],[2]

2022 Restructuring Actions | Severance and Related Benefit Costs

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Incurred Cost

^[3]

2022 Restructuring Actions | Asset Related Charges [Member]

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Incurred Cost

(2)

2022 Restructuring Actions | Contract Termination

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Incurred Cost

^[2]

$ 3

Seed [Member] | 2022 Restructuring Actions

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Incurred Cost

$ (2)

Crop Protection [Member] | 2022 Restructuring Actions

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Incurred Cost

$ 0

$ 5

[1]	The nine months ended September 30, 2024, reflects a benefit of $(2) million, associated with sales of inventory previously reserved for impacting the Seed segment. The three and nine months ended September 30, 2023 reflects charges of $1 million and $10 million, respectively, impacting the Seed segment, and $— and $5 million, respectively, impacting the Crop Protection segment.
[2]	This amount excludes other pre-tax charges recorded during the nine months ended September 30, 2024 and the three and nine months ended September 30, 2023 impacting the Seed segment included in cost of goods sold and other income (expense) – net, in the company’s interim Consolidated Statement of Operations, relating to inventory write-offs and a loss on the sale of the company's interest in an equity investment. See Note 18 - Segment Information, to the interim Consolidated Financial Statements, for additional information.
[3]	Reflects corporate-related charges.

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Earnings Per Share Share Count Information (Details) - shares
shares in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Sep. 30, 2023

Earnings Per Share [Abstract]

Weighted Average Common Shares - basic

691.1

708.4

695.8

710.7

Dilutive effect of equity compensation plans

^[1]

0.0

2.5

2.9

Weighted Average Common Shares - diluted

691.1

708.4

698.3

713.6

Potential shares of common stock excluded from EPS calculations

^[2]

2.5

2.2

3.4

2.4

[1]

Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.

[2]

These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including them would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.

Statement of Stockholders Equity Statement - USD ($) $ in Millions	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comp (Loss) Income	Noncontrolling Interest [Member]	EIDP	EIDP Preferred Stock [Member]	EIDP Common Stock [Member]	EIDP Additional Paid-in Capital [Member]	EIDP Retained Earnings [Member]	EIDP Accumulated Other Comp (Loss) Income	EIDP Noncontrolling Interest [Member]
Beginning Balance at Dec. 31, 2022	$ 25,541	$ 7	$ 27,851	$ 250	$ (2,806)	$ 239	$ 24,749	$ 239	$ 0	$ 24,284	$ 3,031	$ (2,806)	$ 1
Net income (loss)	599			595		4	589				588		(1)
Other comprehensive (loss) income	67				67		67					67
Share-based compensation	(14)		(14)				(14)			(14)
Common Dividends	(107)			(107)
Dividends, Preferred Stock							(3)				(3)
Issuance of Corteva Stock	7		7				7			7
Repurchase of common stock	(252)			(252)
Other-net	(2)			1		(3)	(4)			(2)	(2)
Ending Balance at Mar. 31, 2023	$ 25,839	7	27,844	487	(2,739)	240	25,391	239	0	24,275	3,614	(2,739)	2
Common Stock, Dividends, Per Share, Declared	$ 0.15
Beginning Balance at Dec. 31, 2022	$ 25,541	7	27,851	250	(2,806)	239	24,749	239	0	24,284	3,031	(2,806)	1
Net income (loss)	998						981
Other comprehensive (loss) income	(195)				(195)		(195)
Ending Balance at Sep. 30, 2023	25,467	7	27,895	325	(3,001)	241	25,558	239	0	24,323	3,995	(3,001)	2
Beginning Balance at Mar. 31, 2023	25,839	7	27,844	487	(2,739)	240	25,391	239	0	24,275	3,614	(2,739)	2
Net income (loss)	717			714		3	712				711		(1)
Other comprehensive (loss) income	62				62		62					62
Share-based compensation	13		14	(1)			13			14	(1)
Common Dividends	(107)			(107)
Dividends, Preferred Stock							(2)				(2)
Issuance of Corteva Stock	19		19				19			19
Repurchase of common stock	(81)			(81)
Other-net	(1)			1		(2)	(4)			(2)	(1)		(1)
Ending Balance at Jun. 30, 2023	$ 26,461	7	27,877	1,013	(2,677)	241	26,191	239	0	24,306	4,321	(2,677)	2
Common Stock, Dividends, Per Share, Declared	$ 0.15
Net income (loss)	$ (318)			(321)		3	(320)				(320)
Other comprehensive (loss) income	(324)				(324)		(324)					(324)
Share-based compensation	15		16	(1)			15			16	(1)
Common Dividends	(113)			(113)
Dividends, Preferred Stock							(3)				(3)
Issuance of Corteva Stock	2		2				2			2
Repurchase of common stock	(252)			(252)
Other-net	(4)			(1)		(3)	(3)			(1)	(2)
Ending Balance at Sep. 30, 2023	$ 25,467	7	27,895	325	(3,001)	241	25,558	239	0	24,323	3,995	(3,001)	2
Common Stock, Dividends, Per Share, Declared	$ 0.16
Beginning Balance at Dec. 31, 2023	$ 25,279	7	27,748	(41)	(2,677)	242	25,660	239	0	24,349	3,747	(2,677)	2
Net income (loss)	423			419		4	428				426		(2)
Other comprehensive (loss) income	(333)				(333)		(333)					(333)
Share-based compensation	2		3	(1)			2			3	(1)
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings	(112)		(112)
Dividends, Preferred Stock							(3)				(3)
Issuance of Corteva Stock	8		8				8			8
Repurchase of common stock	(252)		(178)	(74)
Other-net	(7)		(1)	(1)		(5)	(1)						(1)
Ending Balance at Mar. 31, 2024	$ 25,008	7	27,468	302	(3,010)	241	25,761	239	0	24,360	4,169	(3,010)	3
Common Stock, Dividends, Per Share, Declared	$ 0.16
Beginning Balance at Dec. 31, 2023	$ 25,279	7	27,748	(41)	(2,677)	242	25,660	239	0	24,349	3,747	(2,677)	2
Net income (loss)	958						987
Other comprehensive (loss) income	(209)				(209)		(209)
Ending Balance at Sep. 30, 2024	24,979	7	27,518	98	(2,886)	242	26,495	239	0	24,417	4,722	(2,886)	3
Beginning Balance at Mar. 31, 2024	25,008	7	27,468	302	(3,010)	241	25,761	239	0	24,360	4,169	(3,010)	3
Net income (loss)	1,056			1,053		3	1,066				1,066		0
Other comprehensive (loss) income	(314)				(314)		(314)					(314)
Share-based compensation	15		15				15			15
Common Dividends	(111)			(111)
Dividends, Preferred Stock											(2)
Issuance of Corteva Stock	20		20				20			20
Repurchase of common stock	(252)			(252)
Other-net	(1)		1			(2)	4			4			0
Ending Balance at Jun. 30, 2024	$ 25,421	7	27,504	992	(3,324)	242	26,550	239	0	24,399	5,233	(3,324)	3
Common Stock, Dividends, Per Share, Declared	$ 0.16
Net income (loss)	$ (521)			(524)		3	(507)				(508)		(1)
Other comprehensive (loss) income	438				438		438					438
Share-based compensation	13		13				13			13	0
Common Dividends	(117)			(117)
Dividends, Preferred Stock							(3)				(3)
Issuance of Corteva Stock	2		2				2			2
Repurchase of common stock	(253)			(253)
Other-net	(4)		(1)			(3)	2			3	0		(1)
Ending Balance at Sep. 30, 2024	$ 24,979	$ 7	$ 27,518	$ 98	$ (2,886)	$ 242	$ 26,495	$ 239	$ 0	$ 24,417	$ 4,722	$ (2,886)	$ 3
Common Stock, Dividends, Per Share, Declared	$ 0.17

Commitments and Contingent Liabilities - Supplier Finance (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Supplier Finance Program, Obligation, Current	$ 124	$ 115	$ 115
Supplier Finance Program, Obligation [Roll Forward]
Invoices confirmed during the year (Supplier Finance Program, Obligation, Addition)	460
Confirmed invoices paid during the year (Supplier Finance Program, Obligation, Settlement)	$ 451

Summary of Significant Accounting Policies Summary of Accounting Policies (Details) $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Percentage deterioration of the official Peso to USD exchange rate	10.00%
Percentage of annual net sales	4.00%
Foreign government bonds	$ 125
Percentage of Crop Protection and Seed Segment Operating EBITDA	4.00%

Restructuring and Asset Related Charges - Crop Protection Operations Strategy (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

11 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Incurred Cost

$ 32

$ 2

$ 199

$ 95

Crop Protection Strategy Operations Program [Member]

Restructuring Cost and Reserve [Line Items]

Restructuring Reserve, Beginning Balance

Restructuring and Related Cost, Incurred Cost

143

Payments for Restructuring

(7)

$ (10)

Asset write-offs

(79)

Restructuring Reserve, Ending Balance

Restructuring and Related Cost, Cost Incurred to Date

372

Crop Protection Strategy Operations Program [Member] | Minimum [Member]

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Expected Cost

650

Anticipated Cash Payments

330

Crop Protection Strategy Operations Program [Member] | Maximum [Member]

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Expected Cost

700

Anticipated Cash Payments

360

Crop Protection Strategy Operations Program [Member] | Severance and Related Benefit Costs

Restructuring Cost and Reserve [Line Items]

Restructuring Reserve, Beginning Balance

Restructuring and Related Cost, Incurred Cost

^[1]

Payments for Restructuring

(3)

Asset write-offs

Restructuring Reserve, Ending Balance

Restructuring and Related Cost, Cost Incurred to Date

Crop Protection Strategy Operations Program [Member] | Severance and Related Benefit Costs | Minimum [Member]

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Expected Cost

Crop Protection Strategy Operations Program [Member] | Severance and Related Benefit Costs | Maximum [Member]

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Expected Cost

105

Crop Protection Strategy Operations Program [Member] | Asset Related Charges [Member]

Restructuring Cost and Reserve [Line Items]

Restructuring Reserve, Beginning Balance

Restructuring and Related Cost, Incurred Cost

^[2],[3]

Payments for Restructuring

(4)

Asset write-offs

(79)

Restructuring Reserve, Ending Balance

Restructuring and Related Cost, Cost Incurred to Date

309

Crop Protection Strategy Operations Program [Member] | Asset Related Charges [Member] | Minimum [Member]

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Expected Cost

320

Crop Protection Strategy Operations Program [Member] | Asset Related Charges [Member] | Maximum [Member]

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Expected Cost

340

Crop Protection Strategy Operations Program [Member] | Contract Termination

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Cost Incurred to Date

Crop Protection Strategy Operations Program [Member] | Contract Termination | Minimum [Member]

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Expected Cost

245

Crop Protection Strategy Operations Program [Member] | Contract Termination | Maximum [Member]

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Expected Cost

255

Crop Protection Strategy Operations Program [Member] | Facility Closing

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Incurred Cost

2022 Restructuring Actions

Restructuring Cost and Reserve [Line Items]

Anticipated Cash Payments

$ 36

Restructuring and Related Cost, Incurred Cost

^[4],[5]

2022 Restructuring Actions | Severance and Related Benefit Costs

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Incurred Cost

^[6]

2022 Restructuring Actions | Asset Related Charges [Member]

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Incurred Cost

(2)

2022 Restructuring Actions | Contract Termination

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Incurred Cost

^[5]

$ 3

2022 Restructuring Actions | Crop Protection [Member]

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Incurred Cost

2022 Restructuring Actions | Seed [Member]

Restructuring Cost and Reserve [Line Items]

Restructuring and Related Cost, Incurred Cost

$ 1

$ (2)

$ 10

[1]	Reflects corporate-related charges.
[2]	Reflects charges associated with the Crop Protection segment.
[3]	The three and nine months ended September 30, 2024 include charges of $4 million for decommissioning costs associated with the exit of the company’s production activities at its site in Pittsburg, California.
[4]	The nine months ended September 30, 2024, reflects a benefit of $(2) million, associated with sales of inventory previously reserved for impacting the Seed segment. The three and nine months ended September 30, 2023 reflects charges of $1 million and $10 million, respectively, impacting the Seed segment, and $— and $5 million, respectively, impacting the Crop Protection segment.
[5]	This amount excludes other pre-tax charges recorded during the nine months ended September 30, 2024 and the three and nine months ended September 30, 2023 impacting the Seed segment included in cost of goods sold and other income (expense) – net, in the company’s interim Consolidated Statement of Operations, relating to inventory write-offs and a loss on the sale of the company's interest in an equity investment. See Note 18 - Segment Information, to the interim Consolidated Financial Statements, for additional information.
[6]	Reflects corporate-related charges.

Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2024

Derivative [Line Items]

Fair Value of Derivatives Instruments


		September 30, 2024
(In millions)	Balance Sheet Location	Gross		Counterparty and Cash Collateral Netting1		Net Amounts Included in the interim Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Commodity contracts	Other current assets	$	2	$	—	$	2

Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	105		(61)		44
Commodity contracts	Other current assets	3		—		3
Total asset derivatives		$	110	$	(61)	$	49

Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	23	$	—	$	23
Commodity contracts	Accrued and other current liabilities	1		—		1
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	64		(61)		3
Commodity contracts	Accrued and other current liabilities	3		—		3
Total liability derivatives		$	91	$	(61)	$	30


		December 31, 2023
(In millions)	Balance Sheet Location	Gross		Counterparty and Cash Collateral Netting1		Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:

Commodity contracts	Other current assets	$	3	$	—	$	3
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	83		(33)		50
Commodity contracts	Other current assets	2		—		2
Total asset derivatives		$	88	$	(33)	$	55

Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	23	$	—	$	23
Commodity contracts	Accrued and other current liabilities	6		—		6
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	38		(33)		5
Commodity contracts	Accrued and other current liabilities	8		—		8
Total liability derivatives		$	75	$	(33)	$	42


		September 30, 2023
(In millions)	Balance Sheet Location	Gross		Counterparty and Cash Collateral Netting1		Net Amounts Included in the interim Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other current assets	$	7	$	—	$	7
Commodity Contracts	Other current assets	1		—		1
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	45		(39)		6

Total asset derivatives		$	53	$	(39)	$	14

Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	7	$	—	$	7
Commodity contracts	Accrued and other current liabilities	3		—		3
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	87		(39)		48
Commodity contracts	Accrued and other current liabilities	3		—		3
Total liability derivatives		$	100	$	(39)	$	61

Effect of Derivatives


	Amount of Gain (Loss) Recognized in OCI - Pre-Tax1
	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Derivatives designated as hedging instruments:
Net investment hedges:
Foreign currency contracts	$	(36)	$	—	$	(19)	$	—
Cash flow hedges:
Foreign currency contracts	1		11		29		(30)
Commodity contracts	34		(26)		(18)		(133)
Total derivatives designated as hedging instruments	$	(1)	$	(15)	$	(8)	$	(163)

1.OCI is defined as other comprehensive income (loss).


	Amount of Gain (Loss) Recognized in Income - Pre-Tax1
	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Derivatives designated as hedging instruments:
Cash flow hedges:
Foreign currency contracts2	$	(2)	$	(13)	$	(3)	$	(15)
Commodity contracts2	(10)		(3)		(35)		65
Total derivatives designated as hedging instruments	$	(12)	$	(16)	$	(38)	$	50
Derivatives not designated as hedging instruments:
Foreign currency contracts3	$	59	$	(3)	$	(32)	$	(65)
Foreign currency contracts2	(6)		4		12		(67)
Commodity contracts2,4	3		1		(41)		4
Commodity contracts3	1		5		(2)		5
Total derivatives not designated as hedging instruments	$	57	$	7	$	(63)	$	(123)
Total derivatives	$	45	$	(9)	$	(101)	$	(73)

1.For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.

2.Recorded in cost of goods sold in the interim Consolidated Statements of Operations.

Commodity Contract [Member]

Derivative [Line Items]

After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Beginning balance	$	(92)	$	(71)	$	(71)	$	55
Additions and revaluations of derivatives designated as cash flow hedges	25		(20)		(13)		(94)
Clearance of hedge results to earnings	7		2		24		(50)
Ending balance	$	(60)	$	(89)	$	(60)	$	(89)

Foreign Currency Contract [Member]

Derivative [Line Items]

After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Beginning balance	$	20	$	(16)	$	1	$	10
Additions and revaluations of derivatives designated as cash flow hedges	—		7		19		(20)
Clearance of hedge results to earnings	1		9		1		10
Ending balance	$	21	$	—	$	21	$	—

Supplementary Information (Tables)

9 Months Ended

Sep. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Other Nonoperating Income (Expense)


Other Income (Expense) - Net	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Interest income	$	33	$	59	$	93	$	153
Equity in earnings (losses) of affiliates - net	—		(2)		7		4
Net gain (loss) on sales of businesses and other assets	—		10		17		11
Net exchange gains (losses)1	(97)		(102)		(234)		(242)
Non-operating pension and other post employment benefit credits (costs)2	(37)		(30)		(109)		(91)
Miscellaneous income (expenses) - net3	(6)		(84)		(93)		(189)
Other income (expense) - net	$	(107)	$	(149)	$	(319)	$	(354)

Foreign Currency Exchange Gain (Loss)


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Subsidiary Monetary Position Gain (Loss)
Pre-tax exchange gain (loss)	$	(156)	$	(104)	$	(199)	$	(182)
Local tax (expenses) benefits	5		19		23		27
Net after-tax impact from subsidiary exchange gain (loss)	$	(151)	$	(85)	$	(176)	$	(155)

Hedging Program Gain (Loss)
Pre-tax exchange gain (loss)	$	59	$	2	$	(35)	$	(60)
Tax (expenses) benefits	(12)		(4)		7		12
Net after-tax impact from hedging program exchange gain (loss)	$	47	$	(2)	$	(28)	$	(48)

Total Exchange Gain (Loss)
Pre-tax exchange gain (loss)	$	(97)	$	(102)	$	(234)	$	(242)
Tax (expenses) benefits	(7)		15		30		39
Net after-tax exchange gain (loss)	$	(104)	$	(87)	$	(204)	$	(203)

Non-Controlling Interest Adjustment	—		—		1		—

Net after-tax exchange gain (loss) attributable to Corteva	$	(104)	$	(87)	$	(203)	$	(203)

Restrictions on Cash and Cash Equivalents


(In millions)	September 30, 2024		December 31, 2023		September 30, 2023
Cash and cash equivalents	$	2,421	$	2,644	$	2,254
Restricted cash equivalents	335		514		522
Total cash, cash equivalents and restricted cash equivalents	$	2,756	$	3,158	$	2,776

Recent Accounting Guidance Recent Accounting Guidance (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Recent Accounting Guidance	RECENT ACCOUNTING GUIDANCE Recently Adopted Accounting Guidance In August 2023, the FASB issued ASU 2023-05, Business Combinations—Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement. The amendments in this ASU are intended to facilitate consistency in the application of accounting guidance upon the formation of entities qualifying as joint ventures. It generally requires the use of business combinations accounting at the joint venture formation date, which would result in the contributed assets/liabilities being revalued to fair value and potentially result in the recognition of goodwill and other intangible assets on the joint venture’s financial statements. It does not alter the ongoing accounting for the joint venture’s operations. This guidance is effective for joint ventures with formation dates on or after January 1, 2025. Prospective application is required, with early adoption permitted. Retrospective application can be elected for joint ventures formed before January 1, 2025. Beginning in the third quarter of 2024, newly-formed joint ventures have applied this guidance. Accounting Guidance Issued But Not Adopted as of September 30, 2024 In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU requires that an entity disclose specific categories in the effective tax rate reconciliation as well as reconciling items that meet a quantitative threshold. Further, the ASU requires additional disclosures on income tax expense and taxes paid, net of refunds received, by jurisdiction. The new standard is effective for annual periods beginning after December 15, 2024 on a prospective basis with the option to apply it retrospectively. Early adoption is permitted. The adoption of this guidance will result in the company being required to include enhanced income tax related disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This ASU includes amendments that expand the existing reportable segment disclosure requirements and requires disclosure of (i) significant expense categories and amounts by reportable segment as well as the segment’s profit or loss measure(s) that are regularly provided to the chief operating decision maker (the “CODM”) to allocate resources and assess performance; (ii) how the CODM uses each reported segment profit or loss measure to allocate resources and assess performance; (iii) the nature of other segment balances contributing to reported segment profit or loss that are not captured within segment revenues or expenses; and (iv) the title and position of the individual or name of the group or committee identified as the CODM. This guidance requires retrospective application to all prior periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The company will adopt this guidance upon its effective date and will include enhanced disclosures relating to its reportable segments for all subsequent annual and interim periods.

Consolidated Statements of Operations - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Net Sales	$ 2,326	$ 2,590	$ 12,930	$ 13,519
Cost of Goods Sold	1,565	1,646	7,033	7,554
Research and Development Expense	348	335	1,037	980
Selling, General and Administrative Expenses	671	670	2,461	2,441
Amortization of Intangibles	170	174	521	508
Restructuring and Related Cost, Incurred Cost	32	2	199	95
Other income - net	(107)	(149)	(319)	(354)
Interest Expense	66	58	173	171
Income from continuing operations before income taxes	(633)	(444)	1,187	1,416
Provision for (benefit from) income taxes on continuing operations	(114)	(129)	274	244
Income from continuing operations after income taxes	(519)	(315)	913	1,172
Income (loss) from discontinued operations after income taxes	(2)	(3)	45	(174)
Net income	(521)	(318)	958	998
Net income attributable to noncontrolling interests	3	3	10	10
Net income attributable to Corteva	$ (524)	$ (321)	$ 948	$ 988
Basic earnings (loss) per share of common stock from continuing operations	$ (0.76)	$ (0.45)	$ 1.30	$ 1.64
Basic earnings (loss) per share of common stock from discontinued operations	0	0	0.06	(0.24)
Basic earnings (loss) per share of common stock	(0.76)	(0.45)	1.36	1.40
Diluted earnings (loss) per share of common stock from continuing operations	(0.76)	(0.45)	1.29	1.63
Diluted earnings (loss) per share of common stock from discontinued operations	0	0	0.06	(0.24)
Diluted earnings (loss) per share of common stock	$ (0.76)	$ (0.45)	$ 1.35	$ 1.39
EIDP
Net Sales	$ 2,326	$ 2,590	$ 12,930	$ 13,519
Cost of Goods Sold	1,565	1,646	7,033	7,554
Research and Development Expense	348	335	1,037	980
Selling, General and Administrative Expenses	671	670	2,461	2,441
Amortization of Intangibles	170	174	521	508
Restructuring and Related Cost, Incurred Cost	32	2	199	95
Other income - net	(89)	(149)	(281)	(354)
Interest Expense	66	60	173	193
Income from continuing operations before income taxes	(615)	(446)	1,225	1,394
Provision for (benefit from) income taxes on continuing operations	(110)	(129)	283	239
Income from continuing operations after income taxes	(505)	(317)	942	1,155
Income (loss) from discontinued operations after income taxes	(2)	(3)	45	(174)
Net income	(507)	(320)	987	981
Net income attributable to noncontrolling interests	1	0	3	2
Net income attributable to Corteva	$ (508)	$ (320)	$ 984	$ 979

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2024

Equity [Abstract]

Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block]


(Shares in thousands)			Number of Shares
Authorized			23,000
$4.50 Series, callable at $120			1,673
$3.50 Series, callable at $102			700

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]


(In millions)	Cumulative Translation Adjustment1		Derivative Instruments		Pension Benefit Plans		Other Benefit Plans		Unrealized Gain (Loss) on Investments		Total






2023
Balance at January 1, 2023	$	(2,883)	$	80	$	(163)	$	160	$	—	$	(2,806)
Other comprehensive income (loss) before reclassifications	(41)		(114)		6		—		—		(149)
Amounts reclassified from accumulated other comprehensive income (loss)	—		(40)		—		(6)		—		(46)
Net other comprehensive income (loss)	(41)		(154)		6		(6)		—		(195)
Balance at September 30, 2023	$	(2,924)	$	(74)	$	(157)	$	154	$	—	$	(3,001)

2024
Balance at January 1, 2024	$	(2,458)	$	(55)	$	(353)	$	189	$	—	$	(2,677)
Other comprehensive income (loss) before reclassifications	(206)		(8)		2		—		(14)		(226)
Amounts reclassified from accumulated other comprehensive income (loss)	—		25		(1)		(7)		—		17
Net other comprehensive income (loss)	(206)		17		1		(7)		(14)		(209)

Balance at September 30, 2024	$	(2,664)	$	(38)	$	(352)	$	182	$	(14)	$	(2,886)

Tax (Expense) Benefit of Other Comprehensive (Loss) Income


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Derivative instruments	$	(4)	$	(3)	$	(13)	$	59
Pension benefit plans - net	—		—		—		—
Other benefit plans - net	1		1		3		2
Unrealized gains (losses) on investments	—		—		—		—
(Provision for) benefit from income taxes related to other comprehensive income (loss) items	$	(3)	$	(2)	$	(10)	$	61

Reclassification out of Accumulated Other Comprehensive (Loss) Income [Table Text Block]


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Derivative instruments1:	$	12	$	16	$	38	$	(50)
Tax (benefit) expense2	(4)		(5)		(13)		10
After-tax	$	8	$	11	$	25	$	(40)
Amortization of pension benefit plans:
Prior service (benefit) cost3,4	$	(1)	$	—	$	(2)	$	(2)


Settlement (gain) loss3,4	1		1		1		1
Total before tax	$	—	$	1	$	(1)	$	(1)
Tax (benefit) expense2	(1)		—		—		1
After-tax	$	(1)	$	1	$	(1)	$	—
Amortization of other benefit plans:
Prior service (benefit) cost3,4	$	—	$	(1)	$	(1)	$	(1)
Actuarial (gains) loss3,4	(3)		(2)		(9)		(7)

Total before tax	$	(3)	$	(3)	$	(10)	$	(8)
Tax (benefit) expense2	1		1		3		2
After-tax	$	(2)	$	(2)	$	(7)	$	(6)






Total reclassifications for the period, after-tax	$	5	$	10	$	17	$	(46)

1.Reflected in cost of goods sold in the interim Consolidated Statements of Operations.

2.Reflected in provision for (benefit from) income taxes from continuing operations in the interim Consolidated Statements of Operations.

4.Reflected in other income (expense) - net in the interim Consolidated Statements of Operations.

Financial Instruments Financial Instruments (Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Debt Securities, Available-for-sale [Line Items]
Fair Value, Within One Year	$ 16
Fair Value, one to five years	90
Cash Equivalents [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity securities	1,543	$ 1,746	$ 1,619
Marketable Securities [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity securities	$ 56	98	$ 108
Other Assets [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity securities		$ 55

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (aa)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (aaa)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-3

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-3

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-3

+ Details

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (aaa)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5A
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5A
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5B
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5B
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5B

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5B

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5B

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-5

+ Details

Accounts and Notes Receivable (Tables)

9 Months Ended

Sep. 30, 2024

Accounts and Notes Receivable [Abstract]

Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]


(In millions)	September 30, 2024		December 31, 2023		September 30, 2023
Accounts receivable – trade1	$	4,260	$	4,210	$	4,013
Notes receivable – trade1,2	1,241		119		1,307
Other3	1,150		1,159		1,261
Total accounts and notes receivable - net	$	6,651	$	5,488	$	6,581

1.Accounts and notes receivable – trade are net of allowances of $188 million, $205 million and $201 million at September 30, 2024, December 31, 2023 and September 30, 2023, respectively.

2.Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed and chemical products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of September 30, 2024, December 31, 2023 and September 30, 2023, there were no significant impairments related to current loan agreements.

3.Other includes receivables in relation to indemnification assets, royalties, value added tax, general sales tax and other taxes. No individual group represents more than 5 percent of total current assets. In addition, Other includes amounts due from nonconsolidated affiliates of $145 million, $131 million and $137 million as of September 30, 2024, December 31, 2023 and September 30, 2023, respectively.

Accounts Receivable, Allowance for Credit Loss [Table Text Block]


(In millions)
2023
Balance at December 31, 2022	$	194
Net provision for credit losses	10
Other - net of write-offs charged against allowance	(3)
Balance at September 30, 2023	$	201
2024
Balance at December 31, 2023	$	205
Net provision for credit losses	31
Other - net of write-offs charged against allowance	(48)
Balance at September 30, 2024	$	188

Commitments and Contingent Liabilities- DISCOPs (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Loss Contingencies [Line Items]
Income (loss) from discontinued operations after income taxes	$ (2)	$ (3)	$ 45	$ (174)

- Definition

+ References

+ Details

Accounts and Notes Receivable (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Sep. 30, 2023

Dec. 31, 2023

Dec. 31, 2022

Accounts, Notes, Loans and Financing Receivable [Line Items]

Accounts Receivable - trade

^[1]

$ 4,260

$ 4,013

$ 4,260

$ 4,013

$ 4,210

Notes receivable - trade

^[1],[2]

1,241

1,307

1,241

1,307

119

Other

^[3]

1,150

1,261

1,150

1,261

1,159

Accounts and notes receivable - net

6,651

6,581

6,651

6,581

5,488

Accounts Receivable, Allowance for Credit Loss, Current

188

201

188

201

205

$ 194

Amounts due from nonconsolidated affiliates

$ 145

137

$ 145

137

131

Other Receivable, Total Current Assets, Percentage

5.00%

Factoring Agreement [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Trade Receivables Sold

$ 51

$ 118

100

Trade receivables sold the remain outstanding with an element of recourse

$ 2

Loss on Sale of Accounts Receivable

$ 5

$ 4

$ 8

$ 17

[1]	Accounts and notes receivable – trade are net of allowances of $188 million, $205 million and $201 million at September 30, 2024, December 31, 2023 and September 30, 2023, respectively.
[2]	Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed and chemical products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of September 30, 2024, December 31, 2023 and September 30, 2023, there were no significant impairments related to current loan agreements.
[3]	Other includes receivables in relation to indemnification assets, royalties, value added tax, general sales tax and other taxes. No individual group represents more than 5 percent of total current assets. In addition, Other includes amounts due from nonconsolidated affiliates of $145 million, $131 million and $137 million as of September 30, 2024, December 31, 2023 and September 30, 2023, respectively.

Stockholders' Equity Reclassifications out of AOCI (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Sep. 30, 2023

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Amounts Reclassified from Accumulated Other Comprehensive Loss

$ 5

$ 10

$ 17

$ (46)

Pension Plan

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Amounts Reclassified from Accumulated Other Comprehensive Loss

(1)

Other Benefit Plans

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Amounts Reclassified from Accumulated Other Comprehensive Loss

(7)

(6)

Derivative Instruments

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax

^[1]

(50)

Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax

^[2]

(4)

(5)

(13)

Amounts Reclassified from Accumulated Other Comprehensive Loss

(40)

Actuarial (Gains) Losses | Other Benefit Plans

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax

^[3],[4]

(3)

(2)

(9)

(7)

Settlement Loss | Pension Plan

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax

^[3],[4]

Accumulated Defined Benefit Plans Adjustment Attributable to Parent | Pension Plan

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax

(1)

Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax

^[2]

(1)

Amounts Reclassified from Accumulated Other Comprehensive Loss

(1)

Accumulated Defined Benefit Plans Adjustment Attributable to Parent | Other Benefit Plans

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax

(3)

(10)

(8)

Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax

^[2]

Amounts Reclassified from Accumulated Other Comprehensive Loss

(2)

(7)

(6)

Unrealized loss on investments

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Amounts Reclassified from Accumulated Other Comprehensive Loss

Prior Service Benefit | Other Benefit Plans

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax

^[3],[4]

(1)

Prior Service Benefit | Pension Plan

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax

^[3],[4]

$ (1)

$ 0

$ (2)

[1]	Reflected in cost of goods sold in the interim Consolidated Statements of Operations.
[2]	Reflected in provision for (benefit from) income taxes from continuing operations in the interim Consolidated Statements of Operations.
[3]	These accumulated other comprehensive income (loss) components are included in the computation of net periodic benefit (credit) cost of the company's pension and other benefit plans. See Note 15 - Pension Plans and Other Post Employment Benefits, to the interim Consolidated Financial Statements, for additional information.
[4]	Reflected in other income (expense) - net in the interim Consolidated Statements of Operations.

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2024

Fair Value Disclosures [Abstract]

Fair Value of Assets and Liabilities Measured on Recurring Basis


		September 30, 2024			December 31, 2023		September 30, 2023
(In millions)	Level 21			Level 21	Level 21
Assets at fair value:

Marketable securities		$	56		$	98	$	108
Debt securities:
Foreign government bonds2		106			—		—
Derivatives relating to:3
Foreign currency		105			83		52
Commodity contracts		5			5		1


Total assets at fair value		$	272		$	186	$	161
Liabilities at fair value:
Derivatives relating to:3
Foreign currency		$	87		$	61	$	94
Commodity contracts		4			14		6

Total liabilities at fair value		$	91		$	75	$	100

1.Reflects significant other observable inputs.

2.Represents the company's investments in debt securities that are classified as available-for-sale, which are included in marketable securities and other assets in the interim Consolidated Balance Sheets.

3.See Note 16 - Financial Instruments for the classification of derivatives in the interim Consolidated Balance Sheets.

Fair Value Measurements (Details) - USD ($)
$ in Millions

Sep. 30, 2024

Dec. 31, 2023

Sep. 30, 2023

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Derivative Asset

$ 110

$ 88

$ 53

Derivative Liability

100

Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Marketable Securities

^[1]

108

Assets at Fair Value

272

186

161

Liabilities at Fair Value

100

Available - for- sale securities

106

^[1],[2]

^[2]

Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Foreign Currency Contract [Member]

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Derivative Asset

^[1],[3]

105

Derivative Liability

^[1],[3]

Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Commodity Contract [Member]

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Derivative Asset

^[1],[3]

Derivative Liability

^[1],[3]

$ 4

$ 14

$ 6

[1]	Reflects significant other observable inputs.
[2]	Represents the company's investments in debt securities that are classified as available-for-sale, which are included in marketable securities and other assets in the interim Consolidated Balance Sheets.
[3]	See Note 16 - Financial Instruments for the classification of derivatives in the interim Consolidated Balance Sheets.

Restructuring and Asset Related Charges

9 Months Ended

Sep. 30, 2024

Restructuring and Related Activities [Abstract]

Restructuring and Related Activities Disclosure [Text Block]

RESTRUCTURING AND ASSET RELATED CHARGES - NET

Crop Protection Operations Strategy Restructuring Program

On November 5, 2023, management of the company approved a plan to further optimize its Crop Protection network of manufacturing and external partners (the "Crop Protection Operations Strategy Restructuring Program"). In October 2024, management of the company amended the Crop Protection Operations Strategy Restructuring Program to include revisions to its previous estimates and decommissioning and demolition costs associated with the ceasing of operations, primarily at the Pittsburg, California site.

The company expects to record aggregate pre-tax restructuring and asset related charges of $650 million to $700 million, comprised of $85 million to $105 million of severance and related benefit costs, $320 million to $340 million of asset-related and impairment charges and $245 million to $255 million of costs related to exiting the company’s production activities and ceasing operations (inclusive of contract terminations and decommissioning and demolition costs). Decommissioning and demolition costs will be expensed on an as-incurred basis. Reductions in workforce are subject to local regulatory requirements. Through the third quarter of 2024, the company recorded net pre-tax restructuring and asset related charges of $372 million, comprised of $60 million of severance and related benefit costs, $309 million of asset-related and impairment charges and $3 million of costs related to contract terminations. The pre-tax restructuring and asset related charges noted above includes charges relating to spare parts write-offs recognized during the fourth quarter of 2023, which impacted the Crop Protection segment, and were included in cost of goods sold, in the company’s Consolidated Statement of Operations for the year ended December 31, 2023. See Note 23 – Segment Information, to the Consolidated Financial Statements, in the company’s 2023 Annual Report for additional information.

Cash payments related to these charges are anticipated to be $330 million to $360 million, which primarily relate to the payment of severance and related benefits, contract terminations and decommissioning and demolition. Through the third quarter of 2024, the company paid $10 million associated with these charges. The restructuring actions associated with these charges are expected to be substantially complete by the end of 2026.

The following table is a summary of charges incurred related to the Crop Protection Operations Strategy Restructuring Program for the three and nine months ended September 30, 2024.


(In millions)	Three Months Ended September 30, 2024		Nine Months Ended September 30, 2024
Severance and related benefit costs1	$	19	$	60
Asset related charges2, 3	10		83

Total restructuring and asset related charges - net	$	29	$	143

1.Reflects corporate-related charges.

2.Reflects charges associated with the Crop Protection segment.

A reconciliation of the December 31, 2023 to the September 30, 2024 liability balances related to the Crop Protection Operations Strategy Restructuring Program is summarized below:


(In millions)	Severance and Related Benefit Costs		Asset Related Charges1		Total
Balance at December 31, 2023	$	—	$	—	$	—
Charges to income from continuing operations	60		83		143
Payments	(3)		(4)		(7)
Asset write-offs	—		(79)		(79)
Balance at September 30, 2024	$	57	$	—	$	57

1. Includes charges of $4 million for decommissioning costs associated with the exit of the company’s production activities at its site in Pittsburg, California.

2022 Restructuring Actions

In connection with the company’s shift to a global business unit model during 2022, the company assessed its business priorities and operational structure to maximize the customer experience and deliver on growth and earnings potential. As a result of this assessment, the company committed to restructuring actions during the second quarter of 2022, which included the company’s separate announcement to withdraw from Russia (“Russia Exit”) (collectively the “2022 Restructuring Actions”). The company does not anticipate any additional material charges from the 2022 Restructuring Actions as actions associated with this charge are substantially complete.

The remaining cash payments related to these charges is $36 million, and primarily relate to the payment of severance and related benefits and contract terminations.

The following table is a summary of charges incurred related to the 2022 Restructuring Actions for the three and nine months ended September 30, 2024 and 2023.


	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Severance and related benefit costs1	$	—	$	—	$	—	$	4
Asset related charges	—		—		(2)		11
Contract termination charges3	3		1		3		4
Total restructuring and asset related charges - net2,3	$	3	$	1	$	1	$	19

1.Reflects corporate-related charges.

Other Asset Related Charges

The company recognized charges (benefits) of $55 million for the nine months ended September 30, 2024, and $(2) million and $66 million for the three and nine months ended September 30, 2023 respectively, in restructuring and asset related charges - net, in the interim Consolidated Statement of Operations, from non-cash accelerated prepaid royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits, which as of the end of the second quarter of 2024 is now complete.

Segment Reporting Significant Items (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Sep. 30, 2023

Segment Reporting Information [Line Items]

Restructuring Charges

$ 199

$ 95

Gain (loss) on sale of assets

Net Sales

$ 2,326

$ 2,590

12,930

13,519

Seed [Member]

Segment Reporting Information [Line Items]

Net Sales

691

878

7,773

7,837

Crop Protection [Member]

Segment Reporting Information [Line Items]

Net Sales

1,635

1,712

5,157

5,682

Segment Reconciling Items [Member]

Segment Reporting Information [Line Items]

Restructuring Charges

^[1]

(2)

(95)

Estimated Settlement Expense

^[2]

(66)

(101)

(156)

Gain (Loss) on Disposition of Business

^[3]

Inventory Write-down

^[3]

(7)

Gain (loss) on sale of assets

^[3]

Acquisition-related costs

(1)

^[4]

(7)

(6)

^[4]

(41)

^[4]

Employee Retention Credit

Significant Items (benefits) charge

(33)

(71)

(297)

(271)

Restructuring and Asset related charges, net

^[1]

(32)

(199)

Segment Reconciling Items [Member] | 2022 Restructuring Actions- Russia Exit

Segment Reporting Information [Line Items]

Inventory Write-down

^[3]

Russia Seed Sale, pre-tax benefit

^[3],[5]

Segment Reconciling Items [Member] | Seed [Member]

Segment Reporting Information [Line Items]

Restructuring Charges

^[1]

(3)

(56)

(74)

Estimated Settlement Expense

^[2]

Gain (Loss) on Disposition of Business

^[3]

Inventory Write-down

^[3]

(7)

Gain (loss) on sale of assets

^[3]

Acquisition-related costs

^[4]

Employee Retention Credit

Significant Items (benefits) charge

(3)

(50)

(59)

Segment Reconciling Items [Member] | Seed [Member] | 2022 Restructuring Actions- Russia Exit

Segment Reporting Information [Line Items]

Russia Seed Sale, pre-tax benefit

^[3],[5]

Net Sales

Cost of Revenue

Segment Reconciling Items [Member] | Crop Protection [Member]

Segment Reporting Information [Line Items]

Restructuring Charges

^[1]

(10)

(83)

(11)

Estimated Settlement Expense

^[2]

(66)

(101)

(156)

Gain (Loss) on Disposition of Business

^[3]

Inventory Write-down

^[3]

Gain (loss) on sale of assets

^[3]

Acquisition-related costs

(1)

^[4]

(7)

(6)

^[4]

(41)

^[4]

Employee Retention Credit

Significant Items (benefits) charge

(11)

(73)

(187)

(202)

Segment Reconciling Items [Member] | Crop Protection [Member] | 2022 Restructuring Actions- Russia Exit

Segment Reporting Information [Line Items]

Russia Seed Sale, pre-tax benefit

Segment Reconciling Items [Member] | Corporate Segment

Segment Reporting Information [Line Items]

Restructuring Charges

^[1]

(19)

(3)

(60)

(10)

Estimated Settlement Expense

^[2]

Gain (Loss) on Disposition of Business

Inventory Write-down

^[3]

Gain (loss) on sale of assets

^[3]

Acquisition-related costs

^[4]

Employee Retention Credit

Significant Items (benefits) charge

$ (19)

$ (3)

$ (60)

(10)

Segment Reconciling Items [Member] | Corporate Segment | 2022 Restructuring Actions- Russia Exit

Segment Reporting Information [Line Items]

Russia Seed Sale, pre-tax benefit

$ 0

[1]	Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements, for additional information.
[2]	Consists of estimated Lorsban® related charges.
[3]	Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions. The nine months ended September 30, 2024 includes a $2 million benefit associated with sales of inventory previously reserved for in association with the 2022 Restructuring Actions.
[4]	Relates to acquisition-related costs, including transaction and third-party integration costs associated with the completed acquisitions of Stoller and Symborg as well as the recognition of the inventory fair value step-up. See Note 3 - Business Combinations, to the interim Consolidated Financial Statements, for additional information.
[5]	Includes a benefit (charge) of $18 million for the nine months ended September 30, 2023, relating to the sale of seeds already under production in Russia when the decision to exit the country was made and that the company was contractually required to purchase. It consists of $71 million of net sales and $53 million of cost of goods sold for the nine months ended September 30, 2023.

Stockholders' Equity Common Stock (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Sep. 13, 2022	Aug. 05, 2021	Jun. 26, 2019
Class of Stock [Line Items]
Common Stock, Par Value	$ 0.01	$ 0.01	$ 0.01	$ 0.01	$ 0.01
Repurchase of Common Stock			$ 757	$ 585
2021 Stock Repurchase Program
Class of Stock [Line Items]
Stock Repurchased and Retired During Period, Shares					4,098,000	17,425,000	5,572,000
Stock Repurchase Program, Authorized Amount									$ 1,500
Repurchase of Common Stock					$ 250	$ 1,000	$ 250
2022 Stock Repurchase Program
Class of Stock [Line Items]
Stock Repurchased and Retired During Period, Shares	4,722,000	4,913,000	13,838,000	6,330,000
Stock Repurchase Program, Authorized Amount								$ 2,000
Repurchase of Common Stock	$ 250	$ 250	$ 750	$ 330
Corteva [Member]
Class of Stock [Line Items]
Common Stock, Par Value	$ 0.01		$ 0.01							$ 0.01

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef
-Topic 272
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483014/272-10-45-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 272
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482987/272-10-50-1

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27)(b))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(i)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(i)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(i)(2)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(i)(2)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3

+ Details

Commitments and Contingent Liabilities Environmental (Details) - USD ($)
$ in Millions

Sep. 30, 2024

Jan. 28, 2022

Loss Contingencies [Line Items]

Indemnification Asset

$ 259

Accrual for Environmental Loss Contingencies

477

Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual

644

Non-PFAS

Loss Contingencies [Line Items]

Request for Remediation Funding Source ("RFS")

$ 900

Loss Contingencies [Line Items]

Indemnification Asset

^[1],[2]

150

Accrual for Environmental Loss Contingencies

^[1],[2],[3]

153

Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual

^[1],[2],[3]

277

Discontinued Operations [Member]

Loss Contingencies [Line Items]

Indemnification Asset

^[1]

Other discontinued or divested business obligations [Member]

Loss Contingencies [Line Items]

Accrual for Environmental Loss Contingencies

^[1],[3]

Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual

^[1],[3]

203

Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member]

Loss Contingencies [Line Items]

Indemnification Asset

^[2]

Accrual for Environmental Loss Contingencies

^[2],[3]

Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual

^[2],[3]

Not subject to indemnification [Member]

Loss Contingencies [Line Items]

Indemnification Asset

Accrual for Environmental Loss Contingencies

105

Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual

Indemnification liabilities related to the MOU

Loss Contingencies [Line Items]

Indemnification Asset

^[4]

Accrual for Environmental Loss Contingencies

^[3],[4]

Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual

^[3],[4]

DuPont de Nemours [Member] | DuPont de Nemours [Member]

Loss Contingencies [Line Items]

Stray liability threshold

200

Superfund Sites [Member]

Loss Contingencies [Line Items]

Accrual for Environmental Loss Contingencies

Superfund Sites [Member] | Chemours [Member] | Indemnification Agreement [Member]

Loss Contingencies [Line Items]

Indemnification Asset

$ 19

[1]	Represents liabilities that are subject to the $200 million threshold and sharing arrangements as discussed on page 23, under the header "Corteva Separation Agreement."
[2]	The company has recorded an indemnification asset related to these accruals, including $19 million related to the Superfund sites.
[3]	Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balance includes $47 million for remediation of Superfund sites. Amounts do not include all possible impacts from the remediation elements of the EPA's October 2021 PFAS Strategic Roadmap (as applicable), except as disclosed on page 28 relating to Chemours' remediation activities at the Fayetteville Works Facility pursuant to the Consent Order with the North Carolina Department of Environmental Quality ("NC DEQ").
[4]	Represents liabilities that are subject to the $150 million threshold and sharing agreements as discussed on page 22, under the header "Chemours Separation Agreement (Performance Chemicals)."

Revenue Contract Balances (Details) - USD ($)
$ in Millions

9 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Dec. 31, 2023

Disaggregation of Revenue [Line Items]

Accounts and notes receivable - trade

^[1]

$ 5,501

$ 5,320

$ 4,329

Contract assets - current

^[2]

Contract assets - noncurrent

^[3]

Deferred Revenue

429

552

3,406

Deferred revenue recognized during the period

3,314

3,287

Other noncurrent obligations

Disaggregation of Revenue [Line Items]

Deferred Revenue

^[4]

$ 115

$ 109

$ 108

[1]	Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets.
[2]	Included in other current assets in the interim Consolidated Balance Sheets.
[3]	Included in other assets in the interim Consolidated Balance Sheets.
[4]	Included in other noncurrent obligations in the interim Consolidated Balance Sheets.

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Supplementary Information Other Income (Expense) - Net (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Sep. 30, 2023

Interest income

$ 33

$ 59

$ 93

$ 153

Equity in earnings (losses) of affiliates - net

(2)

Net gain (loss) on sales of businesses and other assets

Net exchange gains (losses)

^[1]

(97)

(102)

(234)

(242)

Non-operating pension and other post employment benefit credit

^[2]

(37)

(30)

(109)

(91)

Miscellaneous expenses - net

^[3]

(6)

(84)

(93)

(189)

Other income - net

(107)

(149)

(319)

(354)

Hedging Program [Member]

Net exchange gains (losses)

(35)

(60)

Hedging Program [Member] | Argentine Peso Devaluation [Member]

Net exchange gains (losses)

$ (26)

$ (83)

$ (54)

$ (150)

[1]	Includes net pre-tax exchange gains (losses) of $(26) million and $(54) million associated with impacts from the devaluation of the Argentine Peso for the three and nine months ended September 30, 2024, respectively, and $(83) million and $(150) million for the three and nine months ended September 30, 2023, respectively.
[2]	Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)).
[3]	The three and nine months ended September 30, 2024 includes tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont ("Tax Indemnification Adjustments"), while the nine months ended September 30, 2024 additionally includes the receipt of an indemnification payment negotiated with the prior Stoller owners and estimated settlement reserves. The three and nine months ended September 30, 2023 includes Tax Indemnification Adjustments and an adjustment to the Employee Retention Credit pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”) due to a change in estimate as well as estimated settlement reserves. The nine months ended September 30, 2023 also includes gains on the sale of assets, and a loss on the sale of the company's interest in an equity investment.

- Definition

Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.

+ References + Details

Financial Instruments (Details) $ in Millions	3 Months Ended	9 Months Ended
Financial Instruments (Details) $ in Millions	Sep. 30, 2024 USD ($)	Sep. 30, 2024 USD ($)
Schedule of Held-to-maturity Securities [Line Items]
Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss, Current	$ 55	$ 55
Debt Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-Sale, Unrealized Gain (Loss)	(13)	(1)
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five	103	103
Amortized Cost, Within One Year	17	17
Fair Value, Within One Year	16	16
Fair Value, one to five years	$ 90	$ 90

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

Segment Reporting (Notes)

9 Months Ended

Sep. 30, 2024

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

SEGMENT INFORMATION


As of and for the Three Months Ended September 30, (In millions)	Seed		Crop Protection		Total
2024
Net sales	$	691	$	1,635	$	2,326
Segment operating EBITDA	(320)		246		(74)
Segment assets1	22,192		14,895		37,087

2023
Net sales	$	878	$	1,712	$	2,590
Segment operating EBITDA	(138)		184		46
Segment assets1	22,829		15,446		38,275

1. Segment assets at December 31, 2023 were $22,732 million and $15,004 million for Seed and Crop Protection, respectively.


As of and for the Nine Months Ended September 30, (In millions)	Seed		Crop Protection		Total
2024
Net sales	$	7,773	$	5,157	$	12,930
Segment operating EBITDA	2,126		811		2,937


2023
Net sales	$	7,837	$	5,682	$	13,519
Segment operating EBITDA	1,972		1,107		3,079

Reconciliation to interim Consolidated Financial Statements


Income (loss) from continuing operations after income taxes to segment operating EBITDA	Three Months Ended September 30,				Nine Months Ended September 30,
(In millions)	2024		2023		2024		2023
Income (loss) from continuing operations after income taxes	$	(519)	$	(315)	$	913	$	1,172
Provision for (benefit from) income taxes on continuing operations	(114)		(129)		274		244
Income (loss) from continuing operations before income taxes	$	(633)	$	(444)	$	1,187	$	1,416
Depreciation and amortization	306		306		925		899
Interest income	(33)		(59)		(93)		(153)
Interest expense	66		58		173		171
Exchange (gains) losses	97		102		234		242
Non-operating (benefits) costs	50		28		132		115

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges	14		(44)		(4)		34
Significant items (benefit) charge	33		71		297		271

Corporate expenses	26		28		86		84
Segment operating EBITDA	$	(74)	$	46	$	2,937	$	3,079


Segment assets to total assets (In millions)	September 30, 2024		December 31, 2023		September 30, 2023
Total segment assets	$	37,087	$	37,736	$	38,275
Corporate assets	4,821		5,260		4,835
Total assets	$	41,908	$	42,996	$	43,110

Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA

The three and nine months ended September 30, 2024 and 2023, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA:


(In millions)	Seed		Crop Protection		Corporate		Total
For the Three Months Ended September 30, 2024
Restructuring and asset related charges - net1	$	(3)	$	(10)	$	(19)	$	(32)



Acquisition-related costs4	—		(1)		—		(1)

Total	$	(3)	$	(11)	$	(19)	$	(33)


(In millions)	Seed		Crop Protection		Corporate		Total
For the Three Months Ended September 30, 2023
Restructuring and asset related charges - net1	$	1	$	—	$	(3)	$	(2)
Estimated settlement expense2	—		(66)		—		(66)
Gain (loss) on sale of business, assets and equity investments3	4		—		—		4

Acquisition-related costs4	—		(7)		—		(7)

Total	$	5	$	(73)	$	(3)	$	(71)


(In millions)	Seed		Crop Protection		Corporate		Total
For the Nine Months Ended September 30, 2024
Restructuring and asset related charges - net1	$	(56)	$	(83)	$	(60)	$	(199)
Estimated settlement expense2	—		(101)		—		(101)
Inventory write-offs3	2		—		—		2
Gain (loss) on sale of assets3	4		3		—		7
Acquisition-related costs4	—		(6)		—		(6)

Total	$	(50)	$	(187)	$	(60)	$	(297)


(In millions)	Seed		Crop Protection		Corporate		Total
For the Nine Months Ended September 30, 2023
Restructuring and asset related charges - net1	$	(74)	$	(11)	$	(10)	$	(95)
Estimated settlement expense2	—		(156)		—		(156)
Inventory write-offs3	(7)		—		—		(7)
Gain (loss) on sale of business, assets and equity investments3	4		3		—		7
Seed sale associated with Russia Exit3,5	18		—		—		18
Acquisition-related costs4	—		(41)		—		(41)
Employee Retention Credit	—		3		—		3
Total	$	(59)	$	(202)	$	(10)	$	(271)

2.Consists of estimated Lorsban® related charges.

- Definition

+ References

+ Details

Inventories (Tables)

9 Months Ended

Sep. 30, 2024

Inventory Disclosure [Abstract]

Schedule of Inventory, Current [Table Text Block]


(In millions)	September 30, 2024		December 31, 2023		September 30, 2023
Finished products	$	2,399	$	3,273	$	2,786
Semi-finished products	2,785		2,775		2,690
Raw materials and supplies	490		851		844
Total inventories	$	5,674	$	6,899	$	6,320

Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service Cost	$ 3	$ 3	$ 12	$ 13
Interest Cost	162	171	488	518
Expected return on plan assets	(133)	(151)	(399)	(454)
Amortization of Prior Service Benefit	0	0	(2)	(2)
Settlement Loss (Gain)	1	1	1	1
Defined Benefit Plan, Net Periodic Benefit (Credit) Cost	33	24	100	76
Other Benefit Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service Cost	0	1	0	1
Interest Cost	11	12	31	36
Amortization of unrecognized loss (gain)	(3)	(2)	(9)	(7)
Amortization of Prior Service Benefit	(1)	(1)	(1)	(1)
Defined Benefit Plan, Net Periodic Benefit (Credit) Cost	$ 7	$ 10	$ 21	$ 29

Other Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets


	September 30, 2024						December 31, 2023						September 30, 2023
(In millions)	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Intangible assets subject to amortization (finite-lived):
Germplasm	$	6,291	$	(1,272)	$	5,019	$	6,291	$	(1,081)	$	5,210	$	6,291	$	(1,017)	$	5,274
Customer-related	2,413		(844)		1,569		2,427		(734)		1,693		2,403		(688)		1,715
Developed technology	1,838		(1,126)		712		1,849		(1,004)		845		1,845		(958)		887
Trademarks/trade names	2,056		(359)		1,697		2,111		(339)		1,772		2,110		(314)		1,796

Other1	388		(306)		82		395		(294)		101		395		(288)		107
Total other intangible assets with finite lives	12,986		(3,907)		9,079		13,073		(3,452)		9,621		13,044		(3,265)		9,779

Intangible assets not subject to amortization (indefinite-lived):
In-process research & development	5		—		5		5		—		5		16		—		16


Total other intangible assets with indefinite lives	5		—		5		5		—		5		16		—		16
Total other intangible assets	$	12,991	$	(3,907)	$	9,084	$	13,078	$	(3,452)	$	9,626	$	13,060	$	(3,265)	$	9,795

1.Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

Segment Reporting Segment Information (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Sep. 30, 2023

Dec. 31, 2023

Segment Reporting Information [Line Items]

Net Sales

$ 2,326

$ 2,590

$ 12,930

$ 13,519

Segment operating EBITDA

(74)

2,937

3,079

Total Assets

41,908

43,110

41,908

43,110

$ 42,996

Income (loss) from continuing operations after income taxes

(519)

(315)

913

1,172

Interest Expense

173

171

Income from continuing operations before income taxes

(633)

(444)

1,187

1,416

Interest income

153

Segments

Segment Reporting Information [Line Items]

Net Sales

2,326

2,590

Segment operating EBITDA

(74)

Total Assets

37,087

38,275

37,087

38,275

37,736

Segment Reconciling Items [Member]

Segment Reporting Information [Line Items]

Corporate Expenses

Interest income

(33)

(59)

(93)

(153)

EIDP

Segment Reporting Information [Line Items]

Net Sales

2,326

2,590

12,930

13,519

Segment operating EBITDA

(74)

2,937

3,079

Total Assets

43,413

43,327

43,413

43,327

43,373

Income (loss) from continuing operations after income taxes

(505)

(317)

942

1,155

Interest Expense

173

193

Income from continuing operations before income taxes

(615)

(446)

1,225

1,394

EIDP | Segment Reconciling Items [Member]

Segment Reporting Information [Line Items]

Corporate Expenses

Interest income

(51)

(59)

(131)

(153)

Seed [Member]

Segment Reporting Information [Line Items]

Net Sales

691

878

7,773

7,837

Seed [Member] | Segments

Segment Reporting Information [Line Items]

Net Sales

691

878

7,773

Segment operating EBITDA

(320)

(138)

2,126

1,972

Total Assets

22,192

^[1]

22,829

^[1]

22,192

^[1]

22,829

^[1]

22,732

Crop Protection [Member]

Segment Reporting Information [Line Items]

Net Sales

1,635

1,712

5,157

5,682

Crop Protection [Member] | Segments

Segment Reporting Information [Line Items]

Net Sales

1,635

Segment operating EBITDA

246

184

811

1,107

Total Assets

$ 14,895

^[1]

$ 15,446

$ 14,895

^[1]

$ 15,446

$ 15,004

[1]

Segment assets at December 31, 2023 were $22,732 million and $15,004 million for Seed and Crop Protection, respectively.


As of and for the Nine Months Ended September 30, (In millions)	Seed		Crop Protection		Total
2024
Net sales	$	7,773	$	5,157	$	12,930
Segment operating EBITDA	2,126		811		2,937


2023
Net sales	$	7,837	$	5,682	$	13,519
Segment operating EBITDA	1,972		1,107		3,079

Statement of Stockholders' Equity Parentheticals (Parentheticals) - $ / shares	3 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023
Common Stock, Dividends, Per Share, Declared	$ 0.17	$ 0.16	$ 0.16	$ 0.16	$ 0.15	$ 0.15
EIDP \| $4.50 Series Preferred Stock [Member]
Preferred Stock, Dividends Per Share, Declared	1.125	1.125	1.125	1.125	1.125	1.125
EIDP \| $3.50 Series Preferred Stock [Member]
Preferred Stock, Dividends Per Share, Declared	$ 0.875	$ 0.875	$ 0.875	$ 0.875	$ 0.875	$ 0.875

Other Intangible Assets Future Amortization Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 170	$ 174	$ 521	$ 508
Continuing Operations [Member]
Finite-Lived Intangible Assets [Line Items]
Pre-tax amortization expense, remainder of 2024	164		164
Pre-tax amortization expense, 2025	644		644
Pre-tax amortization expense, 2026	634		634
Pre-tax amortization expense, 2027	574		574
Pre-tax amortization expense, 2028	552		552
Pre-tax amortization expense, 2029	$ 529		$ 529

Income Taxes Income Tax Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Effective Income Tax Rate	18.00%	29.10%	23.10%	17.20%
Net Tax Benefits	$ 10	$ 11	$ 25	$ 79
Repurchase of Common Stock			$ 757	$ 585
Effective Income Tax Rate	18.00%	29.10%	23.10%	17.20%
EIDP
Income Tax Disclosure [Abstract]
Effective Income Tax Rate	17.90%	28.90%	23.10%	17.10%
Effective Income Tax Rate	17.90%	28.90%	23.10%	17.10%

Financial Instruments Effect of Derivative Instruments (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Sep. 30, 2023

Derivative Instruments, Gain (Loss) [Line Items]

Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]

Cost of Goods Sold

Gain (Loss) on Derivative Instruments, Net, Pretax

$ 45

$ (9)

$ (101)

$ (73)

Designated as Hedging Instrument [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax

(1)

(15)

(8)

(163)

Amount of gain (loss) recognized in Income - Pre-tax

^[1]

(12)

(16)

(38)

Designated as Hedging Instrument [Member] | Net Investment Hedging [Member] | Foreign Currency Contract [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax

(36)

(19)

Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Foreign Currency Contract [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax

(30)

Amount of gain (loss) recognized in Income - Pre-tax

^[1],[2]

(2)

(13)

(3)

(15)

Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Commodity Contract [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax

(26)

(18)

(133)

Amount of gain (loss) recognized in Income - Pre-tax

^[1],[2]

(10)

(3)

(35)

Not Designated as Hedging Instrument [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in income - pre-tax

(63)

(123)

Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Cost of Goods Sold

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in income - pre-tax

^[2]

(6)

(67)

Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Other Income - net

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in income - pre-tax

^[3]

(3)

(32)

(65)

Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Cost of Goods Sold

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in income - pre-tax

^[2],[4]

(41)

Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Other Income - net

Derivative Instruments, Gain (Loss) [Line Items]

Amount of gain (loss) recognized in income - pre-tax

^[3]

$ 1

$ 5

$ (2)

$ 5

[1]	For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.
[2]	Recorded in cost of goods sold in the interim Consolidated Statements of Operations.
[3]	Recognized in other income (expense). Note that net loss from foreign currency contracts was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 - Supplementary Information, to the interim Consolidated Financial Statements, for additional information.
[4]	The net gain (loss) relating to commodity contracts that are not designated as hedging instruments that were recorded in cost of goods sold, in the interim Consolidated Statements of Operations, are mostly offset by the related net gain (loss) on third-party grower contracts denominated as liabilities.

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Repurchase Facility and Revolving Credit Facilities (Details) $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Feb. 20, 2024 USD ($)	Dec. 31, 2023 USD ($)	May 01, 2023 USD ($)	Feb. 01, 2023 USD ($)
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	$ 5,750
Line of Credit Facility, Maximum Borrowing Capacity	5,750
Proceeds from debt	3,047	$ 3,427
Repayments of Long-term Debt	1,529	1,314
EIDP
Line of Credit Facility [Line Items]
Proceeds from debt	3,047	3,427
Repayments of Long-term Debt	1,529	1,314
Foreign Currency Loans
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	38
Revolving Credit Facilities due 2025 [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 2,000
Debt Instrument, Term	3 years
Revolving Credit Facilities due 2025 [Member] \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Line of Credit Facility [Line Items]
Adjusted Term SOFR	0.10%
Revolving Credit Facilities due 2027
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	$ 1,900
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,900
Debt Instrument, Term	3 years
Revolving Credit Facilities due 2027 \| EIDP
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 3,000
Debt Instrument, Term	5 years
Revolving Credit Facility
Line of Credit Facility [Line Items]
Ratio of Indebtedness to Net Capital	0.60
364-day Revolving Credit Facilities due 2023
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity					$ 1,000	$ 1,000
Ratio of Indebtedness to Net Capital	0.60
364-day Revolving Credit Facilities due 2023 \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Line of Credit Facility [Line Items]
Adjusted Term SOFR	0.10%
364-day Revolving Credit Facilities due 2025
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	$ 1,000
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,000		$ 1,000
Debt Instrument, Term	364 days
Securities Sold under Agreements to Repurchase [Member] \| 364-day Revolving Credit Facilities due 2023
Line of Credit Facility [Line Items]
Short-term borrowings	$ 0	$ 0		$ 0

Inventories Schedule of Inventory (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Inventory Disclosure [Abstract]
Finished Products	$ 2,399	$ 3,273	$ 2,786
Semi-finished Products	2,785	2,775	2,690
Raw Materials and Supplies	490	851	844
Total inventories	$ 5,674	$ 6,899	$ 6,320

Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	$ (3)	$ (2)	$ (10)	$ 61
Pension Plan
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	0	0	0	0
Other Benefit Plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	1	1	3	2
Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	$ (4)	$ (3)	$ (13)	$ 59

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

- Definition

Amount of tax expense (benefit) allocated to other comprehensive income (loss).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 12
-SubTopic 10
-Topic 220
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482790/220-10-45-12

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482765/220-10-50-4

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481674/830-30-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481694/830-30-45-17

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 20
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481694/830-30-45-20

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-10

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482659/740-20-45-11

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482659/740-20-45-2

+ Details

Stockholders' Equity Preferred Stock (Details) - EIDP - USD ($)	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
$4.50 Series Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	1,673,000	1,673,000	1,673,000
Preferred Stock, Redemption Amount	$ 120	$ 120	$ 120
Preferred Stock, Dividend Rate, Per-Dollar-Amount	$ 4.50
$3.50 Series Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	700,000	700,000	700,000
Preferred Stock, Redemption Amount	$ 102	$ 102	$ 102
Preferred Stock, Dividend Rate, Per-Dollar-Amount	$ 3.50
Corteva [Member]
Class of Stock [Line Items]
Ownership interest in an entity	100.00%

Commitments and Contingent Liabilities Other PFOA Matters / Fayetteville (Details) $ in Millions		3 Months Ended	9 Months Ended	12 Months Ended
	Jan. 31, 2021 USD ($)	Jun. 30, 2017 USD ($)	Sep. 30, 2024 USD ($) lawsuits	Dec. 31, 2023 USD ($)
Firefighting Foam [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number \| lawsuits			4,500
PFOA Matters: Multi-District Litigation [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party		$ 670.0
Chemours Contribution to MDL Settlement
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party	$ 29.0
NEW JERSEY \| Natural Resources Damages [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number			2
OHIO \| PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number \| lawsuits			2
Litigation Settlement, Amount Awarded to Other Party				$ 110.0
OHIO \| Corteva Contribution to Ohio NRD Settlement \| PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party			$ 16.0
NORTH CAROLINA \| PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Number of Property Owners			2,400
DELAWARE \| Natural Resources Damages [Member] \| Corteva [Member] \| DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Threshold for payments to fund the NRST Trust			$ 50.0
Supplemental payment threshold			$ 25.0
Period for supplemental payment			8 years
Estimated Litigation Liability			$ 4.0
Alabama Water Utility [Member] \| Natural Resources Damages [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number			1

EIDP Segment FN Segment Asset Reconciliation (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Segment Reporting Information [Line Items]
Total Assets	$ 41,908	$ 42,996	$ 43,110
EIDP
Segment Reporting Information [Line Items]
Total Assets	$ 43,413	$ 43,373	$ 43,327

- Definition

+ References

+ Details

Fair Value Measurements

9 Months Ended

Sep. 30, 2024

Fair Value Disclosures [Abstract]

Fair Value Disclosures [Text Block]

FAIR VALUE MEASUREMENTS

The following tables summarize the basis used to measure certain assets and liabilities at fair value on a recurring basis:


		September 30, 2024			December 31, 2023		September 30, 2023
(In millions)	Level 21			Level 21	Level 21
Assets at fair value:

Marketable securities		$	56		$	98	$	108
Debt securities:
Foreign government bonds2		106			—		—
Derivatives relating to:3
Foreign currency		105			83		52
Commodity contracts		5			5		1


Total assets at fair value		$	272		$	186	$	161
Liabilities at fair value:
Derivatives relating to:3
Foreign currency		$	87		$	61	$	94
Commodity contracts		4			14		6

Total liabilities at fair value		$	91		$	75	$	100

1.Reflects significant other observable inputs.

3.See Note 16 - Financial Instruments for the classification of derivatives in the interim Consolidated Balance Sheets.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Short-term borrowings and finance lease obligations (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Short-term Debt [Line Items]
Long-term Debt Payable within one year	$ 500	$ 196	$ 188
Finance Lease, Liability, Current	1	1	1
Short-term borrowings and finance lease obligations	3,741	198	3,609
Commercial Paper [Member]
Short-term Debt [Line Items]
Short-term borrowings	2,969	0	3,417
Other loans - various currencies [Member]
Short-term Debt [Line Items]
Short-term borrowings	271	1	3
364-day Revolving Credit Facilities due 2023 \| Securities Sold under Agreements to Repurchase [Member]
Short-term Debt [Line Items]
Short-term borrowings	$ 0	$ 0	$ 0

Commitments and Contingent Liabilities Guarantee Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Guarantor Obligations [Line Items]
Guarantee Obligations	$ 75	$ 84	$ 73
Greater than one year
Guarantor Obligations [Line Items]
Guarantee Obligations	15
Factoring Agreement [Member]
Guarantor Obligations [Line Items]
Guarantee Obligations	4	2	4
Agreements with lenders to provide financing for select customers [Member]
Guarantor Obligations [Line Items]
Accounts Receivable, after Allowance for Credit Loss	$ 598	$ 187	$ 492

Other Intangible Assets

9 Months Ended

Sep. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets Disclosure

OTHER INTANGIBLE ASSETS

The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows:


	September 30, 2024						December 31, 2023						September 30, 2023
(In millions)	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Intangible assets subject to amortization (finite-lived):
Germplasm	$	6,291	$	(1,272)	$	5,019	$	6,291	$	(1,081)	$	5,210	$	6,291	$	(1,017)	$	5,274
Customer-related	2,413		(844)		1,569		2,427		(734)		1,693		2,403		(688)		1,715
Developed technology	1,838		(1,126)		712		1,849		(1,004)		845		1,845		(958)		887
Trademarks/trade names	2,056		(359)		1,697		2,111		(339)		1,772		2,110		(314)		1,796

Other1	388		(306)		82		395		(294)		101		395		(288)		107
Total other intangible assets with finite lives	12,986		(3,907)		9,079		13,073		(3,452)		9,621		13,044		(3,265)		9,779

Intangible assets not subject to amortization (indefinite-lived):
In-process research & development	5		—		5		5		—		5		16		—		16


Total other intangible assets with indefinite lives	5		—		5		5		—		5		16		—		16
Total other intangible assets	$	12,991	$	(3,907)	$	9,084	$	13,078	$	(3,452)	$	9,626	$	13,060	$	(3,265)	$	9,795

1.Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $170 million and $521 million for the three and nine months ended September 30, 2024, respectively, and $174 million and $508 million for the three and nine months ended September 30, 2023, respectively. The current estimated aggregate pre-tax amortization expense from continuing operations for the remainder of 2024 and each of the next five years is approximately $164 million, $644 million, $634 million, $574 million, $552 million and $529 million, respectively.

EIDP - Related Party Transactions (Notes)	9 Months Ended
EIDP - Related Party Transactions (Notes)	Sep. 30, 2024
EIDP
Related Party Transaction [Line Items]
Related Party Transactions Disclosure [Text Block]	RELATED PARTY TRANSACTIONS Transactions with Corteva In the second quarter of 2019, EIDP entered into a related party revolving loan from Corteva, Inc., with a maturity date in 2024. EIDP repaid the outstanding related party revolving loan balance during the fourth quarter of 2023. As of September 30, 2023, the outstanding related party loan balance was $115 million (which approximates fair value), with an interest rate of 7.00%. The balance at September 30, 2023 was reflected as short-term borrowings - related party in EIDP's interim Consolidated Balance Sheets. Additionally, EIDP incurred interest expense of $2 million and $22 million for the three and nine months ended September 30, 2023, respectively, associated with the related party loan from Corteva, Inc., net of interest income earned from the below-noted Master In-House Banking Agreement. EIDP and Corteva, including certain consolidated subsidiaries (collectively the “Participating Companies”), are party to a Master In-House Banking Agreement, which established banking arrangements to facilitate the management of the cash and liquidity needs of the Participating Companies. EIDP had receivables from Corteva, Inc. of $1,505 million, $377 million, and $217 million related to this agreement included in other assets in EIDP's interim Consolidated Balance Sheets as of September 30, 2024, December 31, 2023, and September 30, 2023 respectively. Additionally, EIDP earned interest income from Corteva, Inc. of $18 million and $38 million under this agreement for the three and nine months ended September 30, 2024, respectively, which is reflected as other income (expense) - net in EIDP's interim Consolidated Statements of Operations. As of September 30, 2024, December 31, 2023 and September 30, 2023, EIDP had payables to Corteva, Inc., of $19 million, $30 million and $38 million included in accrued and other current liabilities, respectively, and $141 million, $106 million and $108 million, included in other noncurrent obligations, respectively, in the interim Consolidated Balance Sheets related to Corteva's indemnification liabilities to Dow and DuPont per the Separation Agreements (refer to page 23 of the Corteva, Inc. interim Consolidated Financial Statements for further details of the Separation Agreements).

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(e))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//850/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-6

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

+ Details

Consolidated Balance Sheets (Parentheticals) - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Common Stock, Par Value	$ 0.01	$ 0.01	$ 0.01
Common Stock, Shares Authorized	1,666,667,000	1,666,667,000	1,666,667,000
Common Stock, Shares, Outstanding	689,170,000	701,260,000	704,880,000
EIDP
Common Stock, Par Value	$ 0.30	$ 0.30	$ 0.30
Common Stock, Shares Authorized	1,800,000,000	1,800,000,000	1,800,000,000
Common Stock, Shares, Outstanding	200	200	200
EIDP \| $4.50 Series Preferred Stock [Member]
Preferred Stock, Par Value	$ 0	$ 0	$ 0
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	1,673,000	1,673,000	1,673,000
Preferred Stock, Redemption Amount	$ 120	$ 120	$ 120
EIDP \| $3.50 Series Preferred Stock [Member]
Preferred Stock, Par Value	$ 0	$ 0	$ 0
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	700,000	700,000	700,000
Preferred Stock, Redemption Amount	$ 102	$ 102	$ 102

Recent Accounting Guidance	9 Months Ended
Recent Accounting Guidance	Sep. 30, 2024
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Guidance	RECENT ACCOUNTING GUIDANCE Recently Adopted Accounting Guidance In August 2023, the FASB issued ASU 2023-05, Business Combinations—Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement. The amendments in this ASU are intended to facilitate consistency in the application of accounting guidance upon the formation of entities qualifying as joint ventures. It generally requires the use of business combinations accounting at the joint venture formation date, which would result in the contributed assets/liabilities being revalued to fair value and potentially result in the recognition of goodwill and other intangible assets on the joint venture’s financial statements. It does not alter the ongoing accounting for the joint venture’s operations. This guidance is effective for joint ventures with formation dates on or after January 1, 2025. Prospective application is required, with early adoption permitted. Retrospective application can be elected for joint ventures formed before January 1, 2025. Beginning in the third quarter of 2024, newly-formed joint ventures have applied this guidance. Accounting Guidance Issued But Not Adopted as of September 30, 2024 In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU requires that an entity disclose specific categories in the effective tax rate reconciliation as well as reconciling items that meet a quantitative threshold. Further, the ASU requires additional disclosures on income tax expense and taxes paid, net of refunds received, by jurisdiction. The new standard is effective for annual periods beginning after December 15, 2024 on a prospective basis with the option to apply it retrospectively. Early adoption is permitted. The adoption of this guidance will result in the company being required to include enhanced income tax related disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This ASU includes amendments that expand the existing reportable segment disclosure requirements and requires disclosure of (i) significant expense categories and amounts by reportable segment as well as the segment’s profit or loss measure(s) that are regularly provided to the chief operating decision maker (the “CODM”) to allocate resources and assess performance; (ii) how the CODM uses each reported segment profit or loss measure to allocate resources and assess performance; (iii) the nature of other segment balances contributing to reported segment profit or loss that are not captured within segment revenues or expenses; and (iv) the title and position of the individual or name of the group or committee identified as the CODM. This guidance requires retrospective application to all prior periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The company will adopt this guidance upon its effective date and will include enhanced disclosures relating to its reportable segments for all subsequent annual and interim periods.

- Definition

The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480016/944-40-65-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480016/944-40-65-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480016/944-40-65-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480016/944-40-65-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (h)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480016/944-40-65-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 5
-Subparagraph (SAB Topic 11.M.Q2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480530/250-10-S99-5

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (i)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480528/815-20-65-6

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 842
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 5
-Subparagraph (f)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479832/842-10-65-5

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 842
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 5
-Subparagraph (f)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479832/842-10-65-5

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (c)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483550/848-10-65-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479343/105-10-65-6

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 8
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482615/740-10-65-8

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 8
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482615/740-10-65-8

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 8
-Subparagraph (e)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482615/740-10-65-8

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482833/825-10-65-6

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482833/825-10-65-6

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (e)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482833/825-10-65-6

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479654/326-10-65-4

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479654/326-10-65-4

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 926
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (f)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483194/926-20-65-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 926
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483194/926-20-65-2

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 926
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (f)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483194/926-20-65-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480530/250-10-S99-6

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-1

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-1

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 250
-Publisher FASB
-URI https://asc.fasb.org//250/tableOfContent

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (d)(1)
-SubTopic 20
-Topic 310
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481925/310-20-65-2

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (d)(2)
-SubTopic 20
-Topic 310
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481925/310-20-65-2

+ Details

Accounts and Notes Receivable (Notes)

9 Months Ended

Sep. 30, 2024

Accounts and Notes Receivable [Abstract]

Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

ACCOUNTS AND NOTES RECEIVABLE - NET


(In millions)	September 30, 2024		December 31, 2023		September 30, 2023
Accounts receivable – trade1	$	4,260	$	4,210	$	4,013
Notes receivable – trade1,2	1,241		119		1,307
Other3	1,150		1,159		1,261
Total accounts and notes receivable - net	$	6,651	$	5,488	$	6,581

1.Accounts and notes receivable – trade are net of allowances of $188 million, $205 million and $201 million at September 30, 2024, December 31, 2023 and September 30, 2023, respectively.

Accounts and notes receivable are carried at the expected amount to be collected, which approximates fair value. The company establishes the allowance for doubtful receivables using a loss-rate method where the loss rate is developed using past events, historical experience, current conditions and forecasts that affect the collectability of the financial assets.

The following table summarizes changes in the allowance for doubtful receivables for the nine months ended September 30, 2024 and 2023:


(In millions)
2023
Balance at December 31, 2022	$	194
Net provision for credit losses	10
Other - net of write-offs charged against allowance	(3)
Balance at September 30, 2023	$	201
2024
Balance at December 31, 2023	$	205
Net provision for credit losses	31
Other - net of write-offs charged against allowance	(48)
Balance at September 30, 2024	$	188

The company enters into various factoring agreements with third-party financial institutions to sell its trade receivables under both recourse and non-recourse agreements in exchange for cash proceeds. These financing arrangements result in a transfer of the company's receivables and risks to the third party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are derecognized from the interim Consolidated Balance Sheets upon transfer, and the company receives a payment for the receivables from the third party within a mutually agreed upon time period. For arrangements involving an element of recourse, which is typically provided through a guarantee of accounts in the event of customer default, the guarantee obligation is measured using market data from similar transactions and reported as a current liability in the interim Consolidated Balance Sheets.

Trade receivables sold under these agreements were $51 million and $118 million for the three and nine months ended September 30, 2024, respectively, and $57 million and $100 million for the three and nine months ended September 30, 2023, respectively. The trade receivables sold that remained outstanding under these agreements which include an element of recourse as of September 30, 2024, December 31, 2023 and September 30, 2023 were $17 million, $2 million and $19 million, respectively. The net proceeds received are included in cash provided by (used for) operating activities in the interim Consolidated Statements of Cash Flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in other income (expense) - net, in the interim Consolidated Statements of Operations. The loss on sale of receivables was $5 million and $8 million for the three and nine months ended September 30, 2024, respectively, and $4 million and $17 million for the three and nine months ended September 30, 2023, respectively. See Note 13 - Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements, for additional information on the company’s guarantees.

Business Combinations and Asset Acquisitions	3 Months Ended
Business Combinations and Asset Acquisitions	Sep. 30, 2024
Business Combination and Asset Acquisition [Abstract]
Business Combination Disclosure	BUSINESS COMBINATIONS On March 1, 2023 ("Acquisition Date"), Corteva completed the acquisitions of all the outstanding equity interests in Stoller Group, Inc. (“Stoller”), one of the largest independent companies in the Biologicals industry, and Quorum Vital Investment, S.L. and its affiliates (“Symborg”), an expert in microbiological technologies. The purchase price for Stoller and Symborg was $1,220 million, inclusive of a working capital adjustment, and $370 million, respectively. These acquisitions supplement the Crop Protection business with additional biological tools that complement evolving farming practices. The company finalized the purchase price allocation and assessment of the fair value of the assets acquired and liabilities assumed as of the Acquisition Date in the first quarter of 2024. There were no material adjustments recognized during the measurement period. For additional information regarding the acquisition of Stoller and Symborg, see Note 4 - Business Combinations, to the Consolidated Financial Statements, in the company's 2023 Annual Report.

Financial Instruments Notional Amounts (Details) € in Millions, $ in Millions	Sep. 30, 2024 USD ($)	Jul. 31, 2024 EUR (€)	May 31, 2024 EUR (€)	Feb. 29, 2024 EUR (€)	Dec. 31, 2023 USD ($)	Sep. 30, 2023 USD ($)	Mar. 31, 2020 EUR (€)
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount \| $	$ 1,305				$ 1,600	$ 2,199
Designated as Hedging Instrument [Member] \| Foreign Currency Contract [Member] \| Net Investment Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount \| €		€ 500	€ 500	€ 1,200			€ 450